Bilateral Microtia-Deafness-Cleft Palate Syndrome

Mendelian MONDO:0012854 Pathograph 35 Show in embeddings browser congenital malformation of the ear neurocristopathy hereditary disease

HOXA2-related bilateral microtia is a developmental ear-malformation spectrum with autosomal recessive and dominant presentations. A homozygous homeodomain p.Gln186Lys allele in an Iranian family is associated with grade II bilateral microtia, severe to profound mixed hearing impairment and partial cleft palate. Heterozygous truncating alleles cause dominant bilateral microtia with variable hearing impairment; mixed loss is documented in a dominant family, whereas examined members of another family had normal hearing. These allelic presentations are retained as separate subtypes of the same entry. HOXA2 assigns second-pharyngeal-arch identity and supports auricular and middle-ear development. Mouse null and conditional experiments establish dose- and timing-sensitive developmental functions, but do not demonstrate that human ossicular malformations reproduce the complete homeotic transformation of a mouse null. Most of the auricle is linked to second-arch mesenchyme; descriptions that include the tragus and auricular root require first-arch contributions to be considered. Haploinsufficiency is an inferred mechanism for dominant truncating alleles, with impaired HMX1 enhancer activation shown in reporter assays for p.Lys213* and p.Gln235*. Residual function of p.Gln186Lys and the relative contributions of tongue mechanics and intrinsic palatal fusion to the human cleft remain unresolved.

Ask OpenScientist

Ask a research question about Bilateral Microtia-Deafness-Cleft Palate Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

2
Inheritance
9
Pathophys.
10
Phenotypes
3
Gaps
35
Pathograph
1
Genes
4
Variants
6
Medical Actions
2
Subtypes
1
Differentials
7
Models
15
References
1
Deep Research
👪

Inheritance

2
Autosomal recessive HP:0000007
Homozygosity for the HOXA2 homeodomain missense p.Q186K in a consanguineous Iranian family, mapped by genome-wide linkage to 7p14.3-p15.3.
Autosomal recessive inheritance
Show evidence (1 reference)
PMID:18394579 SUPPORT Human Clinical
"We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
Recessive segregation in a consanguineous pedigree establishes the biallelic mode for this subtype.
Autosomal dominant HP:0000006
Heterozygous truncating HOXA2 variants segregate with bilateral microtia in multigeneration pedigrees. Hearing impairment is variable, so auricular morphology and audiology both contribute to family assessment.
Autosomal dominant inheritance
Show evidence (2 references)
PMID:23775976 SUPPORT Human Clinical
"The HOXA2 variant was segregated with microtia and hearing loss in the family and was not seen in 6,500 individuals sequenced by the NHLBI Exome Sequencing Project or in 218 control individuals sequenced in this study."
Co-segregation with the trait plus absence from large control sets supports the dominant allele's causality.
PMID:27503514 SUPPORT Human Clinical
"In our family, sequence analysis detected a heterozygous protein truncating nonsense variant"
Full segregation of a second heterozygous truncating allele in an independent family.
◆

Subtypes

2
Autosomal recessive microtia, hearing impairment and cleft palate (HOXA2 p.Q186K)
HOXA2 hgnc:5103 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in HOXA2 (hgnc:5103). hgnc:5103 is a gene from the HUGO Gene Nomenclature Committee.
The original consanguineous Iranian family has homozygous p.Gln186Lys with bilateral microtia, prelingual severe to profound mixed hearing impairment and partial cleft palate. Three examined relatives had marked canal stenosis and ossicular abnormalities; one had unilateral inner-ear agenesis. These observations do not establish universal features of all biallelic HOXA2 variants.
Show evidence (1 reference)
PMID:18394579 SUPPORT Human Clinical
"We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
Defines the recessive subtype's three-component phenotype in the family the disease concept is named for.
Autosomal dominant nonsyndromic bilateral microtia (HOXA2 haploinsufficiency)
HOXA2 hgnc:5103 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in HOXA2 (hgnc:5103). hgnc:5103 is a gene from the HUGO Gene Nomenclature Committee.
Heterozygous truncating HOXA2 variants segregate with dominant bilateral microtia. Hearing varies among families: the p.Gln235* family studied by Brown and colleagues includes mild to severe mixed loss, whereas the examined p.Glu224* family members had normal hearing. The characterized dominant families do not show the cleft-palate presentation of the original recessive family. Haploinsufficiency is proposed; transcript decay and an exact reduction in patient protein abundance were not measured in these reports.
Show evidence (2 references)
PMID:23775976 SUPPORT Human Clinical
"Our data extend these conclusions and define HOXA2 haploinsufficiency as the first genetic cause for autosomal-dominant nonsyndromic microtia."
Establishes the dominant, haploinsufficiency-driven subtype.
PMID:27503514 SUPPORT Human Clinical
"Here we describe a five-generation family with isolated bilateral microtia segregating as an autosomal dominant trait."
A second, independent dominant family in which the microtia is isolated.
?

Discussions and Knowledge Gaps

3
Why does complete Hoxa2 loss kill mice at birth with a full second-to-first arch homeotic transformation, while human HOXA2 loss-of-function alleles produce a viable, largely isolated ear malformation?
HUMAN MODEL MISMATCH hoxa2_mouse_null_lethality_vs_human_viability
The complete mouse null is perinatally lethal with extensive skeletal homeosis, whereas characterized human heterozygous truncating and homozygous p.Gln186Lys genotypes are viable. Dose, developmental timing and species differences may contribute. Mouse hypomorphic alleles establish dose sensitivity, but residual activity of the human missense allele was not measured in the founding study. Human ossicular dysplasia therefore should not be described as proven partial homeotic duplication.
Show evidence (3 references)
PMID:7903600 SUPPORT Model Organism
"Mice homozygous for a targeted mutation of the Hoxa-2 (Hox 1.11) gene are born with cleft palates and die within 24 hr of birth."
The lethal mouse null phenotype at one end of the mismatch.
PMID:27503514 SUPPORT Human Clinical
"Here we describe a five-generation family with isolated bilateral microtia segregating as an autosomal dominant trait."
A five-generation pedigree of viable, isolated human disease at the other end of the mismatch.
PMID:24067355 SUPPORT Model Organism
"In mice, Hoxa2 inactivation at early gestational stages results in external auditory canal (EAC) duplication and absence of the auricle, whereas its late inactivation results in a hypomorphic auricle, mimicking the human HOXA2 mutant condition."
Shows that timing of Hoxa2 loss alone spans much of the severity gap, which is part of the candidate resolution.
What explains the sensorineural component of hearing loss in HOXA2-affected ears without demonstrated inner-ear agenesis?
KNOWLEDGE GAP hoxa2_sensorineural_component_unexplained
The original recessive family includes one left inner-ear agenesis confirmed by CT and MRI, while two other examined relatives had normal inner-ear structures despite mixed hearing loss. Mixed loss also occurs in the p.Gln235* dominant family. Thus the gap is not absence of any human inner-ear characterization: the unresolved question is why sensorineural dysfunction occurs in other ears, and how it relates to HOXA2 development.
Show evidence (3 references)
"The inner-ear structures were normal in patients V: 2 and V: 3, but there were no inner-ear structures on the left side for IV: 3."
Unilateral inner-ear agenesis in one recessive-family member, with normal inner-ear anatomy in the other two imaged relatives.
PMID:23775976 SUPPORT DIRECT Human Clinical
"Audiometric testing was performed on three of the affected family members and showed mild to severe bilateral mixed hearing loss (Fig. 1C)."
Direct dominant-family audiology. The figure caption includes a mild conductive-only left ear in one relative, so not every tested ear had both components.
"All four affected family individuals showed bilateral symmetric severe to profound mixed hearing impairment affecting all frequencies and leading to a flat audiometric shape."
The four affected members of the original recessive family; this severity should not be transferred to all dominant cases.
Is the Hoxa2-associated cleft palate secondary to abnormal tongue musculature, intrinsic to the palatal shelves, or both?
CONTROVERSY hoxa2_cleft_palate_tongue_versus_intrinsic_palate
Two mouse accounts are on record and they are not the same claim. Barrow and Capecchi report that mis-attachment of the hyoglossus correlates exactly with cleft palate in Hoxa2 mutants and suggest that the resulting tongue posture blocks the shelves, with a genetic rescue in Hoxa1/Hoxa2 double mutants as support. Smith and colleagues report Hoxa2 expression in the palate itself and reduced fusion of Hoxa2-null shelves cultured without a tongue, and conclude explicitly that the cleft is not solely due to the tongue musculature. The two are compatible - a mechanical obstruction and a shelf-intrinsic fusion defect could both contribute - but their relative contribution has not been quantified, and neither has been examined in a HOXA2-mutant patient, in whom the cleft is partial rather than complete. Until that is settled, this entry carries both nodes and asserts neither as the mechanism of the human cleft.
Show evidence (3 references)
PMID:10529419 SUPPORT Model Organism
"We suggest that the hyoglossus, whose function is to depress the lateral edges of the tongue, when unable to make its proper attachment to the greater horn of the hyoid, forces the tongue to adopt an abnormal posture which blocks closure of the palatal shelves."
The tongue-musculature position, in its authors' own hedged wording.
PMID:19653318 SUPPORT BACKGROUND Model Organism
"The cleft palate exhibited by Hoxa2 null murine embryos has been described as being secondary to abnormalities of tongue musculature, and Hoxa2 was presumed to not play a direct role in palate development."
The second group's statement of the prior position, which is what they set out to test.
PMID:19653318 SUPPORT Model Organism
"These results demonstrate the cleft palate phenotype of Hoxa2 null embryos is not solely due to abnormal tongue musculature, and indicate a direct role of Hoxa2 in regulating murine palatogenesis."
The palate-intrinsic position, stated as a conclusion.
⚙

Pathophysiology

9
HOXA2 Loss of Function
Disease-associated alleles include heterozygous truncating variants p.Lys213*, p.Glu224* and p.Gln235*, and the recessive homeodomain missense p.Gln186Lys. Dominant haploinsufficiency is inferred from segregation and variant class, with impaired enhancer activation measured for two truncating alleles. The p.Gln186Lys DNA-binding effect is a homology-model prediction; the founding study did not measure residual protein activity or show functional complementation.
HOXA2 hgnc:5103 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves HOXA2 (hgnc:5103). hgnc:5103 is a gene from the HUGO Gene Nomenclature Committee.
anterior/posterior pattern specification GO:0009952 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal anterior/posterior pattern specification (GO:0009952). GO:0009952 is a biological process from the Gene Ontology. ⚠ ABNORMAL
DNA-binding transcription factor activity GO:0003700 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves DNA-binding transcription factor activity (GO:0003700), qualified as loss of function. GO:0003700 is a molecular function from the Gene Ontology. ⇓ LOSS OF FUNCTION
Show evidence (3 references)
PMID:23775976 SUPPORT Human Clinical
"Exome sequencing of affected family members detected only seven shared, rare, heterozygous, nonsynonymous variants, including one protein truncating variant, a HOXA2 nonsense change (c.703C>T, p.Q235*)."
Identifies the truncating allele class underlying the dominant form.
PMID:18394579 SUPPORT Human Clinical
"Subsequent DNA sequence analysis of the HOXA1 and HOXA2 homeobox genes from the candidate region identified an interesting HOXA2 homeodomain variant: a change in a highly conserved amino acid (p.Q186K)."
Identifies the recessive homeodomain missense allele.
PMID:18394579 SUPPORT INDIRECT Computational
"In the model of the mutant homeodomain, the position of the mutant lysine side chain is consistently farther away from a nearby phosphate group; this altered position results in the loss of a hydrogen bond and affects the DNA-binding activity."
The DNA-binding consequence of p.Q186K is a homology-modelling prediction, not a measurement; recorded as computational and indirect.
Impaired Transactivation of the Long-Range HMX1 Enhancer
The p.Lys213* and p.Gln235* variants impair activation of a long-range HMX1 enhancer in dual-luciferase assays. Prior mouse work places Hoxa2 upstream of Hmx1 in ear development. The assay links these patient variants to a candidate effector, but does not measure the entire developmental pathway in human auricular tissue.
HOXA2 hgnc:5103 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves HOXA2 (hgnc:5103). hgnc:5103 is a gene from the HUGO Gene Nomenclature Committee.
ear morphogenesis GO:0042471 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal ear morphogenesis (GO:0042471). GO:0042471 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Show evidence (2 references)
PMID:32649979 SUPPORT BACKGROUND Model Organism
"In mouse, Hoxa2 can bind to a long-range enhancer and regulate expression of the Hmx1 gene, which is a crucial transcription factor in eye and ear development."
Establishes the HOXA2-HMX1 enhancer relationship; demonstrated in mouse.
PMID:32649979 SUPPORT DIRECT In Vitro
"Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation of the long-range enhancer of HMX1."
Direct reporter result for p.Lys213* and p.Gln235*; impairment is not equivalent to a proven null effect.
Loss of Second Pharyngeal Arch Neural Crest Identity
Hoxa2-null mouse embryos retain rhombomeric and neural crest segmentation but lose normal second-arch mesenchymal identity, producing first-arch-like skeletal derivatives. This supports an identity-assignment role. The cited abstract does not separately demonstrate normal migration, cell number or survival, and the complete-null result should not be equated with every human HOXA2 allele.
second-arch neural crest cell CL:0011012 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves second-arch neural crest cell, annotated with neural crest cell (CL:0011012). CL:0011012 is a cell type from the Cell Ontology.
neural crest cell development GO:0014032 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal neural crest cell development (GO:0014032). GO:0014032 is a biological process from the Gene Ontology. ⚠ ABNORMAL pharyngeal system development GO:0060037 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal pharyngeal system development (GO:0060037). GO:0060037 is a biological process from the Gene Ontology. ⚠ ABNORMAL
second pharyngeal arch UBERON:0003066 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in second pharyngeal arch, annotated with pharyngeal arch 2 (UBERON:0003066). UBERON:0003066 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:7903601 SUPPORT Model Organism
"While rhombomeric and neural crest cell (NCC) segmentation was not affected, mesenchymal NCC derivatives of the second arch were lacking, and second arch mesenchymal NCC identity was changed to first arch identity, resulting in homeotic transformation of second to first arch skeletal elements."
Direct mouse evidence for preserved segmentation with changed second-arch identity; migration and survival were not separately established by this quotation.
url:https://pmc.ncbi.nlm.nih.gov/articles/4143470/ SUPPORT DIRECT REVIEW SYNTHESIS Other
"By definition, the pinna encompasses all external structures of the ear, including the tragus and root."
This review qualifies the terminology of the mouse lineage claim; it is not a new lineage-tracing experiment.
Homeotic Transformation of Second-Arch Skeletal Derivatives
Hoxa2-null mice lose second-arch skeletal elements and develop duplicated first-arch structures, including middle-ear ossification centers and a second Meckel cartilage beside the otic capsule. This is a model-organism developmental phenotype. Human imaging and surgery establish ossicular dysplasia and fixation, but do not demonstrate this complete homeotic duplication. This node has no downstream human-phenotype links because the complete homeotic transformation is documented only in mice.
neural crest cell CL:0011012 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neural crest cell (CL:0011012). CL:0011012 is a cell type from the Cell Ontology.
embryonic cranial skeleton morphogenesis GO:0048701 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal embryonic cranial skeleton morphogenesis (GO:0048701). GO:0048701 is a biological process from the Gene Ontology. ⚠ ABNORMAL embryonic skeletal system morphogenesis GO:0048704 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal embryonic skeletal system morphogenesis (GO:0048704). GO:0048704 is a biological process from the Gene Ontology. ⚠ ABNORMAL
auditory ossicle UBERON:0001686 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in auditory ossicle, annotated with auditory ossicle bone (UBERON:0001686). UBERON:0001686 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:7903600 SUPPORT Model Organism
"Analysis of stained skeletons revealed that homozygous mutant animals contained multiple cranial skeletal defects, including a duplication of the ossification centers of the bones of the middle ear."
Documents the middle-ear skeletal consequence of the second-arch transformation.
PMID:7903600 SUPPORT Model Organism
"Skeletal elements normally derived from the second arch were absent in the mutants."
Confirms loss, not merely mis-shaping, of the second-arch skeletal derivatives.
Middle-Ear Ossicular Dysplasia
Malformed or fixed ossicles are documented directly in both recessive and dominant HOXA2 families. Recessive cases had a malformed chain apparently fixed by an incomplete atretic plate; dominant cases included abnormal stapes crura, absent stapedial tendon and a rigid chain. These observations support a conductive deficit without assuming mouse-like duplication in humans.
auditory ossicle bone UBERON:0001686 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in auditory ossicle bone (UBERON:0001686). UBERON:0001686 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (3 references)
"In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate."
CT findings in the three examined members of the recessive family; fixation was described as apparent on imaging.
PMID:23775976 SUPPORT DIRECT Human Clinical
"In individual II.2, the stapes was noted to have a thickened posterior crus and an absent anterior crus, and the stapedial tendon was absent."
Operative observation in one dominant-family member.
PMID:23775976 SUPPORT DIRECT Human Clinical
"Individual II.4 had a rigid ossicular chain."
Operative observation in another member of the same dominant family.
Failed Auricular Morphogenesis
The auricle fails to form normally. Timing determines severity in the mouse: early Hoxa2 inactivation abolishes the auricle and duplicates the external auditory canal, while late inactivation leaves a hypomorphic auricle resembling the human phenotype. Hoxa2 acts on pinna morphogenesis partly through BMP signalling and Eya1 expression.
ear morphogenesis GO:0042471 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal ear morphogenesis (GO:0042471). GO:0042471 is a biological process from the Gene Ontology. ⚠ ABNORMAL face morphogenesis GO:0060325 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal face morphogenesis (GO:0060325). GO:0060325 is a biological process from the Gene Ontology. ⚠ ABNORMAL
auricle UBERON:0001757 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in auricle, annotated with pinna (UBERON:0001757). UBERON:0001757 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:24067355 SUPPORT Model Organism
"In mice, Hoxa2 inactivation at early gestational stages results in external auditory canal (EAC) duplication and absence of the auricle, whereas its late inactivation results in a hypomorphic auricle, mimicking the human HOXA2 mutant condition."
Establishes both the auricular defect and its dependence on the timing of Hoxa2 loss.
PMID:24067355 SUPPORT Model Organism
"Hoxa2 partly controls the morphogenesis of the pinna through the BMP signalling pathway and expression of Eya1, which in humans is involved in branchio-oto-renal syndrome."
Names the downstream effectors through which HOXA2 shapes the pinna; the authors qualify this as partial control.
Mis-Attachment of the Extrinsic Tongue and Hyoid Muscles
In Hoxa2 mutant mice the attachments and trajectories of the extrinsic tongue and hyoid muscles are abnormal. The abnormal trajectory of two of them, the styloglossus and the stylohyoideus, blocks the attachment of the hyoglossus to the greater horn of the hyoid, and that blocked attachment correlated exactly with the presence of cleft palate in those animals. The node is mouse-derived; no comparable observation has been reported in HOXA2-mutant patients, in whom tongue and hyoid muscle anatomy has not been described.
muscle attachment GO:0016203 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal muscle attachment (GO:0016203). GO:0016203 is a biological process from the Gene Ontology. ⚠ ABNORMAL
extrinsic muscle of tongue UBERON:0001575 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in extrinsic muscle of tongue (UBERON:0001575). UBERON:0001575 is an anatomical location from the Uberon multi-species anatomy ontology. hyoglossus muscle UBERON:0001572 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in hyoglossus muscle (UBERON:0001572). UBERON:0001572 is an anatomical location from the Uberon multi-species anatomy ontology. hyoid bone greater horn UBERON:0003997 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in hyoid bone greater horn (UBERON:0003997). UBERON:0003997 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:10529419 SUPPORT Model Organism
"We also uncovered multiple defects in the attachments and trajectories of the extrinsic tongue and hyoid muscles in Hoxa2 mutants."
Records the muscle attachment and trajectory defects this node represents, in Hoxa2 mutants.
PMID:10529419 SUPPORT Model Organism
"the abnormal trajectory of two of these muscles, the styloglossus and the stylohyoideus, blocked the attachment of the hyoglossus to the greater horn of the hyoid, which in turn correlated exactly with the presence of cleft palate in Hoxa2 mutants"
Names the specific muscles involved and reports the exact correlation between the blocked hyoglossus attachment and cleft palate, which is the observation - as distinct from the interpretation on the next node.
Abnormal Tongue Posture Obstructing Palatal Shelf Closure
The proposed mechanical consequence, stated by its authors as a suggestion rather than an observation: with the hyoglossus unable to depress the lateral edges of the tongue, the tongue adopts an abnormal posture that blocks closure of the palatal shelves. It is not the only published account of the Hoxa2 cleft - see the hoxa2_cleft_palate_tongue_versus_intrinsic_palate discussion and the Intrinsic Palatal Shelf Fusion Defect node - and neither account has been tested in a human patient.
secondary palate development GO:0062009 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal secondary palate development (GO:0062009). GO:0062009 is a biological process from the Gene Ontology. ⚠ ABNORMAL
tongue UBERON:0001723 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in tongue (UBERON:0001723). UBERON:0001723 is an anatomical location from the Uberon multi-species anatomy ontology. secondary palatal shelf UBERON:0005619 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in secondary palatal shelf (UBERON:0005619). UBERON:0005619 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (1 reference)
PMID:10529419 SUPPORT Model Organism
"We suggest that the hyoglossus, whose function is to depress the lateral edges of the tongue, when unable to make its proper attachment to the greater horn of the hyoid, forces the tongue to adopt an abnormal posture which blocks closure of the palatal shelves."
The proposal this node represents, quoted in full so that its status as the authors' suggestion is visible in the evidence itself.
Intrinsic Palatal Shelf Fusion Defect
A second, independent route to the same cleft. Hoxa2 is expressed in the developing palate itself between E12.5 and E15.5, and Hoxa2-null palatal shelves cultured in the absence of the tongue fuse at lower rates than heterozygous or wild-type shelves, as do shelves in which Hoxa2 is knocked down with antisense constructs. Null palates show an overall increase in cell proliferation, and Hoxa2 represses Msx1, Bmp4, Barx1 and Ptx1 within the palate. On the authors' reading the mouse cleft is therefore not solely secondary to the tongue. Whether either route operates in HOXA2-mutant humans is unknown.
secondary palate development GO:0062009 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal secondary palate development (GO:0062009). GO:0062009 is a biological process from the Gene Ontology. ⚠ ABNORMAL
secondary palatal shelf UBERON:0005619 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in secondary palatal shelf (UBERON:0005619). UBERON:0005619 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (3 references)
PMID:19653318 SUPPORT Model Organism
"we detected Hoxa2 expression in the developing palate at both the mRNA and protein levels between embryonic day (E) 12.5 and E15.5"
Hoxa2 is expressed in the palate itself, the precondition for a route that does not run through the tongue.
PMID:19653318 SUPPORT In Vitro
"Organ cultures of Hoxa2(-/-) palates maintained in the absence of the tongue showed decreased fusion rates than either Hoxa2(+/-) or Hoxa2(+/+) palate cultures."
Palatal shelves fuse less well without Hoxa2 even when the tongue is removed from the system - explant culture, hence IN_VITRO.
PMID:19653318 SUPPORT Model Organism
"These results demonstrate the cleft palate phenotype of Hoxa2 null embryos is not solely due to abnormal tongue musculature, and indicate a direct role of Hoxa2 in regulating murine palatogenesis."
The authors' own conclusion that the tongue route is not the whole account, which is why this node is curated alongside it rather than instead of it.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Bilateral Microtia-Deafness-Cleft Palate Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

10
Ear 8
Bilateral Microtia HP:0008551 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bilateral microtia, annotated with Microtia (HP:0008551), qualified as laterality bilateral. HP:0008551 is a phenotype from the Human Phenotype Ontology.
Laterality: BILATERAL
Pedigree observations do not supply a population-level penetrance or frequency estimate.
Show evidence (5 references)
PMID:18394579 SUPPORT Human Clinical
"We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
Bilateral microtia in the recessive family.
PMID:23775976 SUPPORT Human Clinical
"We ascertained a three-generation family with bilateral microtia and hearing loss segregating as an autosomal dominant trait."
Bilateral microtia in the first dominant family.
PMID:27503514 SUPPORT Human Clinical
"Here we describe a five-generation family with isolated bilateral microtia segregating as an autosomal dominant trait."
Bilateral microtia in a second dominant family.
+ 2 more references
Hearing Impairment HP:0000365 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hearing impairment (HP:0000365). HP:0000365 is a phenotype from the Human Phenotype Ontology.
Normal hearing in an affected family member does not exclude dominant HOXA2-related microtia.
Show evidence (4 references)
PMID:23775976 SUPPORT Human Clinical
"We ascertained a three-generation family with bilateral microtia and hearing loss segregating as an autosomal dominant trait."
Hearing loss co-segregating in a dominant family.
PMID:32649979 SUPPORT BACKGROUND Human Clinical
"To date, only four HOXA2 mutations were reported in families with autosomal-recessive or dominant microtia, with or without hearing impairment."
The literature summary records hearing impairment as a variable rather than constant feature of HOXA2-related microtia.
PMID:23775976 SUPPORT DIRECT Human Clinical
"Audiometric testing was performed on three of the affected family members and showed mild to severe bilateral mixed hearing loss (Fig. 1C)."
Direct dominant-family audiology. The figure caption includes a mild conductive-only left ear in one relative, so not every tested ear had both components.
+ 1 more reference
Mixed Hearing Impairment HP:0000410 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Mixed hearing impairment (HP:0000410), qualified as laterality bilateral. HP:0000410 is a phenotype from the Human Phenotype Ontology.
Laterality: BILATERAL
The dominant-family figure also documents a conductive-only ear; severity and audiological subtype should be assessed per ear.
Show evidence (3 references)
PMID:18394579 SUPPORT Human Clinical
"We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
Specifies the mixed, symmetrical, severe-to-profound character of the recessive subtype's hearing loss.
PMID:23775976 SUPPORT DIRECT Human Clinical
"Audiometric testing was performed on three of the affected family members and showed mild to severe bilateral mixed hearing loss (Fig. 1C)."
Direct dominant-family audiology. The figure caption includes a mild conductive-only left ear in one relative, so not every tested ear had both components.
"All four affected family individuals showed bilateral symmetric severe to profound mixed hearing impairment affecting all frequencies and leading to a flat audiometric shape."
The four affected members of the original recessive family; this severity should not be transferred to all dominant cases.
External Auditory Canal Stenosis Stenosis of the external auditory canal HP:0000402 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Stenosis of the external auditory canal (HP:0000402), qualified as laterality bilateral. HP:0000402 is a phenotype from the Human Phenotype Ontology.
Laterality: BILATERAL
Show evidence (1 reference)
"The results of high-resolution CT scanning confirmed that the external auditory canal was severely narrowed bilaterally in the cartilaginous part of the auditory canal and almost atretic in part of the bony portion in all patients."
CT in the three examined recessive-family members, not every person with HOXA2-related disease.
Abnormal Middle-Ear Ossicles Abnormality of the middle ear ossicles HP:0004452 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormality of the middle ear ossicles (HP:0004452). HP:0004452 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
"In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate."
CT findings in the three examined members of the recessive family; fixation was described as apparent on imaging.
PMID:23775976 SUPPORT DIRECT Human Clinical
"In individual II.2, the stapes was noted to have a thickened posterior crus and an absent anterior crus, and the stapedial tendon was absent."
Operative observation in one dominant-family member.
PMID:23775976 SUPPORT DIRECT Human Clinical
"Individual II.4 had a rigid ossicular chain."
Operative observation in another member of the same dominant family.
Unilateral Inner-Ear Aplasia Aplasia of the inner ear HP:0011372 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Aplasia of the inner ear (HP:0011372), qualified as laterality left. HP:0011372 is a phenotype from the Human Phenotype Ontology.
Laterality: LEFT
Show evidence (1 reference)
"The inner-ear structures were normal in patients V: 2 and V: 3, but there were no inner-ear structures on the left side for IV: 3."
Unilateral inner-ear agenesis in one recessive-family member, with normal inner-ear anatomy in the other two imaged relatives.
Thickened Helices HP:0000391 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Thickened helices (HP:0000391). HP:0000391 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:23775976 SUPPORT DIRECT Human Clinical
"All five affected family members had small, malformed ears with a thickened helix and a superficial postauricular sulcus (Fig. 1B)."
Clinical morphology in five enrolled affected members of the p.Gln235* family.
Underdeveloped Antitragus HP:0011251 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Underdeveloped antitragus (HP:0011251). HP:0011251 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"underdeveloped antitragus, serpiginous antihelix stem, deep incisura between tragus and antitragus with a laterally dislocated hypoplastic lobe."
Proband morphology from the author thesis describing the same p.Glu224* pedigree later reported in PMID:27503514; this is not an additional family.
Head and Neck 2
Cleft Palate HP:0000175 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cleft palate (HP:0000175). HP:0000175 is a phenotype from the Human Phenotype Ontology.
The subtype association is based on a small number of characterized pedigrees; it is not a universal genotype-phenotype rule.
Show evidence (3 references)
PMID:18394579 SUPPORT Human Clinical
"We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
Partial cleft palate in the recessive family.
PMID:27503514 SUPPORT BACKGROUND Human Clinical
"HOXA2 biallelic mutations were also described in an inbreed family with autosomal recessive microtia, hearing impairment and incomplete cleft palate."
The later article summarizes the same recessive family; it does not provide independent replication of its cleft phenotype.
PMID:7903600 SUPPORT Model Organism
"Mice homozygous for a targeted mutation of the Hoxa-2 (Hox 1.11) gene are born with cleft palates and die within 24 hr of birth."
Cleft palate in the homozygous mouse null provides model evidence for developmental relevance; the abstract does not supply a penetrance denominator.
Unilateral Facial Paresis Unilateral facial palsy HP:0012799 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Unilateral facial palsy (HP:0012799), qualified as laterality right. HP:0012799 is a phenotype from the Human Phenotype Ontology.
Laterality: RIGHT
Show evidence (1 reference)
"Individual number V: 2 also had a paresis on the right side of the face."
Single affected relative; facial-nerve hypoplasia was suspected clinically but was not confirmed by brain MRI.
🧬

Genetic Associations

1
HOXA2 pathogenic variants (Causal)
Gene: HOXA2 hgnc:5103 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is HOXA2 (hgnc:5103). hgnc:5103 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (2 references)
PMID:18394579 SUPPORT Human Clinical
"Genome-wide linkage analysis localized the responsible gene to chromosome 7p14.3-p15.3 with a maximum multi-point LOD score of 4.17."
Linkage to the HOXA cluster interval is the mapping evidence that identified the gene.
PMID:32649979 SUPPORT Human Clinical
"Next generation sequencing identified two heterozygous nonsense HOXA2 mutations, one in each family."
Two independent families carrying heterozygous nonsense alleles; p.Gln235* recurs from an earlier pedigree.
Variants (4)
p.Q186K homeodomain missense (recessive) Pathogenic
Homozygous homeodomain missense p.Gln186Lys segregated in the original recessive family and was absent from the reported control panels. The founding paper predicts altered DNA binding by homology modeling but does not measure residual function. Protein notation avoids conflating historical nucleotide numbering with a normalized transcript-specific HGVS description.
Show evidence (1 reference)
PMID:18394579 SUPPORT Human Clinical
"The variant was not found in 231 Iranian and 109 Belgian control samples."
Control-panel absence supporting pathogenicity of p.Q186K.
p.Q235* nonsense (dominant) Pathogenic
A recurrent heterozygous nonsense allele, found independently in a three-generation US family and in one of the two Chinese families.
Show evidence (1 reference)
PMID:32649979 SUPPORT Human Clinical
"One mutation (c.637A > T, p.Lys213*) is newly reported, while the other one (c.703C > T,p.Gln235*) is consistent with a previous report."
Documents recurrence of p.Gln235* across unrelated families.
p.E224* nonsense (dominant) Pathogenic
A heterozygous truncating allele segregating in all affected members of a five-generation Italian family and absent from public databases.
Show evidence (2 references)
PMID:27503514 SUPPORT Human Clinical
"In our family, sequence analysis detected a heterozygous protein truncating nonsense variant"
Defines the allele and its segregation.
"Sanger analysis of the index patient (V:1) identified a previously unreported heterozygous variant ... NM_006735.3: c.670G>T, p.(Glu224*) ... in the second exon of the HOXA2 gene (Figure 17a)."
Primary thesis data identifying p.Glu224* in the same Italian pedigree as the journal article.
p.Lys213* nonsense (dominant) Pathogenic
Heterozygous p.Lys213* was found in one Chinese family; a dual-luciferase assay showed impaired HMX1 enhancer activation. The result supports loss of activity without establishing patient transcript decay.
Show evidence (2 references)
PMID:32649979 SUPPORT Human Clinical
"One mutation (c.637A > T, p.Lys213*) is newly reported, while the other one (c.703C > T,p.Gln235*) is consistent with a previous report."
Identifies the newly reported p.Lys213* allele and distinguishes it from recurrent p.Gln235*.
PMID:32649979 SUPPORT DIRECT In Vitro
"Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation of the long-range enhancer of HMX1."
Direct reporter result for p.Lys213* and p.Gln235*; impairment is not equivalent to a proven null effect.
💊

Medical Actions

6
Auricular Reconstruction
Action: auricular reconstructionNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is auricular reconstruction, annotated with Reconstructive Surgery (NCIT:C25351). NCIT:C25351 is a clinical intervention from the NCI Thesaurus. Ontology label: Reconstructive Surgery NCIT:C25351
Platform: Surgery
Discuss observation, an external prosthesis, autologous cartilage reconstruction and alloplastic reconstruction according to the individual goals and anatomy. Reconstruction is elective; coordinate its sequence with any hearing implant or canal surgery. The recommendations come from general microtia care, not a HOXA2 outcome series.
Mechanism Target:
BYPASSES Bilateral Microtia — Reconstruction changes the visible auricular manifestation; it does not reverse the prenatal HOXA2 patterning defect.
Show evidence (1 reference)
DOI:10.3389/fsurg.2022.944223 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"In discussing the spectrum of reconstructive options, observation should be presented with associated bene fits and drawbacks."
General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment effect is measured.
Show evidence (1 reference)
DOI:10.3389/fsurg.2022.944223 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"In discussing the spectrum of reconstructive options, observation should be presented with associated bene fits and drawbacks."
General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment effect is measured.
Cleft Palate Repair
Action: cleft palate repairNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is cleft palate repair, annotated with Palatorrhaphy (NCIT:C168380). NCIT:C168380 is a clinical intervention from the NCI Thesaurus. Ontology label: Palatorrhaphy NCIT:C168380
Platform: Surgery
For patients with cleft palate, craniofacial-team assessment determines whether and when palatoplasty is indicated. General ACPA guidance places primary repair commonly at 9–14 months and ideally by 18 months, with individual readiness and airway risk considered. The source supplies general care recommendations, not genotype-specific efficacy.
Mechanism Target:
BYPASSES Cleft Palate — Palatoplasty restores palatal continuity and function after the congenital cleft has formed; it does not correct the embryonic HOXA2 mechanism.
Show evidence (1 reference)
"The goal of cleft palate surgery is to obtain normal function for speech and swallowing, as well as to optimize airway and dental facial relations."
General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific outcomes.
Show evidence (2 references)
"The goal of cleft palate surgery is to obtain normal function for speech and swallowing, as well as to optimize airway and dental facial relations."
General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific outcomes.
"Primary surgery of cleft palate often occurs between 9-14 months of age. The timing should take into account the patient and/or family readiness (physically and emotionally). Ideally, the cleft palate should be closed by the age of 18 months."
General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific outcomes. Timing is individualized, rather than an outcome established for this genotype.
Hearing Amplification
Action: hearing amplificationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is hearing amplification, annotated with Supportive Care (NCIT:C15747), qualified as medical device hearing aid. NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
Platform: Device
Provide early hearing rehabilitation according to per-ear thresholds, canal anatomy and cochlear reserve. General bilateral microtia/atresia guidance recommends amplification by four months and early intervention by three to six months. Worn bone-conduction devices can bypass a narrowed or atretic canal; patients with patent canals may use conventional amplification if appropriate. Mixed loss requires assessment of the sensorineural component and device limits, rather than assuming normal cochlear function.
Mechanism Target:
BYPASSES Hearing Impairment — Amplification improves access to sound within the usable cochlear reserve. Bone conduction bypasses canal and middle-ear transmission abnormalities but does not repair inner-ear agenesis or restore intrinsic cochlear function.
Show evidence (1 reference)
DOI:10.3389/fsurg.2022.944223 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"Diagnostic audiological assessment should be completed by 2 – 3 months of age and the infant provided with hearing ampli fication by 4 months of age and enrolled in early intervention (EI) by 3 – 6 months of age to optimize speech and language development."
General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment effect is measured. The timing recommendation is for bilateral microtia with atresia.
Show evidence (2 references)
DOI:10.3389/fsurg.2022.944223 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"Diagnostic audiological assessment should be completed by 2 – 3 months of age and the infant provided with hearing ampli fication by 4 months of age and enrolled in early intervention (EI) by 3 – 6 months of age to optimize speech and language development."
General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment effect is measured. The timing recommendation is for bilateral microtia with atresia.
DOI:10.3389/fsurg.2022.944223 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"Clinicians should encourage early use of these worn bone conduction devices for infants with CHL."
General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment effect is measured.
Speech and Language Therapy
Action: speech and language therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is speech and language therapy, annotated with Speech Language Therapy (NCIT:C159273). NCIT:C159273 is a clinical intervention from the NCI Thesaurus. Ontology label: Speech Language Therapy NCIT:C159273
Platform: Behavioral / lifestyle
Assess speech and language development in either subtype when hearing impairment or a palatal defect is present. Coordinate early intervention, educational support and targeted therapy. Speech therapy can address learned articulation errors; structural velopharyngeal dysfunction requires a separate surgical or prosthetic assessment.
Show evidence (1 reference)
"The need for speech and/or language therapy for patients with a CL/P and/or other craniofacial difference, as well as the recommended nature of that therapy, should be based on results of a formal speech and language assessment and current best practices."
General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific outcomes.
Genetic Counseling
Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Platform: Behavioral / lifestyle
Discuss the identified genotype and variable phenotype with the family. When both parents carry a recessive pathogenic allele, each pregnancy has a 25% probability of an affected child; a heterozygous parent with a dominant pathogenic allele has a 50% transmission probability. These are Mendelian expectations conditional on parental genotypes, not empirically measured penetrance. Severity and hearing status cannot be predicted from transmission probability alone.
Show evidence (2 references)
PMID:23775976 SUPPORT INDIRECT Human Clinical
"Our data extend these conclusions and define HOXA2 haploinsufficiency as the first genetic cause for autosomal-dominant nonsyndromic microtia."
Supports the inheritance mode. The stated recurrence probability is the Mendelian consequence of the specified parental genotype, rather than a measured outcome in this pedigree.
PMID:18394579 SUPPORT INDIRECT Human Clinical
"We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
Supports the inheritance mode. The stated recurrence probability is the Mendelian consequence of the specified parental genotype, rather than a measured outcome in this pedigree.
Feeding and nutrition support for cleft palate
Action: Supportive CareNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. NCIT:C15747
Platform: Other
Assess feeding technique, intake, growth and hydration when cleft palate is present. A cleft team can select an appropriate specialized feeding system and monitor weight gain. This addresses the general functional risk of a cleft; a HOXA2-specific rate of feeding failure is not established.
Mechanism Target:
BYPASSES Cleft Palate — A specialized feeding system compensates for impaired suction without closing the cleft.
Show evidence (1 reference)
"Because infants with cleft palate cannot sustain the suction needed to maintain nutrition exclusively from the breast or standard bottle, they typically require specialized feeding systems to achieve adequate nutrition and hydration."
General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific outcomes. Feeding difficulty is a care risk, not an additional measured HOXA2 phenotype frequency.
Show evidence (1 reference)
"Because infants with cleft palate cannot sustain the suction needed to maintain nutrition exclusively from the breast or standard bottle, they typically require specialized feeding systems to achieve adequate nutrition and hydration."
General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific outcomes. Feeding difficulty is a care risk, not an additional measured HOXA2 phenotype frequency.
🔬

Diagnosis

3
Clinical and audiological examination
Inspect both auricles, ear canals, palate and facial movement, and obtain age-appropriate air- and bone-conduction hearing thresholds. Mixed loss can occur in either inheritance subtype, and a normal hearing result does not exclude dominant HOXA2 microtia. General microtia guidance recommends diagnostic ABR by two to three months, followed by behavioral assessment as development permits.
Show evidence (3 references)
PMID:18394579 SUPPORT Human Clinical
"We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
The clinical and audiological characterisation that defines the presentation.
DOI:10.3389/fsurg.2022.944223 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"A diagnostic ABR should be performed as early as possible."
General microtia diagnostic guidance, extrapolated to affected infants.
DOI:10.3389/fsurg.2022.944223 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"Air conduction and bone conduction testing should performed."
The source recommends testing both pathways; the quotation preserves its grammatical omission.
HOXA2 sequencing
Identify a phenotype-compatible HOXA2 variant through targeted sequencing, a relevant hearing/craniofacial panel or exome analysis, and test segregation where feasible. Interpret variant class, zygosity and family phenotype together; a rare missense finding alone is not diagnostic. Heterozygous truncating alleles and the original homozygous p.Gln186Lys allele have different inheritance and clinical associations.
Show evidence (2 references)
PMID:23775976 SUPPORT Human Clinical
"Exome sequencing of affected family members detected only seven shared, rare, heterozygous, nonsynonymous variants, including one protein truncating variant, a HOXA2 nonsense change (c.703C>T, p.Q235*)."
Exome sequencing as the diagnostic route in a dominant family.
PMID:23775976 SUPPORT DIRECT Human Clinical
"Both of these nonsynonymous changes affect leucine residues with high evolutionary conservation; however, each of these variants was also found in one control, indicating that either these variants are benign or that these variants in combination with another undetected HOXA2 variant (possibly..."
The study itself did not establish causality for every rare missense variant; the proposed second-variant explanation was untested.
Temporal-bone imaging when clinically indicated
CT characterizes canal narrowing, atretic plates and ossicles; MRI can assess inner-ear and neural anatomy. The original recessive family had both ossicular abnormalities and one unilateral inner-ear agenesis. General microtia guidance reserves routine reconstructive CT for surgical planning or suspected cholesteatoma rather than the newborn period; unusual mixed loss or neurologic findings require individualized specialist assessment.
Show evidence (2 references)
"The MRI of the auditory system in individual V: 3 was unremarkable for the inner ear and cerebellopontine angle, but an MRI confirmed the inner-ear agenesis on the left side of individual IV: 3 as seen on CT-images."
Human diagnostic imaging, with both normal and abnormal findings.
DOI:10.3389/fsurg.2022.944223 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"A CT scan of the temporal bone is not recommended in the newborn period."
General microtia imaging guidance; this does not preclude individualized imaging for a specific diagnostic concern.
📊

Prevalence

1
Worldwide
Cases In Literature
Published evidence consists of a small number of pedigrees. No HOXA2-specific population prevalence is established by these reports; all-cause microtia birth prevalence should not be assigned to this molecular disorder.
Show evidence (1 reference)
PMID:32649979 SUPPORT BACKGROUND Human Clinical
"To date, only four HOXA2 mutations were reported in families with autosomal-recessive or dominant microtia, with or without hearing impairment."
A time-specific literature summary illustrates sparse pedigree evidence; it does not establish a current worldwide family count or population prevalence.
🔀

Differential Diagnoses

1

Conditions with similar clinical presentations that must be differentiated from Bilateral Microtia-Deafness-Cleft Palate Syndrome:

🧫

Experimental Models

2
HOXA2 variant HMX1 enhancer reporter assay OTHER
Dual-luciferase assays compare enhancer activation by p.Lys213* and p.Gln235* variants. The accessible abstract does not specify the host-cell identity, so no cell-line or tissue origin is inferred.
Show evidence (1 reference)
PMID:32649979 SUPPORT DIRECT In Vitro
"Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation of the long-range enhancer of HMX1."
Variant-specific reporter assay for p.Lys213* and p.Gln235*.
Tongue-free Hoxa2 mutant palate organ culture OTHER
Null palatal shelves cultured without a tongue have reduced fusion; antisense Hoxa2 knockdown also reduces fusion. This demonstrates an intrinsic component in the mouse system alongside the separate tongue-mechanics hypothesis.
Show evidence (1 reference)
PMID:19653318 SUPPORT DIRECT In Vitro
"Organ cultures of Hoxa2(-/-) palates maintained in the absence of the tongue showed decreased fusion rates than either Hoxa2(+/-) or Hoxa2(+/+) palate cultures."
Tongue-free mouse organ culture isolates a palate-intrinsic contribution.
🐁

Animal Models

5
Hoxa2 null mouse (Rijli 1993)
Homozygous targeted disruption causes perinatal death and loss of normal second-arch mesenchymal identity despite preserved rhombomeric and neural crest segmentation. The source supports an identity defect; normal migration and survival are not separately demonstrated by the cached abstract.
Species
Mouse
Genotype
Hoxa2 homozygous null (targeted disruption)
Publication
Hoxa-2 null mouse (Gendron-Maguire 1993)
An independent null allele reported simultaneously. Homozygotes are born with cleft palate and die within 24 hours, with duplicated middle-ear ossification centres and a second Meckel's cartilage beside the otic capsule.
Species
Mouse
Genotype
Hoxa-2 (Hox 1.11) homozygous targeted mutation
Publication
Hoxa1/Hoxa2 double mutant mouse (Barrow 1999)
A single allele disrupting both linked genes, analysed against the single mutants. Some double-mutant craniofacial defects are additive combinations of the single-mutant ones and others appear only in the double mutant. The result that matters here is a rescue: compensatory defects associated with loss of Hoxa1 restore the hyoglossus attachment that is blocked in Hoxa2 mutants, and the penetrance of cleft palate falls sharply.
Species
Mouse
Genotype
Compound targeted allele disrupting both of the linked genes Hoxa1 and Hoxa2
Publication
Conditional Hoxa2 inactivation mouse (Minoux 2013)
Stage-specific conditional inactivation separates the auricular phenotype from the lethal null. Early inactivation abolishes the auricle and duplicates the external auditory canal; late inactivation yields a hypomorphic auricle that the authors take to mimic the human HOXA2 mutant condition. The reciprocal gain-of-function experiment - ectopic Hoxa2 in first-arch crest - duplicates the pinna and eliminates the canal.
Species
Mouse
Genotype
Conditional Hoxa2 inactivation at early versus late gestational stages, plus conditional ectopic Hoxa2 in first-arch neural crest
Publication
Hoxa2 hypomorphic dosage-series mouse
An allele with about 45% of wild-type transcriptional activity was combined with normal and null alleles to create a dosage series. Second-arch development was more sensitive than hindbrain patterning, and proximal-caudal arch regions were more sensitive than rostro-distal regions. This supports regional dose sensitivity without assigning a residual activity to a human variant.
Species
Mouse
Genotype
Hypomorphic Hoxa2 allele combined with wild-type or null alleles
Publication
Show evidence (2 references)
PMID:11578867 SUPPORT DIRECT Model Organism
"We have created a Hoxa2 allele that is about 45% as active in transcription as its wild-type counterpart."
Engineered mouse allele, not a measured residual level in a patient.
PMID:11578867 SUPPORT DIRECT Model Organism
"Analysis of these embryos indicates that in general the hindbrain is more resistant to Hoxa2 deficiencies than the second branchial arch."
Different embryonic regions respond differently to experimental Hoxa2 dose.
{ }

Source YAML

click to show
name: Bilateral Microtia-Deafness-Cleft Palate Syndrome
creation_date: "2026-09-03T00:00:00Z"
category: Mendelian
description: >-
  HOXA2-related bilateral microtia is a developmental ear-malformation spectrum with autosomal recessive and
  dominant presentations. A homozygous homeodomain p.Gln186Lys allele in an Iranian family is associated with
  grade II bilateral microtia, severe to profound mixed hearing impairment and partial cleft palate. Heterozygous
  truncating alleles cause dominant bilateral microtia with variable hearing impairment; mixed loss is documented
  in a dominant family, whereas examined members of another family had normal hearing. These allelic presentations
  are retained as separate subtypes of the same entry.

  HOXA2 assigns second-pharyngeal-arch identity and supports auricular and middle-ear development. Mouse null
  and conditional experiments establish dose- and timing-sensitive developmental functions, but do not demonstrate
  that human ossicular malformations reproduce the complete homeotic transformation of a mouse null. Most of
  the auricle is linked to second-arch mesenchyme; descriptions that include the tragus and auricular root
  require first-arch contributions to be considered. Haploinsufficiency is an inferred mechanism for dominant
  truncating alleles, with impaired HMX1 enhancer activation shown in reporter assays for p.Lys213* and p.Gln235*.
  Residual function of p.Gln186Lys and the relative contributions of tongue mechanics and intrinsic palatal
  fusion to the human cleft remain unresolved.
disease_term:
  preferred_term: bilateral microtia-deafness-cleft palate syndrome
  term:
    id: MONDO:0012854
    label: bilateral microtia-deafness-cleft palate syndrome
parents:
- congenital malformation of the ear
- neurocristopathy
- hereditary disease
synonyms:
- microtia, hearing impairment, and cleft palate
- microtia with or without hearing impairment
- HOXA2-related microtia
- MHIC
references:
- reference: PMID:18394579
  title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
- reference: PMID:23775976
  title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
- reference: PMID:27503514
  title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
- reference: PMID:32649979
  title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.

- reference: DOI:10.3389/fsurg.2022.944223
  title: Integrated microtia and aural atresia management
- reference: PMID:10529419
  title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
- reference: PMID:11578867
  title: Different levels of Hoxa2 are required for particular developmental processes.
- reference: PMID:19653318
  title: Hoxa2 plays a direct role in murine palate development.
- reference: PMID:24067355
  title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
- reference: PMID:7903600
  title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
- reference: PMID:7903601
  title: A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene.
- reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
  title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
- reference: url:https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
  title: https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
  title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
- reference: url:https://pmc.ncbi.nlm.nih.gov/articles/4143470/
  title: 'The genetics of auricular development and malformation: new findings in model systems driving future directions for microtia research - PMC'
has_subtypes:
- name: AR-MHIC
  display_name: Autosomal recessive microtia, hearing impairment and cleft palate (HOXA2 p.Q186K)
  description: >-
    The original consanguineous Iranian family has homozygous p.Gln186Lys with bilateral microtia, prelingual
    severe to profound mixed hearing impairment and partial cleft palate. Three examined relatives had marked
    canal stenosis and ossicular abnormalities; one had unilateral inner-ear agenesis. These observations do
    not establish universal features of all biallelic HOXA2 variants.
  genes:
  - preferred_term: HOXA2
    term:
      id: hgnc:5103
      label: HOXA2
  evidence:
  - reference: PMID:18394579
    reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
    explanation: >-
      Defines the recessive subtype's three-component phenotype in the family
      the disease concept is named for.
- name: AD-Microtia
  display_name: Autosomal dominant nonsyndromic bilateral microtia (HOXA2 haploinsufficiency)
  description: >-
    Heterozygous truncating HOXA2 variants segregate with dominant bilateral microtia. Hearing varies among
    families: the p.Gln235* family studied by Brown and colleagues includes mild to severe mixed loss, whereas
    the examined p.Glu224* family members had normal hearing. The characterized dominant families do not show
    the cleft-palate presentation of the original recessive family. Haploinsufficiency is proposed; transcript
    decay and an exact reduction in patient protein abundance were not measured in these reports.
  genes:
  - preferred_term: HOXA2
    term:
      id: hgnc:5103
      label: HOXA2
  evidence:
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our data extend these conclusions and define HOXA2 haploinsufficiency as the first genetic cause for autosomal-dominant nonsyndromic microtia."
    explanation: Establishes the dominant, haploinsufficiency-driven subtype.
  - reference: PMID:27503514
    reference_title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we describe a five-generation family with isolated bilateral microtia segregating as an autosomal dominant trait."
    explanation: >-
      A second, independent dominant family in which the microtia is isolated.

inheritance:
- name: Autosomal recessive
  description: >-
    Homozygosity for the HOXA2 homeodomain missense p.Q186K in a consanguineous
    Iranian family, mapped by genome-wide linkage to 7p14.3-p15.3.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:18394579
    reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
    explanation: >-
      Recessive segregation in a consanguineous pedigree establishes the
      biallelic mode for this subtype.
- name: Autosomal dominant
  description: >-
    Heterozygous truncating HOXA2 variants segregate with bilateral microtia in multigeneration pedigrees.
    Hearing impairment is variable, so auricular morphology and audiology both contribute to family assessment.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The HOXA2 variant was segregated with microtia and hearing loss in the family and was not seen in 6,500 individuals sequenced by the NHLBI Exome Sequencing Project or in 218 control individuals sequenced in this study."
    explanation: >-
      Co-segregation with the trait plus absence from large control sets
      supports the dominant allele's causality.
  - reference: PMID:27503514
    reference_title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In our family, sequence analysis detected a heterozygous protein truncating nonsense variant"
    explanation: >-
      Full segregation of a second heterozygous truncating allele in an
      independent family.

pathophysiology:
- name: HOXA2 Loss of Function
  biological_scale: MOLECULAR
  description: >-
    Disease-associated alleles include heterozygous truncating variants p.Lys213*, p.Glu224* and p.Gln235*,
    and the recessive homeodomain missense p.Gln186Lys. Dominant haploinsufficiency is inferred from segregation
    and variant class, with impaired enhancer activation measured for two truncating alleles. The p.Gln186Lys
    DNA-binding effect is a homology-model prediction; the founding study did not measure residual protein
    activity or show functional complementation.
  genes:
  - preferred_term: HOXA2
    term:
      id: hgnc:5103
      label: HOXA2
  molecular_functions:
  - preferred_term: DNA-binding transcription factor activity
    modifier: LOSS_OF_FUNCTION
    term:
      id: GO:0003700
      label: DNA-binding transcription factor activity
  biological_processes:
  - preferred_term: anterior/posterior pattern specification
    modifier: ABNORMAL
    term:
      id: GO:0009952
      label: anterior/posterior pattern specification
  evidence:
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Exome sequencing of affected family members detected only seven shared, rare, heterozygous, nonsynonymous variants, including one protein truncating variant, a HOXA2 nonsense change (c.703C>T, p.Q235*)."
    explanation: Identifies the truncating allele class underlying the dominant form.
  - reference: PMID:18394579
    reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Subsequent DNA sequence analysis of the HOXA1 and HOXA2 homeobox genes from the candidate region identified an interesting HOXA2 homeodomain variant: a change in a highly conserved amino acid (p.Q186K)."
    explanation: Identifies the recessive homeodomain missense allele.
  - reference: PMID:18394579
    reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    directness: INDIRECT
    snippet: "In the model of the mutant homeodomain, the position of the mutant lysine side chain is consistently farther away from a nearby phosphate group; this altered position results in the loss of a hydrogen bond and affects the DNA-binding activity."
    explanation: >-
      The DNA-binding consequence of p.Q186K is a homology-modelling prediction,
      not a measurement; recorded as computational and indirect.
  downstream:
  - target: Impaired Transactivation of the Long-Range HMX1 Enhancer
    description: >-
      The p.Lys213* and p.Gln235* variants impair activation of the long-range HMX1 enhancer in a dual-luciferase
      assay; the abstract does not establish complete abolition of activity.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:32649979
      reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation of the long-range enhancer of HMX1."
      explanation: >-
        The reporter assay directly measures impaired enhancer activation by these two variants, rather than
        proving complete absence of activity in patients.
  - target: Loss of Second Pharyngeal Arch Neural Crest Identity
    description: >-
      HOXA2 is the selector gene that assigns second-arch identity to the
      cranial neural crest cells populating that arch; without it they adopt
      first-arch identity.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:7903601
      reference_title: "A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "The ground pattern program appears to be modified in the mouse first arch by a Hox-independent process, whereas Hoxa-2 acts as a selector gene in the second arch."
      explanation: >-
        Establishes HOXA2's selector-gene role in the second arch, the step this
        edge represents.
  - target: Intrinsic Palatal Shelf Fusion Defect
    description: >-
      A route that does not run through the pharyngeal arches at all. Hoxa2 is
      expressed in the palate itself, and knocking it down there reduces the
      rate at which the shelves fuse. The intermediates the authors name -
      increased cell proliferation, and de-repression of the Hoxa2 targets
      Msx1, Bmp4, Barx1 and Ptx1 - are candidates they identify but do not
      trace to the fusion failure.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:19653318
      reference_title: Hoxa2 plays a direct role in murine palate development.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Knocking down Hoxa2 expression with antisense retroviral constructs resulted in decreased fusion rates than corresponding controls."
      explanation: >-
        Loss of Hoxa2 in the palate reduces shelf fusion, the step this edge
        represents; the experiment is a knockdown in palate culture.
      directness: INDIRECT
    - reference: PMID:19653318
      reference_title: Hoxa2 plays a direct role in murine palate development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Hoxa2 also repressed the expression of its downstream targets Msx1, Bmp4, Barx1, and Ptx1 within the palate."
      explanation: >-
        Altered target-gene expression provides candidates, but the study does not trace a complete causal
        chain from any one target to failed fusion.

      directness: INDIRECT
  - target: External Auditory Canal Stenosis
    description: >-
      The HOXA2 genotype segregates with canal narrowing in the recessive family; the specific developmental
      intermediates remain unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
      reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        The results of high-resolution CT scanning confirmed that the external auditory canal was severely
        narrowed bilaterally in the cartilaginous part of the auditory canal and almost atretic in part of
        the bony portion in all patients.
      explanation: >-
        CT in the three examined recessive-family members, not every person with HOXA2-related disease.
  - target: Unilateral Inner-Ear Aplasia
    description: >-
      The inner-ear malformation co-occurs with homozygous p.Gln186Lys in one relative. Its developmental relation
      to HOXA2 remains uncertain and should not be attributed to ossicular homeosis.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
      reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        The inner-ear structures were normal in patients V: 2 and V: 3, but there were no inner-ear structures
        on the left side for IV: 3.
      explanation: >-
        Unilateral inner-ear agenesis in one recessive-family member, with normal inner-ear anatomy in the
        other two imaged relatives.
  - target: Unilateral Facial Paresis
    description: >-
      Facial weakness was observed in one homozygous relative; a specific neural developmental mechanism was
      not established.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
      reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        Individual number V: 2 also had a paresis on the right side of the face.
      explanation: >-
        Single affected relative; facial-nerve hypoplasia was suspected clinically but was not confirmed by
        brain MRI.
- name: Impaired Transactivation of the Long-Range HMX1 Enhancer
  biological_scale: MOLECULAR
  description: >-
    The p.Lys213* and p.Gln235* variants impair activation of a long-range HMX1 enhancer in dual-luciferase
    assays. Prior mouse work places Hoxa2 upstream of Hmx1 in ear development. The assay links these patient
    variants to a candidate effector, but does not measure the entire developmental pathway in human auricular
    tissue.
  genes:
  - preferred_term: HOXA2
    term:
      id: hgnc:5103
      label: HOXA2
  biological_processes:
  - preferred_term: ear morphogenesis
    modifier: ABNORMAL
    term:
      id: GO:0042471
      label: ear morphogenesis
  evidence:
  - reference: PMID:32649979
    reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "In mouse, Hoxa2 can bind to a long-range enhancer and regulate expression of the Hmx1 gene, which is a crucial transcription factor in eye and ear development."
    explanation: >-
      Establishes the HOXA2-HMX1 enhancer relationship; demonstrated in mouse.
    quote_role: BACKGROUND
  - reference: PMID:32649979
    reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: >-
      Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation of
      the long-range enhancer of HMX1.
    explanation: >-
      Direct reporter result for p.Lys213* and p.Gln235*; impairment is not equivalent to a proven null effect.
  downstream:
  - target: Failed Auricular Morphogenesis
    description: >-
      Reduced HMX1 activation is the candidate route from the HOXA2 alleles to
      the external ear defect; the link to the human auricle phenotype is
      inferred, not measured in patient tissue.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:32649979
      reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "In mouse, Hoxa2 can bind to a long-range enhancer and regulate expression of the Hmx1 gene, which is a crucial transcription factor in eye and ear development."
      explanation: >-
        Supports HMX1 as an ear-development effector downstream of HOXA2;
        the connection to the human auricle is an inference from this.

      directness: INDIRECT
      quote_role: BACKGROUND
- name: Loss of Second Pharyngeal Arch Neural Crest Identity
  biological_scale: CELLULAR
  conforms_to: "pharyngeal_arch_patterning_serial_homology#Cranial Neural Crest and Pharyngeal Arch Program Perturbation"
  description: >-
    Hoxa2-null mouse embryos retain rhombomeric and neural crest segmentation but lose normal second-arch mesenchymal
    identity, producing first-arch-like skeletal derivatives. This supports an identity-assignment role. The
    cited abstract does not separately demonstrate normal migration, cell number or survival, and the complete-null
    result should not be equated with every human HOXA2 allele.
  cell_types:
  - preferred_term: second-arch neural crest cell
    term:
      id: CL:0011012
      label: neural crest cell
  biological_processes:
  - preferred_term: neural crest cell development
    modifier: ABNORMAL
    term:
      id: GO:0014032
      label: neural crest cell development
  - preferred_term: pharyngeal system development
    modifier: ABNORMAL
    term:
      id: GO:0060037
      label: pharyngeal system development
  locations:
  - preferred_term: second pharyngeal arch
    term:
      id: UBERON:0003066
      label: pharyngeal arch 2
  evidence:
  - reference: PMID:7903601
    reference_title: "A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "While rhombomeric and neural crest cell (NCC) segmentation was not affected, mesenchymal NCC derivatives of the second arch were lacking, and second arch mesenchymal NCC identity was changed to first arch identity, resulting in homeotic transformation of second to first arch skeletal elements."
    explanation: >-
      Direct mouse evidence for preserved segmentation with changed second-arch identity; migration and survival
      were not separately established by this quotation.
  - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/4143470/
    reference_title: 'The genetics of auricular development and malformation: new findings in model systems driving future directions for microtia research - PMC'
    supports: SUPPORT
    evidence_source: OTHER
    directness: DIRECT
    snippet: >-
      By definition, the pinna encompasses all external structures of the ear, including the tragus and root.
    explanation: >-
      This review qualifies the terminology of the mouse lineage claim; it is not a new lineage-tracing experiment.
    quote_role: REVIEW_SYNTHESIS
  downstream:
  - target: Homeotic Transformation of Second-Arch Skeletal Derivatives
    description: >-
      Mis-specified second-arch crest builds first-arch structures instead of
      second-arch ones.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:7903600
      reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Histological analysis suggested that this duplication resulted from the transformation of skeletal elements derived from the second branchial arch into more anterior structures, resulting in a duplication of Meckel's cartilage adjacent to the otic capsule."
      explanation: >-
        Independently documents the transformation of second-arch skeletal
        elements toward anterior (first-arch) structures.
  - target: Failed Auricular Morphogenesis
    description: >-
      Hoxa2-expressing second-arch mesenchyme supplies the auricular territory examined in the mouse fate-mapping
      study. Its loss disrupts that territory; the result should not be generalized to every human external-ear
      structure.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:24067355
      reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "By genetic fate mapping we found that the mouse auricle (or pinna) derives from the Hoxa2-expressing neural crest-derived mesenchyme of the second pharyngeal arch, and not from a composite of first and second arch mesenchyme as previously proposed based on morphological observation of human embryos."
      explanation: >-
        Mouse fate mapping supports a major second-arch contribution. The extent depends on how the auricle
        is defined; the tragus and root require separate consideration.
  - target: Mis-Attachment of the Extrinsic Tongue and Hyoid Muscles
    description: >-
      The same rhombencephalic neural crest that builds the craniofacial
      skeleton also patterns the craniofacial muscles, and Hoxa2 mutants have
      abnormal attachments and trajectories of the extrinsic tongue and hyoid
      muscles. How the arch-identity lesion produces that particular
      mis-routing was not worked out, so the intermediates are recorded as
      unknown.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:10529419
      reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "The rhombencephalic neural crest play several roles in craniofacial development. They give rise to the cranial sensory ganglia and much of the craniofacial skeleton, and are vital for patterning of the craniofacial muscles."
      explanation: >-
        States that craniofacial muscle patterning depends on the same neural
        crest population whose identity is lost at this node.

  - target: Middle-Ear Ossicular Dysplasia
    description: >-
      The relationship of second-arch patterning to human ossicular dysplasia is inferred from developmental
      models and family anatomy; the intervening human developmental steps have not been measured.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
      reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate.
      explanation: >-
        CT findings in the three examined members of the recessive family; fixation was described as apparent
        on imaging.
- name: Homeotic Transformation of Second-Arch Skeletal Derivatives
  biological_scale: TISSUE
  conforms_to: "pharyngeal_arch_patterning_serial_homology#Disrupted Pharyngeal-Arch Patterning and Neural-Crest Skeletogenesis"
  description: >-
    Hoxa2-null mice lose second-arch skeletal elements and develop duplicated first-arch structures, including
    middle-ear ossification centers and a second Meckel cartilage beside the otic capsule. This is a model-organism
    developmental phenotype. Human imaging and surgery establish ossicular dysplasia and fixation, but do not
    demonstrate this complete homeotic duplication. This node has no downstream human-phenotype links because
    the complete homeotic transformation is documented only in mice.
  cell_types:
  - preferred_term: neural crest cell
    term:
      id: CL:0011012
      label: neural crest cell
  biological_processes:
  - preferred_term: embryonic cranial skeleton morphogenesis
    modifier: ABNORMAL
    term:
      id: GO:0048701
      label: embryonic cranial skeleton morphogenesis
  - preferred_term: embryonic skeletal system morphogenesis
    modifier: ABNORMAL
    term:
      id: GO:0048704
      label: embryonic skeletal system morphogenesis
  locations:
  - preferred_term: auditory ossicle
    term:
      id: UBERON:0001686
      label: auditory ossicle bone
  evidence:
  - reference: PMID:7903600
    reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Analysis of stained skeletons revealed that homozygous mutant animals contained multiple cranial skeletal defects, including a duplication of the ossification centers of the bones of the middle ear."
    explanation: >-
      Documents the middle-ear skeletal consequence of the second-arch
      transformation.
  - reference: PMID:7903600
    reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Skeletal elements normally derived from the second arch were absent in the mutants."
    explanation: >-
      Confirms loss, not merely mis-shaping, of the second-arch skeletal
      derivatives.
- name: Middle-Ear Ossicular Dysplasia
  description: >-
    Malformed or fixed ossicles are documented directly in both recessive and dominant HOXA2 families. Recessive
    cases had a malformed chain apparently fixed by an incomplete atretic plate; dominant cases included abnormal
    stapes crura, absent stapedial tendon and a rigid chain. These observations support a conductive deficit
    without assuming mouse-like duplication in humans.
  biological_scale: TISSUE
  evidence:
  - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
    reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate.
    explanation: >-
      CT findings in the three examined members of the recessive family; fixation was described as apparent
      on imaging.
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      In individual II.2, the stapes was noted to have a thickened posterior crus and an absent anterior crus,
      and the stapedial tendon was absent.
    explanation: >-
      Operative observation in one dominant-family member.
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Individual II.4 had a rigid ossicular chain.
    explanation: >-
      Operative observation in another member of the same dominant family.
  downstream:
  - target: Hearing Impairment
    description: >-
      Ossicular malformation and fixation impair sound transmission and can account for the conductive component.
      This mechanism does not explain a sensorineural component.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
      reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate.
      explanation: >-
        CT findings in the three examined members of the recessive family; fixation was described as apparent
        on imaging.
  - target: Mixed Hearing Impairment
    description: >-
      Ossicular malformation and fixation impair sound transmission and can account for the conductive component.
      This mechanism does not explain a sensorineural component.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
      reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate.
      explanation: >-
        CT findings in the three examined members of the recessive family; fixation was described as apparent
        on imaging.
  - target: Abnormal Middle-Ear Ossicles
    description: >-
      The structural abnormality is the directly observed phenotype.
    causal_link_type: DIRECT
    evidence:
    - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
      reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: >-
        In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate.
      explanation: >-
        CT findings in the three examined members of the recessive family; fixation was described as apparent
        on imaging.
  locations:
  - preferred_term: auditory ossicle bone
    term:
      id: UBERON:0001686
      label: auditory ossicle bone
- name: Failed Auricular Morphogenesis
  biological_scale: TISSUE
  conforms_to: "pharyngeal_arch_patterning_serial_homology#Serially Homologous Craniofacial Malformation Across Arch Derivatives"
  description: >-
    The auricle fails to form normally. Timing determines severity in the mouse:
    early Hoxa2 inactivation abolishes the auricle and duplicates the external
    auditory canal, while late inactivation leaves a hypomorphic auricle
    resembling the human phenotype. Hoxa2 acts on pinna morphogenesis partly
    through BMP signalling and Eya1 expression.
  biological_processes:
  - preferred_term: ear morphogenesis
    modifier: ABNORMAL
    term:
      id: GO:0042471
      label: ear morphogenesis
  - preferred_term: face morphogenesis
    modifier: ABNORMAL
    term:
      id: GO:0060325
      label: face morphogenesis
  locations:
  - preferred_term: auricle
    term:
      id: UBERON:0001757
      label: pinna
  evidence:
  - reference: PMID:24067355
    reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "In mice, Hoxa2 inactivation at early gestational stages results in external auditory canal (EAC) duplication and absence of the auricle, whereas its late inactivation results in a hypomorphic auricle, mimicking the human HOXA2 mutant condition."
    explanation: >-
      Establishes both the auricular defect and its dependence on the timing of
      Hoxa2 loss.
  - reference: PMID:24067355
    reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Hoxa2 partly controls the morphogenesis of the pinna through the BMP signalling pathway and expression of Eya1, which in humans is involved in branchio-oto-renal syndrome."
    explanation: >-
      Names the downstream effectors through which HOXA2 shapes the pinna;
      the authors qualify this as partial control.
  downstream:
  - target: Bilateral Microtia
    description: >-
      Failure of pinna morphogenesis presents clinically as bilateral microtia.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:24067355
      reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Thus, Hoxa2 loss- and gain-of-function approaches in mice provide a suitable model to investigate the molecular aetiology of microtia and auricle duplication."
      explanation: >-
        The authors position the Hoxa2 auricular phenotype as the model of human
        microtia aetiology.

    - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
      reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: >-
        Based on the abnormalities observed in this family, the disease was categorized as microtia grade II.
      explanation: >-
        Direct clinical classification of the original family.
  - target: Thickened Helices
    description: >-
      Abnormal auricular morphogenesis includes the thickened helices observed in the dominant family.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:23775976
      reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: >-
        All five affected family members had small, malformed ears with a thickened helix and a superficial
        postauricular sulcus (Fig. 1B).
      explanation: >-
        Clinical morphology in five enrolled affected members of the p.Gln235* family.
  - target: Underdeveloped Antitragus
    description: >-
      Antitragal underdevelopment is one component of the documented auricular dysplasia.
    causal_link_type: DIRECT
    evidence:
    - reference: url:https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
      reference_title: https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: >-
        underdeveloped antitragus, serpiginous antihelix stem, deep incisura between tragus and antitragus
        with a laterally dislocated hypoplastic lobe.
      explanation: >-
        Proband morphology from the author thesis describing the same p.Glu224* pedigree later reported in
        PMID:27503514; this is not an additional family.
- name: Mis-Attachment of the Extrinsic Tongue and Hyoid Muscles
  biological_scale: TISSUE
  description: >-
    In Hoxa2 mutant mice the attachments and trajectories of the extrinsic
    tongue and hyoid muscles are abnormal. The abnormal trajectory of two of
    them, the styloglossus and the stylohyoideus, blocks the attachment of the
    hyoglossus to the greater horn of the hyoid, and that blocked attachment
    correlated exactly with the presence of cleft palate in those animals. The
    node is mouse-derived; no comparable observation has been reported in
    HOXA2-mutant patients, in whom tongue and hyoid muscle anatomy has not been
    described.
  biological_processes:
  - preferred_term: muscle attachment
    modifier: ABNORMAL
    term:
      id: GO:0016203
      label: muscle attachment
  locations:
  - preferred_term: extrinsic muscle of tongue
    term:
      id: UBERON:0001575
      label: extrinsic muscle of tongue
  - preferred_term: hyoglossus muscle
    term:
      id: UBERON:0001572
      label: hyoglossus muscle
  - preferred_term: hyoid bone greater horn
    term:
      id: UBERON:0003997
      label: hyoid bone greater horn
  evidence:
  - reference: PMID:10529419
    reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We also uncovered multiple defects in the attachments and trajectories of the extrinsic tongue and hyoid muscles in Hoxa2 mutants."
    explanation: >-
      Records the muscle attachment and trajectory defects this node
      represents, in Hoxa2 mutants.
  - reference: PMID:10529419
    reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "the abnormal trajectory of two of these muscles, the styloglossus and the stylohyoideus, blocked the attachment of the hyoglossus to the greater horn of the hyoid, which in turn correlated exactly with the presence of cleft palate in Hoxa2 mutants"
    explanation: >-
      Names the specific muscles involved and reports the exact correlation
      between the blocked hyoglossus attachment and cleft palate, which is the
      observation - as distinct from the interpretation on the next node.
  downstream:
  - target: Abnormal Tongue Posture Obstructing Palatal Shelf Closure
    description: >-
      Barrow and Capecchi's interpretation of the correlation: the hyoglossus,
      unable to reach the greater horn, cannot depress the lateral edges of the
      tongue. Support for the link is the rescue arm - restoring the attachment
      in Hoxa1/Hoxa2 double mutants restores palatal closure over a flattened
      tongue - rather than direct observation of tongue posture in the single
      mutants.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:10529419
      reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "We show that two compensatory defects, associated with the loss of Hoxa1 function, restore normal attachment of the hyoglossus to the greater horn thereby allowing the palatal shelves to lift and fuse above the flattened tongue."
      explanation: >-
        The rescue: restoring the hyoglossus attachment restores both the
        flattened tongue and palatal shelf fusion, tying this node to the next.

      directness: INDIRECT
- name: Abnormal Tongue Posture Obstructing Palatal Shelf Closure
  biological_scale: TISSUE
  description: >-
    The proposed mechanical consequence, stated by its authors as a suggestion
    rather than an observation: with the hyoglossus unable to depress the
    lateral edges of the tongue, the tongue adopts an abnormal posture that
    blocks closure of the palatal shelves. It is not the only published account
    of the Hoxa2 cleft - see the
    hoxa2_cleft_palate_tongue_versus_intrinsic_palate discussion and the
    Intrinsic Palatal Shelf Fusion Defect node - and neither account has been
    tested in a human patient.
  biological_processes:
  - preferred_term: secondary palate development
    modifier: ABNORMAL
    term:
      id: GO:0062009
      label: secondary palate development
  locations:
  - preferred_term: tongue
    term:
      id: UBERON:0001723
      label: tongue
  - preferred_term: secondary palatal shelf
    term:
      id: UBERON:0005619
      label: secondary palatal shelf
  evidence:
  - reference: PMID:10529419
    reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We suggest that the hyoglossus, whose function is to depress the lateral edges of the tongue, when unable to make its proper attachment to the greater horn of the hyoid, forces the tongue to adopt an abnormal posture which blocks closure of the palatal shelves."
    explanation: >-
      The proposal this node represents, quoted in full so that its status as
      the authors' suggestion is visible in the evidence itself.
  downstream:
  - target: Cleft Palate
    description: >-
      Shelves that do not close leave a cleft. In Hoxa1/Hoxa2 double mutants,
      where the hyoglossus attachment is restored, the penetrance of cleft
      palate falls sharply - the experimental result that ties the obstruction
      to the cleft.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:10529419
      reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Unexpectedly, in Hoxa1/Hoxa2 double mutants, the penetrance of cleft palate is dramatically reduced."
      explanation: >-
        Restoring the attachment sharply reduces the cleft, which is what makes
        this edge causal rather than merely correlative.

      directness: INDIRECT
- name: Intrinsic Palatal Shelf Fusion Defect
  biological_scale: TISSUE
  description: >-
    A second, independent route to the same cleft. Hoxa2 is expressed in the
    developing palate itself between E12.5 and E15.5, and Hoxa2-null palatal
    shelves cultured in the absence of the tongue fuse at lower rates than
    heterozygous or wild-type shelves, as do shelves in which Hoxa2 is knocked
    down with antisense constructs. Null palates show an overall increase in
    cell proliferation, and Hoxa2 represses Msx1, Bmp4, Barx1 and Ptx1 within
    the palate. On the authors' reading the mouse cleft is therefore not solely
    secondary to the tongue. Whether either route operates in HOXA2-mutant
    humans is unknown.
  biological_processes:
  - preferred_term: secondary palate development
    modifier: ABNORMAL
    term:
      id: GO:0062009
      label: secondary palate development
  locations:
  - preferred_term: secondary palatal shelf
    term:
      id: UBERON:0005619
      label: secondary palatal shelf
  evidence:
  - reference: PMID:19653318
    reference_title: Hoxa2 plays a direct role in murine palate development.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "we detected Hoxa2 expression in the developing palate at both the mRNA and protein levels between embryonic day (E) 12.5 and E15.5"
    explanation: >-
      Hoxa2 is expressed in the palate itself, the precondition for a route
      that does not run through the tongue.
  - reference: PMID:19653318
    reference_title: Hoxa2 plays a direct role in murine palate development.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Organ cultures of Hoxa2(-/-) palates maintained in the absence of the tongue showed decreased fusion rates than either Hoxa2(+/-) or Hoxa2(+/+) palate cultures."
    explanation: >-
      Palatal shelves fuse less well without Hoxa2 even when the tongue is
      removed from the system - explant culture, hence IN_VITRO.
  - reference: PMID:19653318
    reference_title: Hoxa2 plays a direct role in murine palate development.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "These results demonstrate the cleft palate phenotype of Hoxa2 null embryos is not solely due to abnormal tongue musculature, and indicate a direct role of Hoxa2 in regulating murine palatogenesis."
    explanation: >-
      The authors' own conclusion that the tongue route is not the whole
      account, which is why this node is curated alongside it rather than
      instead of it.
  downstream:
  - target: Cleft Palate
    description: >-
      The explant and mouse findings support a palate-intrinsic contribution to clefting, but do not establish
      its quantitative contribution or demonstrate the corresponding intermediate in affected humans.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:19653318
      reference_title: Hoxa2 plays a direct role in murine palate development.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "These results demonstrate the cleft palate phenotype of Hoxa2 null embryos is not solely due to abnormal tongue musculature, and indicate a direct role of Hoxa2 in regulating murine palatogenesis."
      explanation: >-
        The authors' own conclusion that the tongue route is not the whole
        account, which is why this node is curated alongside it rather than
        instead of it.
      directness: INDIRECT
phenotypes:
- name: Bilateral Microtia
  category: Craniofacial
  description: >-
    Bilateral auricular malformation is the characteristic feature in recessive and dominant pedigrees. The
    original recessive family was classified as grade II microtia, with recognizable helix, tragus and antitragus.
    Severity and detailed morphology differ between families.
  phenotype_term:
    preferred_term: Bilateral microtia
    term:
      id: HP:0008551
      label: Microtia
    laterality: BILATERAL
  notes: >-
    Pedigree observations do not supply a population-level penetrance or frequency estimate.
  evidence:
  - reference: PMID:18394579
    reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
    explanation: Bilateral microtia in the recessive family.
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We ascertained a three-generation family with bilateral microtia and hearing loss segregating as an autosomal dominant trait."
    explanation: Bilateral microtia in the first dominant family.
  - reference: PMID:27503514
    reference_title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we describe a five-generation family with isolated bilateral microtia segregating as an autosomal dominant trait."
    explanation: Bilateral microtia in a second dominant family.
  - reference: PMID:32649979
    reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here, we collect two Chinese families with non-syndromic bilateral microtia."
    explanation: Bilateral microtia in two further dominant families.

  - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
    reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Based on the abnormalities observed in this family, the disease was categorized as microtia grade II.
    explanation: >-
      Clinical grade in the original recessive family, not a universal grade for dominant microtia.
- name: Hearing Impairment
  category: Auditory
  description: >-
    Hearing impairment varies across HOXA2 families. The original recessive family had prelingual severe to
    profound mixed loss; the p.Gln235* dominant family had mild to severe mixed loss with one illustrated conductive-only
    ear. In the p.Glu224* pedigree, the proband had normal otoacoustic emissions and the examined mother and
    grandfather had normal audiometry.
  phenotype_term:
    preferred_term: Hearing impairment
    term:
      id: HP:0000365
      label: Hearing impairment
  notes: >-
    Normal hearing in an affected family member does not exclude dominant HOXA2-related microtia.
  evidence:
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We ascertained a three-generation family with bilateral microtia and hearing loss segregating as an autosomal dominant trait."
    explanation: Hearing loss co-segregating in a dominant family.
  - reference: PMID:32649979
    reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To date, only four HOXA2 mutations were reported in families with autosomal-recessive or dominant microtia, with or without hearing impairment."
    explanation: >-
      The literature summary records hearing impairment as a variable rather
      than constant feature of HOXA2-related microtia.

    quote_role: BACKGROUND
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Audiometric testing was performed on three of the affected family members and showed mild to severe bilateral
      mixed hearing loss (Fig. 1C).
    explanation: >-
      Direct dominant-family audiology. The figure caption includes a mild conductive-only left ear in one
      relative, so not every tested ear had both components.
  - reference: url:https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
    reference_title: https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      In both relatives audiometric testing had unremarkable results, as well as intraoral examination.
    explanation: >-
      Normal audiometry in the proband mother and maternal grandfather in the p.Glu224* pedigree; the thesis
      and journal article describe the same family.
- name: Mixed Hearing Impairment
  category: Auditory
  description: >-
    Mixed hearing impairment occurs in both recessive and dominant HOXA2 disease. It was symmetric and severe
    to profound in the original recessive family and mild to severe in the tested p.Gln235* dominant relatives.
    Ossicular abnormalities explain a conductive component. Unilateral inner-ear agenesis explains an anatomic
    substrate in one recessive ear, but does not resolve the sensorineural component in other ears with normal
    or unreported imaging.
  phenotype_term:
    preferred_term: Mixed hearing impairment
    term:
      id: HP:0000410
      label: Mixed hearing impairment
    laterality: BILATERAL
  notes: >-
    The dominant-family figure also documents a conductive-only ear; severity and audiological subtype should
    be assessed per ear.
  evidence:
  - reference: PMID:18394579
    reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
    explanation: >-
      Specifies the mixed, symmetrical, severe-to-profound character of the
      recessive subtype's hearing loss.

  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Audiometric testing was performed on three of the affected family members and showed mild to severe bilateral
      mixed hearing loss (Fig. 1C).
    explanation: >-
      Direct dominant-family audiology. The figure caption includes a mild conductive-only left ear in one
      relative, so not every tested ear had both components.
  - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
    reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      All four affected family individuals showed bilateral symmetric severe to profound mixed hearing impairment
      affecting all frequencies and leading to a flat audiometric shape.
    explanation: >-
      The four affected members of the original recessive family; this severity should not be transferred to
      all dominant cases.
- name: Cleft Palate
  category: Craniofacial
  subtype: AR-MHIC
  description: >-
    Partial cleft palate is documented in the original homozygous p.Gln186Lys family. Examined members of the
    p.Gln235* and p.Glu224* dominant pedigrees had an intact palate or unremarkable intraoral examination.
    Mouse null clefting supports developmental relevance but does not establish the specific mechanism of the
    human cleft.
  phenotype_term:
    preferred_term: Cleft palate
    term:
      id: HP:0000175
      label: Cleft palate
  notes: >-
    The subtype association is based on a small number of characterized pedigrees; it is not a universal genotype-phenotype
    rule.
  evidence:
  - reference: PMID:18394579
    reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
    explanation: Partial cleft palate in the recessive family.
  - reference: PMID:27503514
    reference_title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "HOXA2 biallelic mutations were also described in an inbreed family with autosomal recessive microtia, hearing impairment and incomplete cleft palate."
    explanation: >-
      The later article summarizes the same recessive family; it does not provide independent replication of
      its cleft phenotype.
    quote_role: BACKGROUND
  - reference: PMID:7903600
    reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Mice homozygous for a targeted mutation of the Hoxa-2 (Hox 1.11) gene are born with cleft palates and die within 24 hr of birth."
    explanation: >-
      Cleft palate in the homozygous mouse null provides model evidence for developmental relevance; the abstract
      does not supply a penetrance denominator.

- name: External Auditory Canal Stenosis
  description: >-
    Three imaged recessive relatives had severe bilateral canal narrowing, with near-atresia of portions of
    the bony canal. Canals were normally formed in the characterized p.Gln235* dominant family.
  phenotype_term:
    preferred_term: Stenosis of the external auditory canal
    term:
      id: HP:0000402
      label: Stenosis of the external auditory canal
    laterality: BILATERAL
  evidence:
  - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
    reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      The results of high-resolution CT scanning confirmed that the external auditory canal was severely narrowed
      bilaterally in the cartilaginous part of the auditory canal and almost atretic in part of the bony portion
      in all patients.
    explanation: >-
      CT in the three examined recessive-family members, not every person with HOXA2-related disease.
  subtype: AR-MHIC
- name: Abnormal Middle-Ear Ossicles
  description: >-
    Ossicular malformation and apparent fixation were imaged in three recessive relatives. Dominant-family
    surgery documented abnormal stapes crura, absent stapedial tendon or a rigid ossicular chain.
  phenotype_term:
    preferred_term: Abnormality of the middle ear ossicles
    term:
      id: HP:0004452
      label: Abnormality of the middle ear ossicles
  evidence:
  - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
    reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      In all three patients the malformed ossicular chain seemed fixated by an incomplete atretic plate.
    explanation: >-
      CT findings in the three examined members of the recessive family; fixation was described as apparent
      on imaging.
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      In individual II.2, the stapes was noted to have a thickened posterior crus and an absent anterior crus,
      and the stapedial tendon was absent.
    explanation: >-
      Operative observation in one dominant-family member.
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Individual II.4 had a rigid ossicular chain.
    explanation: >-
      Operative observation in another member of the same dominant family.
- name: Unilateral Inner-Ear Aplasia
  description: >-
    Left inner-ear agenesis was confirmed by CT and MRI in one member of the recessive family. The other two
    imaged relatives had normal inner-ear structures.
  phenotype_term:
    preferred_term: Aplasia of the inner ear
    term:
      id: HP:0011372
      label: Aplasia of the inner ear
    laterality: LEFT
  evidence:
  - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
    reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      The inner-ear structures were normal in patients V: 2 and V: 3, but there were no inner-ear structures
      on the left side for IV: 3.
    explanation: >-
      Unilateral inner-ear agenesis in one recessive-family member, with normal inner-ear anatomy in the other
      two imaged relatives.
  subtype: AR-MHIC
- name: Unilateral Facial Paresis
  description: >-
    Right facial paresis occurred in one examined member of the recessive family. Right facial-nerve hypoplasia
    was suspected clinically; brain MRI was normal and did not confirm that explanation.
  phenotype_term:
    preferred_term: Unilateral facial palsy
    term:
      id: HP:0012799
      label: Unilateral facial palsy
    laterality: RIGHT
  evidence:
  - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
    reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Individual number V: 2 also had a paresis on the right side of the face.
    explanation: >-
      Single affected relative; facial-nerve hypoplasia was suspected clinically but was not confirmed by brain
      MRI.
  subtype: AR-MHIC
- name: Thickened Helices
  description: >-
    The five enrolled affected members of the p.Gln235* dominant family had thickened helices and a superficial
    postauricular sulcus.
  phenotype_term:
    preferred_term: Thickened helices
    term:
      id: HP:0000391
      label: Thickened helices
  evidence:
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      All five affected family members had small, malformed ears with a thickened helix and a superficial postauricular
      sulcus (Fig. 1B).
    explanation: >-
      Clinical morphology in five enrolled affected members of the p.Gln235* family.
  subtype: AD-Microtia
- name: Underdeveloped Antitragus
  description: >-
    The p.Glu224* proband had an underdeveloped antitragus as part of complex auricular dysplasia, including
    a serpiginous antihelix and laterally displaced hypoplastic lobe. These detailed observations come from
    the author thesis on the same published pedigree.
  phenotype_term:
    preferred_term: Underdeveloped antitragus
    term:
      id: HP:0011251
      label: Underdeveloped antitragus
  evidence:
  - reference: url:https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
    reference_title: https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      underdeveloped antitragus, serpiginous antihelix stem, deep incisura between tragus and antitragus with
      a laterally dislocated hypoplastic lobe.
    explanation: >-
      Proband morphology from the author thesis describing the same p.Glu224* pedigree later reported in PMID:27503514;
      this is not an additional family.
  subtype: AD-Microtia
genetic:
- name: HOXA2 pathogenic variants
  association: Causal
  relationship_type: CAUSATIVE
  presence: Pathogenic
  gene_term:
    preferred_term: HOXA2
    term:
      id: hgnc:5103
      label: HOXA2
  notes: >-
    HOXA2 lies in the HOXA cluster at 7p15.2. Linkage and segregation established the recessive family; exome
    or targeted sequencing identified dominant truncating alleles. The curated variants are examples, not an
    exhaustive or current worldwide allele count. Haploinsufficiency is inferred, and the cited family studies
    did not measure patient nonsense-mediated decay or a precise 50% protein reduction.
  evidence:
  - reference: PMID:18394579
    reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Genome-wide linkage analysis localized the responsible gene to chromosome 7p14.3-p15.3 with a maximum multi-point LOD score of 4.17."
    explanation: >-
      Linkage to the HOXA cluster interval is the mapping evidence that
      identified the gene.
  - reference: PMID:32649979
    reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Next generation sequencing identified two heterozygous nonsense HOXA2 mutations, one in each family."
    explanation: >-
      Two independent families carrying heterozygous nonsense alleles; p.Gln235* recurs from an earlier pedigree.
  variants:
  - name: p.Q186K homeodomain missense (recessive)
    description: >-
      Homozygous homeodomain missense p.Gln186Lys segregated in the original recessive family and was absent
      from the reported control panels. The founding paper predicts altered DNA binding by homology modeling
      but does not measure residual function. Protein notation avoids conflating historical nucleotide numbering
      with a normalized transcript-specific HGVS description.
    clinical_significance: PATHOGENIC
    evidence:
    - reference: PMID:18394579
      reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The variant was not found in 231 Iranian and 109 Belgian control samples."
      explanation: Control-panel absence supporting pathogenicity of p.Q186K.
  - name: p.Q235* nonsense (dominant)
    description: >-
      A recurrent heterozygous nonsense allele, found independently in a
      three-generation US family and in one of the two Chinese families.
    clinical_significance: PATHOGENIC
    evidence:
    - reference: PMID:32649979
      reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "One mutation (c.637A > T, p.Lys213*) is newly reported, while the other one (c.703C > T,p.Gln235*) is consistent with a previous report."
      explanation: Documents recurrence of p.Gln235* across unrelated families.
  - name: p.E224* nonsense (dominant)
    description: >-
      A heterozygous truncating allele segregating in all affected members of a
      five-generation Italian family and absent from public databases.
    clinical_significance: PATHOGENIC
    evidence:
    - reference: PMID:27503514
      reference_title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "In our family, sequence analysis detected a heterozygous protein truncating nonsense variant"
      explanation: Defines the allele and its segregation.

    - reference: url:https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
      reference_title: https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: >-
        Sanger analysis of the index patient (V:1) identified a previously unreported heterozygous variant
        ... NM_006735.3: c.670G>T, p.(Glu224*) ... in the second exon of the HOXA2 gene (Figure 17a).
      explanation: >-
        Primary thesis data identifying p.Glu224* in the same Italian pedigree as the journal article.
  - name: p.Lys213* nonsense (dominant)
    description: >-
      Heterozygous p.Lys213* was found in one Chinese family; a dual-luciferase assay showed impaired HMX1
      enhancer activation. The result supports loss of activity without establishing patient transcript decay.
    clinical_significance: PATHOGENIC
    evidence:
    - reference: PMID:32649979
      reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "One mutation (c.637A > T, p.Lys213*) is newly reported, while the other one (c.703C > T,p.Gln235*) is consistent with a previous report."
      explanation: >-
        Identifies the newly reported p.Lys213* allele and distinguishes it from recurrent p.Gln235*.
    - reference: PMID:32649979
      reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: >-
        Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation
        of the long-range enhancer of HMX1.
      explanation: >-
        Direct reporter result for p.Lys213* and p.Gln235*; impairment is not equivalent to a proven null effect.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  notes: >-
    Published evidence consists of a small number of pedigrees. No HOXA2-specific population prevalence is
    established by these reports; all-cause microtia birth prevalence should not be assigned to this molecular
    disorder.
  evidence:
  - reference: PMID:32649979
    reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To date, only four HOXA2 mutations were reported in families with autosomal-recessive or dominant microtia, with or without hearing impairment."
    explanation: >-
      A time-specific literature summary illustrates sparse pedigree evidence; it does not establish a current
      worldwide family count or population prevalence.
    quote_role: BACKGROUND
diagnosis:
- name: Clinical and audiological examination
  description: >-
    Inspect both auricles, ear canals, palate and facial movement, and obtain age-appropriate air- and bone-conduction
    hearing thresholds. Mixed loss can occur in either inheritance subtype, and a normal hearing result does
    not exclude dominant HOXA2 microtia. General microtia guidance recommends diagnostic ABR by two to three
    months, followed by behavioral assessment as development permits.
  evidence:
  - reference: PMID:18394579
    reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
    explanation: >-
      The clinical and audiological characterisation that defines the
      presentation.
  - reference: DOI:10.3389/fsurg.2022.944223
    reference_title: Integrated microtia and aural atresia management
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      A diagnostic ABR should be performed as early as possible.
    explanation: >-
      General microtia diagnostic guidance, extrapolated to affected infants.
    quote_role: REVIEW_SYNTHESIS
  - reference: DOI:10.3389/fsurg.2022.944223
    reference_title: Integrated microtia and aural atresia management
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      Air conduction and bone conduction testing should performed.
    explanation: >-
      The source recommends testing both pathways; the quotation preserves its grammatical omission.
    quote_role: REVIEW_SYNTHESIS
- name: HOXA2 sequencing
  description: >-
    Identify a phenotype-compatible HOXA2 variant through targeted sequencing, a relevant hearing/craniofacial
    panel or exome analysis, and test segregation where feasible. Interpret variant class, zygosity and family
    phenotype together; a rare missense finding alone is not diagnostic. Heterozygous truncating alleles and
    the original homozygous p.Gln186Lys allele have different inheritance and clinical associations.
  evidence:
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Exome sequencing of affected family members detected only seven shared, rare, heterozygous, nonsynonymous variants, including one protein truncating variant, a HOXA2 nonsense change (c.703C>T, p.Q235*)."
    explanation: Exome sequencing as the diagnostic route in a dominant family.

  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Both of these nonsynonymous changes affect leucine residues with high evolutionary conservation; however,
      each of these variants was also found in one control, indicating that either these variants are benign
      or that these variants in combination with another undetected HOXA2 variant (possibly in a noncoding
      portion of the gene) are responsible for microtia in these patients.
    explanation: >-
      The study itself did not establish causality for every rare missense variant; the proposed second-variant
      explanation was untested.
- name: Temporal-bone imaging when clinically indicated
  description: >-
    CT characterizes canal narrowing, atretic plates and ossicles; MRI can assess inner-ear and neural anatomy.
    The original recessive family had both ossicular abnormalities and one unilateral inner-ear agenesis. General
    microtia guidance reserves routine reconstructive CT for surgical planning or suspected cholesteatoma rather
    than the newborn period; unusual mixed loss or neurologic findings require individualized specialist assessment.
  evidence:
  - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
    reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      The MRI of the auditory system in individual V: 3 was unremarkable for the inner ear and cerebellopontine
      angle, but an MRI confirmed the inner-ear agenesis on the left side of individual IV: 3 as seen on CT-images.
    explanation: >-
      Human diagnostic imaging, with both normal and abnormal findings.
  - reference: DOI:10.3389/fsurg.2022.944223
    reference_title: Integrated microtia and aural atresia management
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      A CT scan of the temporal bone is not recommended in the newborn period.
    explanation: >-
      General microtia imaging guidance; this does not preclude individualized imaging for a specific diagnostic
      concern.
    quote_role: REVIEW_SYNTHESIS
treatments:
- name: Auricular Reconstruction
  description: >-
    Discuss observation, an external prosthesis, autologous cartilage reconstruction and alloplastic reconstruction
    according to the individual goals and anatomy. Reconstruction is elective; coordinate its sequence with
    any hearing implant or canal surgery. The recommendations come from general microtia care, not a HOXA2
    outcome series.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: auricular reconstruction
    term:
      id: NCIT:C25351
      label: Reconstructive Surgery
  target_mechanisms:
  - target: Bilateral Microtia
    treatment_effect: BYPASSES
    description: >-
      Reconstruction changes the visible auricular manifestation; it does not reverse the prenatal HOXA2 patterning
      defect.
    evidence:
    - reference: DOI:10.3389/fsurg.2022.944223
      reference_title: Integrated microtia and aural atresia management
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        In discussing the spectrum of reconstructive options, observation should be presented with associated
        bene fits and drawbacks.
      explanation: >-
        General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment
        effect is measured.
      quote_role: REVIEW_SYNTHESIS
  notes: >-
    Observation is a legitimate choice. Choice and timing of reconstruction should account for the patient
    wishes, hearing rehabilitation and surgical risks.
  evidence:
  - reference: DOI:10.3389/fsurg.2022.944223
    reference_title: Integrated microtia and aural atresia management
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      In discussing the spectrum of reconstructive options, observation should be presented with associated
      bene fits and drawbacks.
    explanation: >-
      General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment
      effect is measured.
    quote_role: REVIEW_SYNTHESIS
- name: Cleft Palate Repair
  description: >-
    For patients with cleft palate, craniofacial-team assessment determines whether and when palatoplasty is
    indicated. General ACPA guidance places primary repair commonly at 9–14 months and ideally by 18 months,
    with individual readiness and airway risk considered. The source supplies general care recommendations,
    not genotype-specific efficacy.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: cleft palate repair
    term:
      id: NCIT:C168380
      label: Palatorrhaphy
  target_mechanisms:
  - target: Cleft Palate
    treatment_effect: BYPASSES
    description: >-
      Palatoplasty restores palatal continuity and function after the congenital cleft has formed; it does
      not correct the embryonic HOXA2 mechanism.
    evidence:
    - reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
      reference_title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        The goal of cleft palate surgery is to obtain normal function for speech and swallowing, as well as
        to optimize airway and dental facial relations.
      explanation: >-
        General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report
        HOXA2-specific outcomes.
      quote_role: REVIEW_SYNTHESIS
  notes: >-
    Relevant to the cleft phenotype documented in AR-MHIC. Assess feeding, speech and the airway before and
    after surgery; neither mouse cleft mechanism defines the surgical approach.
  evidence:
  - reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
    reference_title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      The goal of cleft palate surgery is to obtain normal function for speech and swallowing, as well as to
      optimize airway and dental facial relations.
    explanation: >-
      General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific
      outcomes.
    quote_role: REVIEW_SYNTHESIS
  - reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
    reference_title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      Primary surgery of cleft palate often occurs between 9-14 months of age. The timing should take into
      account the patient and/or family readiness (physically and emotionally). Ideally, the cleft palate should
      be closed by the age of 18 months.
    explanation: >-
      General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific
      outcomes. Timing is individualized, rather than an outcome established for this genotype.
    quote_role: REVIEW_SYNTHESIS
- name: Hearing Amplification
  description: >-
    Provide early hearing rehabilitation according to per-ear thresholds, canal anatomy and cochlear reserve.
    General bilateral microtia/atresia guidance recommends amplification by four months and early intervention
    by three to six months. Worn bone-conduction devices can bypass a narrowed or atretic canal; patients with
    patent canals may use conventional amplification if appropriate. Mixed loss requires assessment of the
    sensorineural component and device limits, rather than assuming normal cochlear function.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: hearing amplification
    term:
      id: NCIT:C15747
      label: Supportive Care
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: hearing aid
        term:
          id: NCIT:C183182
          label: Hearing Aid
  target_mechanisms:
  - target: Hearing Impairment
    treatment_effect: BYPASSES
    description: >-
      Amplification improves access to sound within the usable cochlear reserve. Bone conduction bypasses canal
      and middle-ear transmission abnormalities but does not repair inner-ear agenesis or restore intrinsic
      cochlear function.
    evidence:
    - reference: DOI:10.3389/fsurg.2022.944223
      reference_title: Integrated microtia and aural atresia management
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        Diagnostic audiological assessment should be completed by 2 – 3 months of age and the infant provided
        with hearing ampli fication by 4 months of age and enrolled in early intervention (EI) by 3 – 6 months
        of age to optimize speech and language development.
      explanation: >-
        General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment
        effect is measured. The timing recommendation is for bilateral microtia with atresia.
      quote_role: REVIEW_SYNTHESIS
  notes: >-
    Do not delay early hearing support while deciding on cosmetic ear reconstruction. Device and implant selection
    requires current specialist assessment; historical regulatory age cutoffs in the 2022 guidance are not
    generalized here.
  evidence:
  - reference: DOI:10.3389/fsurg.2022.944223
    reference_title: Integrated microtia and aural atresia management
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      Diagnostic audiological assessment should be completed by 2 – 3 months of age and the infant provided
      with hearing ampli fication by 4 months of age and enrolled in early intervention (EI) by 3 – 6 months
      of age to optimize speech and language development.
    explanation: >-
      General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment
      effect is measured. The timing recommendation is for bilateral microtia with atresia.
    quote_role: REVIEW_SYNTHESIS
  - reference: DOI:10.3389/fsurg.2022.944223
    reference_title: Integrated microtia and aural atresia management
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      Clinicians should encourage early use of these worn bone conduction devices for infants with CHL.
    explanation: >-
      General microtia/atresia guidance applied to the relevant HOXA2 phenotype; no HOXA2-specific treatment
      effect is measured.
    quote_role: REVIEW_SYNTHESIS
- name: Speech and Language Therapy
  description: >-
    Assess speech and language development in either subtype when hearing impairment or a palatal defect is
    present. Coordinate early intervention, educational support and targeted therapy. Speech therapy can address
    learned articulation errors; structural velopharyngeal dysfunction requires a separate surgical or prosthetic
    assessment.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: speech and language therapy
    term:
      id: NCIT:C159273
      label: Speech Language Therapy
  evidence:
  - reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
    reference_title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      The need for speech and/or language therapy for patients with a CL/P and/or other craniofacial difference,
      as well as the recommended nature of that therapy, should be based on results of a formal speech and
      language assessment and current best practices.
    explanation: >-
      General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific
      outcomes.
    quote_role: REVIEW_SYNTHESIS
- name: Genetic Counseling
  description: >-
    Discuss the identified genotype and variable phenotype with the family. When both parents carry a recessive
    pathogenic allele, each pregnancy has a 25% probability of an affected child; a heterozygous parent with
    a dominant pathogenic allele has a 50% transmission probability. These are Mendelian expectations conditional
    on parental genotypes, not empirically measured penetrance. Severity and hearing status cannot be predicted
    from transmission probability alone.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our data extend these conclusions and define HOXA2 haploinsufficiency as the first genetic cause for autosomal-dominant nonsyndromic microtia."
    explanation: >-
      Supports the inheritance mode. The stated recurrence probability is the Mendelian consequence of the
      specified parental genotype, rather than a measured outcome in this pedigree.

    directness: INDIRECT
  - reference: PMID:18394579
    reference_title: A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We ascertained a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate."
    explanation: >-
      Supports the inheritance mode. The stated recurrence probability is the Mendelian consequence of the
      specified parental genotype, rather than a measured outcome in this pedigree.
    directness: INDIRECT
- name: Feeding and nutrition support for cleft palate
  description: >-
    Assess feeding technique, intake, growth and hydration when cleft palate is present. A cleft team can select
    an appropriate specialized feeding system and monitor weight gain. This addresses the general functional
    risk of a cleft; a HOXA2-specific rate of feeding failure is not established.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_mechanisms:
  - target: Cleft Palate
    treatment_effect: BYPASSES
    description: >-
      A specialized feeding system compensates for impaired suction without closing the cleft.
    evidence:
    - reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
      reference_title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        Because infants with cleft palate cannot sustain the suction needed to maintain nutrition exclusively
        from the breast or standard bottle, they typically require specialized feeding systems to achieve adequate
        nutrition and hydration.
      explanation: >-
        General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report
        HOXA2-specific outcomes. Feeding difficulty is a care risk, not an additional measured HOXA2 phenotype
        frequency.
      quote_role: REVIEW_SYNTHESIS
  evidence:
  - reference: url:https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
    reference_title: https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      Because infants with cleft palate cannot sustain the suction needed to maintain nutrition exclusively
      from the breast or standard bottle, they typically require specialized feeding systems to achieve adequate
      nutrition and hydration.
    explanation: >-
      General cleft-palate guidance applied when a HOXA2 patient has a cleft; this source does not report HOXA2-specific
      outcomes. Feeding difficulty is a care risk, not an additional measured HOXA2 phenotype frequency.
    quote_role: REVIEW_SYNTHESIS
animal_models:
- name: Hoxa2 null mouse (Rijli 1993)
  species: Mouse
  genotype: Hoxa2 homozygous null (targeted disruption)
  publication: PMID:7903601
  description: >-
    Homozygous targeted disruption causes perinatal death and loss of normal second-arch mesenchymal identity
    despite preserved rhombomeric and neural crest segmentation. The source supports an identity defect; normal
    migration and survival are not separately demonstrated by the cached abstract.
  modeled_mechanisms:
  - target: Loss of Second Pharyngeal Arch Neural Crest Identity
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >-
      The model defines the identity-assignment lesion this node represents.
    limitations: >-
      A complete homozygous null differs from human heterozygous truncating alleles and homozygous p.Gln186Lys.
      Residual function of the human missense allele has not been measured in the cited family study.
    readouts:
    - name: Second-arch neural crest identity
      target: Loss of Second Pharyngeal Arch Neural Crest Identity
      direction: ALTERED
      interpretation: >-
        Second-arch crest adopts first-arch identity, the defining readout of
        the selector-gene lesion.
      evidence:
      - reference: PMID:7903601
        reference_title: "A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "While rhombomeric and neural crest cell (NCC) segmentation was not affected, mesenchymal NCC derivatives of the second arch were lacking, and second arch mesenchymal NCC identity was changed to first arch identity, resulting in homeotic transformation of second to first arch skeletal elements."
        explanation: The identity-change readout behind this link.
    evidence:
    - reference: PMID:7903601
      reference_title: "A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "The ground pattern program appears to be modified in the mouse first arch by a Hox-independent process, whereas Hoxa-2 acts as a selector gene in the second arch."
      explanation: >-
        Establishes the model as informative for HOXA2's second-arch selector
        function.
- name: Hoxa-2 null mouse (Gendron-Maguire 1993)
  species: Mouse
  genotype: Hoxa-2 (Hox 1.11) homozygous targeted mutation
  publication: PMID:7903600
  description: >-
    An independent null allele reported simultaneously. Homozygotes are born
    with cleft palate and die within 24 hours, with duplicated middle-ear
    ossification centres and a second Meckel's cartilage beside the otic
    capsule.
  modeled_mechanisms:
  - target: Homeotic Transformation of Second-Arch Skeletal Derivatives
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Defines the complete-null mouse skeletal homeosis, including duplicated middle-ear ossification centers.
    limitations: >-
      The perinatally lethal complete-null phenotype is more extensive than the observed human ossicular dysplasia.
      Human imaging and surgery do not establish an equivalent homeotic duplication.
    readouts:
    - name: Middle-ear ossification centre duplication
      target: Homeotic Transformation of Second-Arch Skeletal Derivatives
      direction: INCREASED
      interpretation: >-
        Duplicated ossification centres are the skeletal signature of
        second-to-first arch transformation.
      evidence:
      - reference: PMID:7903600
        reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Analysis of stained skeletons revealed that homozygous mutant animals contained multiple cranial skeletal defects, including a duplication of the ossification centers of the bones of the middle ear."
        explanation: The skeletal readout behind this link.
    evidence:
    - reference: PMID:7903600
      reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Skeletal elements normally derived from the second arch were absent in the mutants."
      explanation: >-
        Establishes the model as informative for loss of second-arch skeletal
        derivatives.
  - target: Cleft Palate
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      The mouse null has cleft palate, providing a phenotypic correspondence to the original recessive human
      family.
    limitations: >-
      The complete-null mouse is perinatally lethal, whereas the original human recessive family has a partial
      cleft and viable affected relatives. This does not establish normal long-term survival for every possible
      human genotype.
    readouts:
    - name: Palatal closure
      target: Cleft Palate
      direction: ABOLISHED
      interpretation: >-
        Homozygous null mice were reported with cleft palate; the cached abstract does not provide a denominator
        for penetrance.
      evidence:
      - reference: PMID:7903600
        reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Mice homozygous for a targeted mutation of the Hoxa-2 (Hox 1.11) gene are born with cleft palates and die within 24 hr of birth."
        explanation: The palatal readout behind this link.
    evidence:
    - reference: PMID:7903600
      reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Mice homozygous for a targeted mutation of the Hoxa-2 (Hox 1.11) gene are born with cleft palates and die within 24 hr of birth."
      explanation: >-
        Establishes the model as informative for the palatal phenotype of the
        recessive subtype.
- name: Hoxa1/Hoxa2 double mutant mouse (Barrow 1999)
  species: Mouse
  genotype: Compound targeted allele disrupting both of the linked genes Hoxa1 and Hoxa2
  publication: PMID:10529419
  description: >-
    A single allele disrupting both linked genes, analysed against the single
    mutants. Some double-mutant craniofacial defects are additive combinations
    of the single-mutant ones and others appear only in the double mutant. The
    result that matters here is a rescue: compensatory defects associated with
    loss of Hoxa1 restore the hyoglossus attachment that is blocked in Hoxa2
    mutants, and the penetrance of cleft palate falls sharply.
  modeled_mechanisms:
  - target: Mis-Attachment of the Extrinsic Tongue and Hyoid Muscles
    relationship: RESCUES
    fidelity: MODERATE
    description: >-
      Loss of Hoxa1 on the Hoxa2-mutant background restores normal attachment
      of the hyoglossus to the greater horn of the hyoid.
    limitations: >-
      The rescue is by a second mutation rather than by restoring Hoxa2 or by
      any treatment, so it establishes that the palate depends on the
      attachment without showing how the attachment is normally specified. It
      is also a mouse result with no human counterpart.
    readouts:
    - name: Hyoglossus attachment to the greater horn of the hyoid
      target: Mis-Attachment of the Extrinsic Tongue and Hyoid Muscles
      direction: RESTORED
      interpretation: >-
        The attachment blocked in Hoxa2 single mutants is made again in the
        double mutants.
      evidence:
      - reference: PMID:10529419
        reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "We show that two compensatory defects, associated with the loss of Hoxa1 function, restore normal attachment of the hyoglossus to the greater horn thereby allowing the palatal shelves to lift and fuse above the flattened tongue."
        explanation: The attachment readout behind this link.
    evidence:
    - reference: PMID:10529419
      reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "To understand how these two genes function together in craniofacial development, an allele was generated that disrupts both of these linked genes."
      explanation: >-
        Identifies the compound allele that makes this model informative for
        the muscle-attachment node.
  - target: Cleft Palate
    relationship: RESCUES
    fidelity: MODERATE
    description: >-
      Restoring the hyoglossus attachment sharply reduces the penetrance of
      cleft palate, which is the experimental support for treating the muscle
      defect as causal rather than coincidental.
    limitations: >-
      Penetrance falls but the abstract does not report how far, and the rescue
      is genetic. It also does not exclude the palate-intrinsic route reported
      by Smith and colleagues, which was measured in explant culture rather
      than in this model.
    readouts:
    - name: Cleft palate penetrance
      target: Cleft Palate
      direction: DECREASED
      interpretation: >-
        The cleft that Hoxa2 single mutants show is much less penetrant once
        the attachment is restored; the abstract does not give the figures.
      evidence:
      - reference: PMID:10529419
        reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Unexpectedly, in Hoxa1/Hoxa2 double mutants, the penetrance of cleft palate is dramatically reduced."
        explanation: The palatal readout behind this link.
    evidence:
    - reference: PMID:10529419
      reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "We show that two compensatory defects, associated with the loss of Hoxa1 function, restore normal attachment of the hyoglossus to the greater horn thereby allowing the palatal shelves to lift and fuse above the flattened tongue."
      explanation: >-
        Ties the restored attachment to restored palatal closure, which is what
        makes the model informative for the cleft.
- name: Conditional Hoxa2 inactivation mouse (Minoux 2013)
  species: Mouse
  genotype: Conditional Hoxa2 inactivation at early versus late gestational stages, plus conditional ectopic Hoxa2 in first-arch neural crest
  publication: PMID:24067355
  description: >-
    Stage-specific conditional inactivation separates the auricular phenotype
    from the lethal null. Early inactivation abolishes the auricle and
    duplicates the external auditory canal; late inactivation yields a
    hypomorphic auricle that the authors take to mimic the human HOXA2 mutant
    condition. The reciprocal gain-of-function experiment - ectopic Hoxa2 in
    first-arch crest - duplicates the pinna and eliminates the canal.
  modeled_mechanisms:
  - target: Failed Auricular Morphogenesis
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >-
      Late inactivation produces auricular hypoplasia resembling the human phenotype. Fate mapping defines
      the Hoxa2-expressing territory examined in the mouse study.
    limitations: >-
      Mouse and human pinna morphology differ substantially, and the model's
      resemblance to the human condition is the authors' assessment rather than
      a quantified comparison.
    readouts:
    - name: Auricle size and presence by stage of Hoxa2 inactivation
      target: Failed Auricular Morphogenesis
      direction: DECREASED
      interpretation: >-
        Auricular severity tracks the developmental stage at which Hoxa2 is
        removed, from complete absence to hypoplasia.
      evidence:
      - reference: PMID:24067355
        reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "In mice, Hoxa2 inactivation at early gestational stages results in external auditory canal (EAC) duplication and absence of the auricle, whereas its late inactivation results in a hypomorphic auricle, mimicking the human HOXA2 mutant condition."
        explanation: The stage-dependent auricular readout behind this link.
    - name: Pinna lineage by genetic fate mapping
      target: Failed Auricular Morphogenesis
      direction: ALTERED
      interpretation: >-
        The investigators trace the auricular territory they call pinna to second-arch mesenchyme; the review
        literature notes that including the tragus and root changes the anatomical scope.
      evidence:
      - reference: PMID:24067355
        reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "By genetic fate mapping we found that the mouse auricle (or pinna) derives from the Hoxa2-expressing neural crest-derived mesenchyme of the second pharyngeal arch, and not from a composite of first and second arch mesenchyme as previously proposed based on morphological observation of human embryos."
        explanation: The lineage readout behind this link.
    evidence:
    - reference: PMID:24067355
      reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Thus, Hoxa2 loss- and gain-of-function approaches in mice provide a suitable model to investigate the molecular aetiology of microtia and auricle duplication."
      explanation: >-
        The authors' own statement that the model is suitable for the human
        aetiology this node represents.

- name: Hoxa2 hypomorphic dosage-series mouse
  species: Mouse
  genotype: Hypomorphic Hoxa2 allele combined with wild-type or null alleles
  publication: PMID:11578867
  description: >-
    An allele with about 45% of wild-type transcriptional activity was combined with normal and null alleles
    to create a dosage series. Second-arch development was more sensitive than hindbrain patterning, and proximal-caudal
    arch regions were more sensitive than rostro-distal regions. This supports regional dose sensitivity without
    assigning a residual activity to a human variant.
  modeled_mechanisms:
  - target: Loss of Second Pharyngeal Arch Neural Crest Identity
    relationship: PERTURBS
    model_scale: TISSUE
    limitations: >-
      An engineered transcriptional-dose series does not measure patient missense function or distinguish every
      cause of human-mouse phenotypic divergence.
    evidence:
    - reference: PMID:11578867
      reference_title: Different levels of Hoxa2 are required for particular developmental processes.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: >-
        Analysis of these embryos indicates that in general the hindbrain is more resistant to Hoxa2 deficiencies
        than the second branchial arch.
      explanation: >-
        Different embryonic regions respond differently to experimental Hoxa2 dose.
    - reference: PMID:11578867
      reference_title: Different levels of Hoxa2 are required for particular developmental processes.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: DIRECT
      snippet: >-
        We have created a Hoxa2 allele that is about 45% as active in transcription as its wild-type counterpart.
      explanation: >-
        Engineered mouse allele, not a measured residual level in a patient.
  evidence:
  - reference: PMID:11578867
    reference_title: Different levels of Hoxa2 are required for particular developmental processes.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: >-
      We have created a Hoxa2 allele that is about 45% as active in transcription as its wild-type counterpart.
    explanation: >-
      Engineered mouse allele, not a measured residual level in a patient.
  - reference: PMID:11578867
    reference_title: Different levels of Hoxa2 are required for particular developmental processes.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: DIRECT
    snippet: >-
      Analysis of these embryos indicates that in general the hindbrain is more resistant to Hoxa2 deficiencies
      than the second branchial arch.
    explanation: >-
      Different embryonic regions respond differently to experimental Hoxa2 dose.
discussions:
- discussion_id: hoxa2_mouse_null_lethality_vs_human_viability
  kind: HUMAN_MODEL_MISMATCH
  prompt: >-
    Why does complete Hoxa2 loss kill mice at birth with a full second-to-first
    arch homeotic transformation, while human HOXA2 loss-of-function alleles
    produce a viable, largely isolated ear malformation?
  attaches_to:
  - pathophysiology#Homeotic Transformation of Second-Arch Skeletal Derivatives
  - animal_models#Hoxa2 null mouse (Rijli 1993)
  - animal_models#Hoxa-2 null mouse (Gendron-Maguire 1993)
  rationale: >-
    The complete mouse null is perinatally lethal with extensive skeletal homeosis, whereas characterized human
    heterozygous truncating and homozygous p.Gln186Lys genotypes are viable. Dose, developmental timing and
    species differences may contribute. Mouse hypomorphic alleles establish dose sensitivity, but residual
    activity of the human missense allele was not measured in the founding study. Human ossicular dysplasia
    therefore should not be described as proven partial homeotic duplication.
  evidence:
  - reference: PMID:7903600
    reference_title: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Mice homozygous for a targeted mutation of the Hoxa-2 (Hox 1.11) gene are born with cleft palates and die within 24 hr of birth."
    explanation: The lethal mouse null phenotype at one end of the mismatch.
  - reference: PMID:27503514
    reference_title: Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we describe a five-generation family with isolated bilateral microtia segregating as an autosomal dominant trait."
    explanation: >-
      A five-generation pedigree of viable, isolated human disease at the other
      end of the mismatch.
  - reference: PMID:24067355
    reference_title: Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "In mice, Hoxa2 inactivation at early gestational stages results in external auditory canal (EAC) duplication and absence of the auricle, whereas its late inactivation results in a hypomorphic auricle, mimicking the human HOXA2 mutant condition."
    explanation: >-
      Shows that timing of Hoxa2 loss alone spans much of the severity gap,
      which is part of the candidate resolution.
- discussion_id: hoxa2_sensorineural_component_unexplained
  kind: KNOWLEDGE_GAP
  prompt: >-
    What explains the sensorineural component of hearing loss in HOXA2-affected ears without demonstrated inner-ear
    agenesis?
  attaches_to:
  - phenotypes#Mixed Hearing Impairment
  rationale: >-
    The original recessive family includes one left inner-ear agenesis confirmed by CT and MRI, while two other
    examined relatives had normal inner-ear structures despite mixed hearing loss. Mixed loss also occurs in
    the p.Gln235* dominant family. Thus the gap is not absence of any human inner-ear characterization: the
    unresolved question is why sensorineural dysfunction occurs in other ears, and how it relates to HOXA2
    development.
  evidence:
  - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
    reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      The inner-ear structures were normal in patients V: 2 and V: 3, but there were no inner-ear structures
      on the left side for IV: 3.
    explanation: >-
      Unilateral inner-ear agenesis in one recessive-family member, with normal inner-ear anatomy in the other
      two imaged relatives.
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Audiometric testing was performed on three of the affected family members and showed mild to severe bilateral
      mixed hearing loss (Fig. 1C).
    explanation: >-
      Direct dominant-family audiology. The figure caption includes a mild conductive-only left ear in one
      relative, so not every tested ear had both components.
  - reference: url:https://pmc.ncbi.nlm.nih.gov/articles/2427268/
    reference_title: A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      All four affected family individuals showed bilateral symmetric severe to profound mixed hearing impairment
      affecting all frequencies and leading to a flat audiometric shape.
    explanation: >-
      The four affected members of the original recessive family; this severity should not be transferred to
      all dominant cases.
- discussion_id: hoxa2_cleft_palate_tongue_versus_intrinsic_palate
  kind: CONTROVERSY
  prompt: >-
    Is the Hoxa2-associated cleft palate secondary to abnormal tongue
    musculature, intrinsic to the palatal shelves, or both?
  attaches_to:
  - pathophysiology#Abnormal Tongue Posture Obstructing Palatal Shelf Closure
  - pathophysiology#Intrinsic Palatal Shelf Fusion Defect
  - phenotypes#Cleft Palate
  rationale: >-
    Two mouse accounts are on record and they are not the same claim. Barrow
    and Capecchi report that mis-attachment of the hyoglossus correlates
    exactly with cleft palate in Hoxa2 mutants and suggest that the resulting
    tongue posture blocks the shelves, with a genetic rescue in Hoxa1/Hoxa2
    double mutants as support. Smith and colleagues report Hoxa2 expression in
    the palate itself and reduced fusion of Hoxa2-null shelves cultured without
    a tongue, and conclude explicitly that the cleft is not solely due to the
    tongue musculature. The two are compatible - a mechanical obstruction and a
    shelf-intrinsic fusion defect could both contribute - but their relative
    contribution has not been quantified, and neither has been examined in a
    HOXA2-mutant patient, in whom the cleft is partial rather than complete.
    Until that is settled, this entry carries both nodes and asserts neither as
    the mechanism of the human cleft.
  evidence:
  - reference: PMID:10529419
    reference_title: Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We suggest that the hyoglossus, whose function is to depress the lateral edges of the tongue, when unable to make its proper attachment to the greater horn of the hyoid, forces the tongue to adopt an abnormal posture which blocks closure of the palatal shelves."
    explanation: The tongue-musculature position, in its authors' own hedged wording.
  - reference: PMID:19653318
    reference_title: Hoxa2 plays a direct role in murine palate development.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "The cleft palate exhibited by Hoxa2 null murine embryos has been described as being secondary to abnormalities of tongue musculature, and Hoxa2 was presumed to not play a direct role in palate development."
    explanation: >-
      The second group's statement of the prior position, which is what they
      set out to test.
    quote_role: BACKGROUND
  - reference: PMID:19653318
    reference_title: Hoxa2 plays a direct role in murine palate development.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "These results demonstrate the cleft palate phenotype of Hoxa2 null embryos is not solely due to abnormal tongue musculature, and indicate a direct role of Hoxa2 in regulating murine palatogenesis."
    explanation: The palate-intrinsic position, stated as a conclusion.

notes: >-
  This entry covers the recessive microtia-hearing impairment-cleft palate presentation and dominant HOXA2-related
  microtia as allelic subtypes of one developmental disorder. Cleft palate is documented in the original recessive
  family, but phenotype breadth and hearing severity require individual assessment. Pedigree-based observations
  do not support population frequency bands. General microtia/atresia and cleft-palate care recommendations
  are extrapolated to the relevant manifestations; HOXA2-specific treatment outcomes have not been established
  by the cited sources.

  Source identification: American Cleft Palate Craniofacial Association, 2024 Parameters
  of Care. Feeding, speech and palatal-surgery recommendations are general craniofacial guidance extrapolated
  to the relevant HOXA2 phenotype. Francesca Piceci Sparascio, Study of molecular basis of Oculo-Auricolo-Vertebral-Spectrum,
  Università di Foggia doctoral dissertation, academic year 2015–2016. The HOXA2 section on pages 68–71 describes
  the p.Glu224* pedigree also reported in PMID:27503514. Full text of Alasti et al. 2008 (PMID:18394579; PMCID:PMC2427268).
  The PMID cache supplies the abstract; this linked PMC cache supplies the clinical and imaging passages quoted
  here. Full text of Cox et al. 2014 (PMID:24880027; PMCID:PMC4143470), used for the auricular lineage and
  anatomical terminology discussion.

datasets: []
experimental_models:
- name: HOXA2 variant HMX1 enhancer reporter assay
  experimental_model_type: OTHER
  description: >-
    Dual-luciferase assays compare enhancer activation by p.Lys213* and p.Gln235* variants. The accessible
    abstract does not specify the host-cell identity, so no cell-line or tissue origin is inferred.
  modeled_mechanisms:
  - target: Impaired Transactivation of the Long-Range HMX1 Enhancer
    relationship: MEASURES
    model_scale: MOLECULAR
    limitations: >-
      An isolated reporter does not reproduce human auricular development or quantify clinical penetrance.
    evidence:
    - reference: PMID:32649979
      reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: >-
        Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation
        of the long-range enhancer of HMX1.
      explanation: >-
        Variant-specific reporter assay for p.Lys213* and p.Gln235*.
  evidence:
  - reference: PMID:32649979
    reference_title: Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: >-
      Using dual luciferase reporter assays, we showed that both HOXA2 mutations have impaired activation of
      the long-range enhancer of HMX1.
    explanation: >-
      Variant-specific reporter assay for p.Lys213* and p.Gln235*.
- name: Tongue-free Hoxa2 mutant palate organ culture
  experimental_model_type: OTHER
  description: >-
    Null palatal shelves cultured without a tongue have reduced fusion; antisense Hoxa2 knockdown also reduces
    fusion. This demonstrates an intrinsic component in the mouse system alongside the separate tongue-mechanics
    hypothesis.
  modeled_mechanisms:
  - target: Intrinsic Palatal Shelf Fusion Defect
    relationship: PARTIALLY_RECAPITULATES
    model_scale: TISSUE
    limitations: >-
      Explant fusion rates do not quantify in-vivo penetrance or establish the relative mechanism of the human
      partial cleft.
    evidence:
    - reference: PMID:19653318
      reference_title: Hoxa2 plays a direct role in murine palate development.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: >-
        Organ cultures of Hoxa2(-/-) palates maintained in the absence of the tongue showed decreased fusion
        rates than either Hoxa2(+/-) or Hoxa2(+/+) palate cultures.
      explanation: >-
        Tongue-free mouse organ culture isolates a palate-intrinsic contribution.
  evidence:
  - reference: PMID:19653318
    reference_title: Hoxa2 plays a direct role in murine palate development.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: >-
      Organ cultures of Hoxa2(-/-) palates maintained in the absence of the tongue showed decreased fusion
      rates than either Hoxa2(+/-) or Hoxa2(+/+) palate cultures.
    explanation: >-
      Tongue-free mouse organ culture isolates a palate-intrinsic contribution.
differential_diagnoses:
- name: FGF3-related labyrinthine aplasia, microtia and microdontia
  disease_term:
    preferred_term: deafness with labyrinthine aplasia, microtia, and microdontia
    term:
      id: MONDO:0012541
      label: deafness with labyrinthine aplasia, microtia, and microdontia
  description: >-
    FGF3-related disease can share microtia and inner-ear agenesis. Microdontia and the broader pattern of
    inner-ear malformation help distinguish it; molecular testing separates the disorders.
  distinguishing_features:
  - FGF3-associated microdontia and inner-ear agenesis contrast with variable inner-ear findings in HOXA2 families.
  evidence:
  - reference: PMID:23775976
    reference_title: HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      FGF3 (congenital deafness, inner ear agenesis, microtia, microdontia; MIM  # 164950)
    explanation: >-
      Background clinical differential in the primary HOXA2 report.
    quote_role: BACKGROUND
📚

References & Deep Research

References

15
A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family.
No top-level findings curated for this source.
HOXA2 haploinsufficiency in dominant bilateral microtia and hearing loss.
No top-level findings curated for this source.
Identification of a second HOXA2 nonsense mutation in a family with autosomal dominant non-syndromic microtia and distinctive ear morphology.
No top-level findings curated for this source.
Identification of loss-of-function HOXA2 mutations in Chinese families with dominant bilateral microtia.
No top-level findings curated for this source.
Integrated microtia and aural atresia management
No top-level findings curated for this source.
Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.
No top-level findings curated for this source.
Different levels of Hoxa2 are required for particular developmental processes.
No top-level findings curated for this source.
Hoxa2 plays a direct role in murine palate development.
No top-level findings curated for this source.
Mouse Hoxa2 mutations provide a model for microtia and auricle duplication.
No top-level findings curated for this source.
Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest.
No top-level findings curated for this source.
A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene.
No top-level findings curated for this source.
https://acpacares.org/wp-content/uploads/2025/02/2024-ACPA_ParametersOfCare_Final.pdf
No top-level findings curated for this source.
https://fair.unifg.it/retrieve/de2a638f-fc40-8577-e053-3705fe0aa5f3/tesi%20definitiva.pdf
No top-level findings curated for this source.
A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family - PMC
No top-level findings curated for this source.
The genetics of auricular development and malformation: new findings in model systems driving future directions for microtia research - PMC
No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (2)

Remove fabricated cleft-palate mechanism; curate the two published mouse accounts · 2026-09-04T20:33:14Z · View source

Review of PR #10909 found a fabricated mechanism in an ungated prose field: the Cleft Palate Repair treatment's target_mechanisms description asserted that the cleft was caused by 'ectopic second-arch cartilage obstructing elevation of the palatal shelves'. No cited reference says this. All nine references cited in the entry were grepped for palate, cartilage, shelf, shelves, tongue, hyoglossus and hyoid: the only near neighbour is PMID:7903600's duplicated Meckel's cartilage beside the otic capsule, a middle-ear finding that says nothing about the palate, and PMID:7903600's statement that the mouse null is born with cleft palate, which is the fact and not the mechanism. The falcon deep-research report does not contain the claim either; its own wording is the hedged 'abnormal palate development provides a route to cleft palate'. The clause was removed and replaced with the two mouse accounts that are actually published, each curated as a pathophysiology node with quoted evidence. 1. Barrow and Capecchi 1999 (PMID:10529419, fetched via just fetch-reference): mis-attachment of the extrinsic tongue and hyoid muscles, with the abnormal trajectory of the styloglossus and stylohyoideus blocking the hyoglossus attachment to the greater horn of the hyoid, correlating exactly with cleft palate; and the authors' suggestion that the resulting tongue posture blocks palatal shelf closure. Curated as two nodes so that the observation and the interpretation carry separate evidence, with the Hoxa1/Hoxa2 double-mutant rescue as the support for the link. Added the double-mutant mouse as an animal model with two RESCUES links. 2. Smith et al. 2009 (PMID:19653318, found by PubMed search for HOXA2 AND palatogenesis): Hoxa2 expression in the palate itself, reduced fusion of Hoxa2-null shelves cultured without a tongue, and the authors' explicit conclusion that the cleft is not solely due to the tongue musculature. Curated as the Intrinsic Palatal Shelf Fusion Defect node hanging off HOXA2 Loss of Function. A CONTROVERSY discussion, hoxa2_cleft_palate_tongue_versus_intrinsic_palate, records that the two accounts are both mouse, are compatible, have not been weighed against each other, and have not been examined in a HOXA2-mutant patient. The entry now asserts neither as the mechanism of the human cleft. The downstream edge from Homeotic Transformation of Second-Arch Skeletal Derivatives to Cleft Palate was removed: no source links the skeletal transformation to the cleft. Its evidence, that the mouse null is born with cleft palate, is a genotype-level co-occurrence and was moved to the Cleft Palate phenotype, where the description already made that statement. Smaller prose corrections found in the same sweep: the treatment notes said 'seven cited references' and there are now nine; a model readout interpretation turned 'penetrance dramatically reduced' into 'most double mutants', which the abstract does not support; the HMX1 enhancer node stated Hoxa2-Hmx1 enhancer binding without the 'in mouse' qualifier the source carries; CL:0000008 carried a preferred_term broader than the ontology label; and the notes now record that the falcon report argued against lumping the dominant families and why that was not followed. Validation: just validate (schema, terms, references - 77/77 snippets verified), validate-terms, count-verified-snippets, check-entity-refs, check-duplicate-keys, check-causal-targets, check-enum-values, check-qualifier-terms, check-folded-hyphens, check-snippet-length, check-title-snippets, check-snippet-grading, validate-disorders. Pathograph wiring was checked by hand: no dangling bare-name targets, no node without an incoming edge except the root, and every phenotype is a target.

Review round 1 fixes: prevalence band, two ontology rebindings, deep-research pass, pathograph joins · 2026-09-04T18:08:31Z · View source

Addressed the CHANGES_REQUESTED review of 2026-09-04T06:58Z on PR #10909. All four blocking items fixed and all three suggestions taken, in one push. BLOCKING 1 (fixed). prevalence_class on the all-causes microtia birth-prevalence record was BAND_1_9_PER_100000 while the recorded interval is 10.0-12.5 per 100,000, so the whole interval sat above the band ceiling. Changed to BAND_1_5_PER_10000, which the schema defines as 1-9 per 10,000 equals 10-99 per 100,000. Rate numbers and notes unchanged; the arithmetic was already correct. BLOCKING 2 (fixed). Ran a falcon deep-research pass and committed research/Bilateral_Microtia-Deafness-Cleft_Palate_Syndrome-deep-research-falcon.md with its citations sidecar, artifact, and the eleven DOI reference caches the run fetched. 30 citations, 11 of 11 references verified at 0.0 confabulation, 2 on topic, 1 flagged off topic, 29 of 29 terms resolved. just preflight-dr against MONDO:0012854 returns PASS with HOXA2 mentioned 54 times. The report's outcome is recorded in the entry-level notes: - One real gap found. Meddaugh and Zambrano 2020 (PMID:31567444) is a sixth published HOXA2 family, a four-generation pedigree with microtia and variable hearing impairment, which the manual sweep missed. It cannot be curated as evidence: both the PubMed record and the DOI record are abstract-free, so the caches are title-only and there is no quotable sentence. Recorded in notes rather than added to references: as a tagged-but-not-mined citation, following the same reasoning the sibling hearing-loss entries use for the GeneReviews overview. The report attributes a truncating allele around Glu229 to that family; that is unverified and is explicitly not asserted anywhere in the entry. Softened the two family-count statements (the Bilateral Microtia phenotype notes and the CASES_IN_LITERATURE prevalence notes) so they read as counts of citable families rather than of the literature, without moving the ULTRA_RARE band. - One lead checked and not taken. Wilderman et al. 2024 describe a roughly 600-kb noncoding global control region between NPVF and NFE2L3 driving anterior HOXA expression, whose mouse deletion produces orofacial clefts resembling the Hoxa2 null. That is upstream regulatory architecture for the cluster, not a HOXA2 lesion in any reported patient with this disease; the report says so itself. Recorded as a candidate for a future regulatory-variant node. - One independent confirmation. The report's management citations are all general microtia and aural-atresia literature - international consensus recommendations, integrated atresia management, a national treatment guideline - and none is HOXA2-specific. That corroborates the treatments section's existing statement that no HOXA2-specific outcome data exists, which had rested on the curator's own search. BLOCKING 3 (fixed). Rebound the Loss of Second Pharyngeal Arch Neural Crest Identity cell type from CL:0000333 migratory neural crest cell to CL:0000008 migratory cranial neural crest cell, which matches the node's own preferred_term. Verified through OAK and it passes validate-terms and dynamic-enum membership; both CURIEs were already cached so no cache CSV changed. BLOCKING 4 (fixed). Rebound the Auricular Reconstruction treatment term from the generic NCIT:C15329 Surgical Procedure to NCIT:C25351 Reconstructive Surgery. Confirmed through OAK that NCIT:C25351 has NCIT:C25218 Clinical Intervention or Procedure among its ancestors, so it is a valid TreatmentTerm. SUGGESTION (taken). Added target_mechanisms to the two therapeutic treatments, using bare pathograph names rather than entity-reference syntax. Auricular Reconstruction targets the Bilateral Microtia phenotype and Hearing Amplification targets the Hearing Impairment phenotype, both with treatment_effect: BYPASSES, because neither corrects the developmental lesion. Verified with dismech.graph.build_causal_graph that both edges resolve and orphan_targets is empty. Neither link carries evidence, and each treatment's notes now says why: no published series reports outcomes in HOXA2-mutant patients, so a quote would have to come from the general microtia literature and would attribute to this disease something no source says about it. SUGGESTION (taken). Replaced the ambiguous attaches_to: animal_models#Mouse on the HUMAN_MODEL_MISMATCH discussion, which resolved against species and so pointed at all three mouse models indistinguishably, with the two specific model names the mismatch concerns: Hoxa2 null mouse (Rijli 1993) and Hoxa-2 null mouse (Gendron-Maguire 1993). Both resolve under check-entity-refs. SUGGESTION (taken, in a different form than proposed). Bilaterality is now carried on the Bilateral Microtia phenotype_term's preferred_term, which reads Bilateral microtia against the HP:0008551 Microtia binding. A laterality qualifier was considered and rejected: HP has no non-obsolete bilateral-microtia term (HP:0040111 is obsolete), no dismech entry uses a laterality predicate-value qualifier so there is no precedent to follow, and CLAUDE.md records that qualifier terms are invisible to validate-terms and have previously hidden 32 wrong bindings. Carrying the specificity in preferred_term is the pattern the Ontology Term Contract endorses. Validation. just validate, validate-terms, count-verified-snippets (57/57), check-entity-refs, check-duplicate-keys, check-causal-targets, check-enum-values, check-qualifier-terms all pass on the file. Whole-KB check-folded-hyphens, check-title-snippets, check-snippet-length and check-snippet-grading report no new divergences. check-source-defect-claims reports nothing for this entry. qc-deep-research on the new report shows 11 cited references not consumed into the entry, which is an advisory census and well inside the normal range. No cache/**.csv changed.

Falcon ▸
Disease Characteristics Research Template
Edison Scientific Literature 30 citations 2026-09-04T10:40:47.297006

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on: 1. Key concepts and definitions with current understanding 2. Recent developments and latest research (prioritize 2023-2024 sources) 3. Current applications and real-world implementations 4. Expert opinions and analysis from authoritative sources 5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available. Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Disease Characteristics Research Template

Target Disease

  • Disease Name: Bilateral Microtia-Deafness-Cleft Palate Syndrome
  • MONDO ID: (if available)
  • Category: Mendelian

Research Objectives

Please provide a comprehensive research report on Bilateral Microtia-Deafness-Cleft Palate Syndrome covering all of the disease characteristics listed below. This report will be used to populate a disease knowledge base entry. Be thorough and cite primary literature (PMID preferred) for all claims.

For each section, suggested databases/resources are listed. These are the first places you should search for information on each topic.


1. Disease Information

Search first: OMIM, Orphanet, ICD-10/ICD-11, MeSH, PubMed

  • What is the disease? Provide a concise overview.
  • What are the key identifiers? (OMIM, Orphanet, ICD-10/ICD-11, MeSH, Mondo)
  • What are the common synonyms and alternative names?
  • Is the information derived from individual patients (e.g., EHR) or aggregated disease-level resources?

2. Etiology

  • Disease Causal Factors: What are the primary causes? (genetic, environmental, infectious, mechanistic)
  • Risk Factors:

    Search first: PubMed, Cochrane Library, UpToDate, clinical guidelines, ClinVar, ClinGen, GWAS Catalog, PheGenI, CTD, CDC, WHO, epidemiological databases

  • Genetic risk factors (causal variants, susceptibility loci, modifier genes)
  • Environmental risk factors (toxins, lifestyle, occupational exposures, age, sex, family history)
  • Protective Factors:

    Search first: PubMed, Cochrane Library, clinical trial databases, GWAS Catalog, gnomAD, WHO, CDC, nutrition databases

  • Genetic protective factors (protective variants, modifier alleles)
  • Environmental protective factors (diet, lifestyle, exposures that reduce risk)
  • Gene-Environment Interactions: How do genetic and environmental factors interact to influence disease?

    Search first: CTD, PubMed, PheGenI, GxE databases

3. Phenotypes

Search first: HPO (Human Phenotype Ontology), OMIM, Orphanet, PubMed, clinicaltrials.gov, MedDRA, SNOMED CT, DECIPHER, LOINC

For each phenotype, provide: - Phenotype type: symptoms, clinical signs, physical manifestations, behavioral changes, or laboratory abnormalities

For symptoms/signs: HPO, OMIM, Orphanet, PubMed For behavioral changes: HPO, DSM, RDoC (Research Domain Criteria), PubMed For laboratory abnormalities: LOINC, SNOMED CT, LabTests Online, PubMed - Phenotype characteristics: Search first: OMIM, Orphanet, HPO, PubMed - Age of symptom onset (neonatal, childhood, adult-onset, late-onset) - Symptom severity (mild, moderate, severe, variable) - Symptom progression (stable, progressive, episodic, fluctuating) - Frequency among affected individuals (percentage or qualitative) - Quality of life impact: Effects on daily functioning and well-being (per-phenotype when possible) Search first: EQ-5D database, SF-36, WHO QOL databases, PubMed - Suggest HPO (Human Phenotype Ontology) terms for each phenotype

4. Genetic/Molecular Information

  • Causal Genes: Gene mutations or chromosomal abnormalities responsible for disease (gene symbols, OMIM IDs)

    Search first: OMIM, ClinVar, HGMD, Ensembl, NCBI Gene

  • Pathogenic Variants:
  • Affected genes (gene symbols, HGNC IDs) > Search first: OMIM, NCBI Gene, Ensembl, HGNC, UniProt, GeneCards
  • Variant classification (pathogenic, likely pathogenic, VUS per ACMG/AMP guidelines) > Search first: ClinVar, ClinGen, ACMG/AMP guidelines, VarSome
  • Variant type/class (missense, frameshift, nonsense, splice-site, structural)
  • Allele frequency in population databases > Search first: gnomAD, 1000 Genomes, ExAC, TOPMed, dbSNP
  • Somatic vs germline origin > Search first: COSMIC (somatic), ClinVar, ICGC, TCGA
  • Functional consequences (loss of function, gain of function, dominant negative)
  • Modifier Genes: Genes that modify disease severity or expression
  • Epigenetic Information: DNA methylation, histone modifications, chromatin changes affecting disease

    Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth

  • Chromosomal Abnormalities: Large-scale genetic changes (aneuploidy, translocations, inversions)

    Search first: DECIPHER, ClinVar, ECARUCA, UCSC Genome Browser

5. Environmental Information

  • Environmental Factors: Non-genetic contributing factors (toxins, radiation, pollution, occupational exposure)

    Search first: CTD (Comparative Toxicogenomics Database), TOXNET, PubMed, EPA databases

  • Lifestyle Factors: Behavioral factors (smoking, diet, exercise, alcohol consumption)

    Search first: CDC databases, WHO, PubMed, NHANES

  • Infectious Agents: If applicable, pathogens causing or triggering disease (bacteria, viruses, fungi, parasites)

    Search first: NCBI Taxonomy, ViPR, BV-BRC, MicrobeDB, GIDEON

6. Mechanism / Pathophysiology

Present this section as an ordered causal chain first, then the detail below. Open with a numbered sequence of mechanistic steps running from the initiating lesion (mutation, exposure, infection) to the clinical manifestation, one step per line, each naming what it causes next. State the causal verb explicitly ("leads to", "results in") and say where a step is inferred rather than demonstrated. Where the mechanism branches, show the branch. The categories below are a checklist of what to cover within those steps, not the organizing structure — a step may draw on several of them, and a category may contribute to several steps.

  • Molecular Pathways: Specific signaling cascades or biochemical pathways involved (Wnt, MAPK, mTOR, PI3K-AKT, etc.)

    Search first: KEGG, Reactome, WikiPathways, PathBank, BioCyc

  • Cellular Processes: Cell-level mechanisms (apoptosis, autophagy, cell cycle dysregulation, inflammation, etc.)

    Search first: Gene Ontology (GO), Reactome, KEGG, PubMed

  • Protein Dysfunction: How protein structure or function is altered (misfolding, aggregation, loss of function, gain of function)

    Search first: UniProt, PDB (Protein Data Bank), InterPro, Pfam, AlphaFold

  • Metabolic Changes: Alterations in metabolic processes (energy metabolism, lipid metabolism, amino acid metabolism)

    Search first: KEGG, BioCyc, HMDB (Human Metabolome Database), BRENDA

  • Immune System Involvement: Role of immune response (autoimmunity, immunodeficiency, chronic inflammation)

    Search first: ImmPort, Immunome Database, IEDB, Gene Ontology

  • Tissue Damage Mechanisms: How tissues/ are injured (oxidative stress, ischemia, fibrosis, necrosis)

    Search first: PubMed, Gene Ontology, Reactome

  • Biochemical Abnormalities: Specific molecular defects (enzyme deficiencies, receptor dysfunction, ion channel defects)

    Search first: BRENDA, UniProt, KEGG, OMIM, PubMed

  • Epigenetic Changes: DNA methylation, histone modifications affecting gene expression in disease

    Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth

  • Molecular Profiling (if available):
  • Transcriptomics/gene expression changes > Search first: GEO (Gene Expression Omnibus), ArrayExpress, GTEx, Human Cell Atlas, SRA
  • Proteomics findings > Search first: PRIDE, ProteomeXchange, Human Protein Atlas, STRING, BioGRID
  • Metabolomics signatures > Search first: MetaboLights, Metabolomics Workbench, HMDB, METLIN
  • Lipidomics alterations > Search first: LIPID MAPS, SwissLipids, LipidHome, Metabolomics Workbench
  • Genomic structural features > Search first: UCSC Genome Browser, Ensembl, NCBI, dbVar, DGV
  • Advanced Technologies (if applicable):
  • Single-cell analysis findings (cell-type specific mechanisms, cellular heterogeneity) > Search first: Human Cell Atlas, Single Cell Portal, GEO, CELLxGENE
  • Spatial transcriptomics findings > Search first: GEO, Spatial Research, Vizgen, 10x Genomics data
  • Multi-omics integration results > Search first: TCGA, ICGC, cBioPortal, LinkedOmics, PubMed
  • Functional genomics screens (CRISPR, RNAi) > Search first: DepMap, GenomeRNAi, PubMed, BioGRID ORCS

For each mechanism, describe: - The causal chain from initial trigger to clinical manifestation - Which mechanisms are upstream vs downstream - What cell types and biological processes are involved - Suggest GO terms for biological processes and CL terms for cell types

7. Anatomical Structures Affected

  • Organ Level:
  • Primary organs directly affected
  • Secondary organ involvement (complications, secondary effects)
  • Body systems involved (cardiovascular, nervous, digestive, respiratory, endocrine, etc.)

    Search first: Uberon, FMA (Foundational Model of Anatomy), OMIM, HPO, ICD-11, MeSH, SNOMED CT

  • Tissue and Cell Level:
  • Specific tissue types affected (epithelial, connective, muscle, nervous)
  • Specific cell populations targeted (with Cell Ontology terms)

    Search first: Uberon, Human Protein Atlas, Cell Ontology, Human Cell Atlas, CellMarker, PanglaoDB

  • Subcellular Level:
  • Cellular compartments involved (mitochondria, nucleus, ER, lysosomes) (with GO Cellular Component terms)

    Search first: Gene Ontology (Cellular Component), UniProt, Human Protein Atlas

  • Localization:
  • Specific anatomical sites (with UBERON terms) > Search first: FMA, Uberon, NeuroNames (for brain), SNOMED CT
  • Lateralization (unilateral, bilateral, asymmetric) > Search first: HPO, clinical literature, imaging databases

8. Temporal Development

  • Onset:
  • Typical age of onset (congenital, pediatric, adult, geriatric)
  • Onset pattern (acute, subacute, chronic, insidious)

    Search first: OMIM, Orphanet, HPO, PubMed

  • Progression:
  • Disease stages (early, intermediate, advanced, end-stage) > Search first: Cancer Staging Manual (AJCC), WHO classifications, PubMed
  • Progression rate (rapid, slow, variable)
  • Disease course pattern (episodic, relapsing-remitting, progressive, stable)
  • Disease duration (self-limited, chronic lifelong)

    Search first: Disease registries, longitudinal cohort databases, natural history studies, PubMed, Orphanet, OMIM

  • Patterns:
  • Remission patterns (spontaneous, treatment-induced) > Search first: Clinical trial databases, disease registries, PubMed
  • Critical periods (time windows of vulnerability or opportunity for intervention) > Search first: PubMed, developmental biology databases, clinical guidelines

9. Inheritance and Population

  • Epidemiology:
  • Prevalence (cases per 100,000 at given time)
  • Incidence (new cases per 100,000 per year)

    Search first: Orphanet, CDC, WHO, GBD (Global Burden of Disease), national registries, SEER, disease registries

  • For Genetic Etiology:
  • Inheritance pattern (AD, AR, X-linked, mitochondrial, multifactorial, polygenic) > Search first: OMIM, Orphanet, ClinVar, GTR (Genetic Testing Registry)
  • Penetrance (complete, incomplete, age-dependent) > Search first: ClinVar, OMIM, PubMed, ClinGen
  • Expressivity (variable, consistent) > Search first: OMIM, ClinVar, PubMed
  • Genetic anticipation (increasing severity in successive generations) > Search first: OMIM, PubMed (especially for repeat expansion disorders)
  • Germline mosaicism > Search first: ClinVar, OMIM, genetic counseling literature, PubMed
  • Founder effects (population-specific mutations) > Search first: gnomAD, population genetics databases, PubMed
  • Consanguinity role > Search first: OMIM, population studies, genetic counseling resources
  • Carrier frequency > Search first: gnomAD, carrier screening databases, GeneReviews, GTR
  • Population Demographics:
  • Affected populations (ethnic or demographic groups with higher prevalence) > Search first: gnomAD, 1000 Genomes, PAGE Study, PubMed, population registries
  • Geographic distribution (endemic areas, regional variation) > Search first: WHO, CDC, GBD, Orphanet, geographic epidemiology databases
  • Geographic distribution of specific variants
  • Sex ratio (male:female) > Search first: Disease registries, OMIM, PubMed, epidemiological databases
  • Age distribution of affected individuals > Search first: CDC, disease registries, SEER, Orphanet

10. Diagnostics

  • Clinical Tests:
  • Laboratory tests (blood, urine, tissue chemistry, specific enzyme assays) > Search first: LOINC, LabTests Online, PubMed
  • Biomarkers (proteins, metabolites, genetic markers, circulating biomarkers) > Search first: FDA Biomarker List, BEST (Biomarkers, EndpointS, and other Tools), PubMed
  • Imaging studies (X-ray, CT, MRI, PET, ultrasound) > Search first: RadLex, DICOM, Radiopaedia, imaging databases
  • Functional tests (pulmonary function, cardiac stress tests) > Search first: LOINC, clinical guidelines, PubMed
  • Electrophysiology (EEG, EMG, ECG, nerve conduction studies) > Search first: LOINC, clinical neurophysiology databases, PubMed
  • Biopsy findings (histopathology, immunohistochemistry) > Search first: SNOMED CT, College of American Pathologists resources, PubMed
  • Pathology findings (microscopic examination) > Search first: SNOMED CT, Digital Pathology databases, PubMed
  • Genetic Testing:

    Search first: GTR (Genetic Testing Registry), GeneReviews, ClinGen

  • Overview of recommended genetic testing approach
  • Whole genome sequencing (WGS) utility > Search first: GTR, ClinVar, GEL (Genomics England), gnomAD
  • Whole exome sequencing (WES) utility > Search first: GTR, ClinVar, OMIM, GeneMatcher
  • Gene panels (which panels, which genes) > Search first: GTR, ClinVar, laboratory-specific databases
  • Single gene testing > Search first: GTR, ClinVar, OMIM, GeneReviews
  • Chromosomal microarray (CMA) > Search first: DECIPHER, ClinVar, dbVar, ECARUCA
  • Karyotyping > Search first: Chromosome Abnormality Database, ClinVar, cytogenetics resources
  • FISH > Search first: ClinVar, cytogenetics databases, PubMed
  • Mitochondrial DNA testing > Search first: MITOMAP, MSeqDR, ClinVar, GTR
  • Repeat expansion testing > Search first: GTR, ClinVar, repeat expansion databases, PubMed
  • Omics-Based Diagnostics (if applicable):
  • RNA sequencing / transcriptomics > Search first: GEO, ArrayExpress, GTEx, RNA-seq databases
  • Proteomics > Search first: PRIDE, ProteomeXchange, FDA Biomarker database
  • Metabolomics > Search first: MetaboLights, Metabolomics Workbench, HMDB
  • Epigenomics > Search first: GEO, ENCODE, Roadmap Epigenomics, MethBase
  • Liquid biopsy > Search first: COSMIC, ClinVar, liquid biopsy databases, PubMed
  • Clinical Criteria:
  • Standardized diagnostic criteria (DSM, ICD, society guidelines) > Search first: DSM-5, ICD-11, clinical society guidelines, UpToDate
  • Differential diagnosis (other conditions to rule out, with distinguishing features) > Search first: DynaMed, UpToDate, clinical decision support systems
  • Screening:
  • Screening methods for asymptomatic individuals (newborn screening, carrier screening, cascade screening) > Search first: ACMG recommendations, CDC newborn screening, GTR

11. Outcome/Prognosis

  • Survival and Mortality:
  • Survival rate (5-year, 10-year, overall) > Search first: SEER, cancer registries, disease-specific registries, PubMed
  • Life expectancy (with and without treatment if applicable) > Search first: Orphanet, disease registries, actuarial databases, PubMed
  • Mortality rate > Search first: CDC, WHO, GBD, national mortality databases
  • Disease-specific mortality (deaths directly attributable to disease) > Search first: Disease registries, CDC Wonder, GBD, PubMed
  • Morbidity and Function:
  • Morbidity (disease-related disability and health impacts) > Search first: GBD, WHO, disability databases, PubMed
  • Disability outcomes (long-term functional impairments) > Search first: ICF (International Classification of Functioning), disability registries
  • Quality of life measures (EQ-5D, SF-36, PROMIS, disease-specific tools) > Search first: EQ-5D database, SF-36, PROMIS, PubMed
  • Disease Course:
  • Complications (secondary problems: infections, organ failure, etc.) > Search first: ICD codes, disease registries, clinical databases, PubMed
  • Recovery potential (likelihood and extent of recovery, with vs without treatment) > Search first: Natural history studies, rehabilitation databases, PubMed
  • Prediction:
  • Prognostic factors (age, disease severity, biomarkers, treatment response) > Search first: Prognostic models databases, clinical calculators, PubMed
  • Prognostic biomarkers (molecular markers predicting disease course) > Search first: FDA Biomarker database, PubMed, cancer prognostic databases

12. Treatment

  • Pharmacotherapy:
  • Pharmacological treatments (drug names, drug classes, mechanisms of action) > Search first: DrugBank, RxNorm, ATC classification, DailyMed, FDA databases
  • Pharmacogenomics (how genetic variants affect drug metabolism, efficacy, toxicity) > Search first: PharmGKB, CPIC (Clinical Pharmacogenetics), FDA Table of PGx Biomarkers
  • Advanced Therapeutics:
  • Gene therapy (viral vectors, CRISPR, gene replacement, gene editing) > Search first: ClinicalTrials.gov, FDA gene therapy database, ASGCT resources
  • Cell therapy (stem cell transplant, CAR-T, cellular therapeutics) > Search first: ClinicalTrials.gov, FDA cell therapy database, FACT standards
  • RNA-based therapies (ASOs, siRNA, mRNA therapies) > Search first: ClinicalTrials.gov, FDA approvals, PubMed
  • Targeted therapies (treatments directed at specific molecular targets) > Search first: My Cancer Genome, OncoKB, ClinicalTrials.gov, FDA approvals
  • Immunotherapies (checkpoint inhibitors, monoclonal antibodies) > Search first: Cancer Immunotherapy Database, FDA approvals, ClinicalTrials.gov
  • Surgical and Interventional:
  • Surgical interventions (types of surgery, timing, outcomes) > Search first: CPT codes, surgical registries, clinical guidelines, PubMed
  • Supportive and Rehabilitative:
  • Supportive care (symptom management, pain control, nutrition) > Search first: Clinical guidelines, Cochrane Library, PubMed
  • Rehabilitation (physical therapy, occupational therapy, speech therapy) > Search first: Rehabilitation medicine databases, clinical guidelines, PubMed
  • Experimental:
  • Experimental treatments in clinical trials (with NCT identifiers if available) > Search first: ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP
  • Treatment Outcomes:
  • Treatment response rates > Search first: Clinical trial databases, FDA reviews, systematic reviews, PubMed
  • Side effects and adverse events > Search first: FDA Adverse Event Reporting System (FAERS), MedWatch, PubMed
  • Treatment Strategy:
  • Treatment algorithms (clinical pathways, decision trees) > Search first: Clinical practice guidelines, NCCN Guidelines, UpToDate
  • Combination therapies > Search first: ClinicalTrials.gov, treatment guidelines, PubMed
  • Personalized medicine approaches (genotype-guided treatment) > Search first: My Cancer Genome, CIViC, PharmGKB, precision medicine databases

For each treatment, suggest NCIT (NCI Thesaurus) clinical-intervention terms where applicable.

13. Prevention

  • Prevention Levels:
  • Primary prevention (preventing disease occurrence: vaccination, risk factor modification) > Search first: CDC, WHO, USPSTF recommendations, Cochrane Library
  • Secondary prevention (early detection and treatment: screening programs, early intervention) > Search first: USPSTF, CDC screening guidelines, WHO
  • Tertiary prevention (preventing complications in those with disease) > Search first: Clinical guidelines, disease management protocols, PubMed
  • Immunization: Vaccine strategies (if applicable)

    Search first: CDC vaccine schedules, WHO immunization, FDA vaccine database

  • Screening and Early Detection:
  • Screening programs (population-based: newborn screening, cancer screening) > Search first: CDC screening programs, USPSTF, cancer screening databases
  • Genetic screening (carrier screening, preimplantation genetic diagnosis, prenatal testing) > Search first: ACMG recommendations, ACOG guidelines, GTR
  • Risk stratification (identifying high-risk individuals for targeted prevention) > Search first: Risk prediction models, clinical calculators, PubMed
  • Behavioral Interventions: Lifestyle modifications to reduce risk

    Search first: CDC, WHO, behavioral intervention databases, Cochrane Library

  • Counseling: Genetic counseling (risk assessment, family planning guidance)

    Search first: NSGC resources, ACMG guidelines, GeneReviews

  • Public Health:
  • Public health interventions (sanitation, vector control, health education) > Search first: CDC, WHO, public health databases, PubMed
  • Environmental interventions (reducing environmental risk factors) > Search first: EPA databases, WHO environmental health, PubMed
  • Prophylaxis: Preventive medications or procedures

    Search first: Clinical guidelines, FDA approvals, PubMed

14. Other Species / Natural Disease

  • Taxonomy: Species affected (with NCBI Taxon identifiers)

    Search first: NCBI Taxonomy

  • Breed: Specific breeds affected (with VBO identifiers if applicable)

    Search first: VBO (Vertebrate Breed Ontology)

  • Gene: Orthologous genes in other species (with NCBI Gene IDs)

    Search first: NCBI Gene

  • Natural Disease:
  • Naturally occurring disease in other species (companion animals, wildlife) > Search first: OMIA (Online Mendelian Inheritance in Animals), VetCompass, PubMed
  • Veterinary relevance and importance in animal health > Search first: OMIA, veterinary databases, PubMed
  • Comparative Biology:
  • Comparative pathology (similarities and differences across species) > Search first: OMIA, comparative pathology databases, PubMed
  • Evolutionary conservation of disease mechanisms > Search first: HomoloGene, OrthoMCL, Alliance of Genome Resources
  • Transmission (if applicable):
  • Zoonotic potential > Search first: CDC zoonotic diseases, WHO zoonoses, GIDEON
  • Cross-species susceptibility > Search first: NCBI Taxonomy, veterinary databases, PubMed

15. Model Organisms

  • Model Types:
  • Model organism type (mammalian, invertebrate, cellular, in vitro) > Search first: Alliance of Genome Resources, model organism databases
  • Specific model systems (mouse, rat, zebrafish, Drosophila, C. elegans, yeast, cell lines, organoids, iPSCs) > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, SGD, ATCC, Cellosaurus
  • Induced models (drug treatment, surgical intervention, environmental manipulation) > Search first: MGI, model organism databases, PubMed
  • Genetic Models:
  • Types available (knockout, knock-in, transgenic, conditional, humanized) > Search first: MGI, IMPC, KOMP, EuMMCR, IMSR
  • Model Characteristics:
  • Phenotype recapitulation (how well model reproduces human disease features) > Search first: Model organism databases, comparative studies, PubMed
  • Model limitations (aspects of human disease not captured) > Search first: Model organism databases, PubMed, review articles
  • Applications:
  • Research applications (what aspects of disease can be studied) > Search first: Model organism databases, PubMed
  • Resources:
  • Model databases > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, IMSR, EMMA, MMRRC

Citation Requirements

  • Cite primary literature (PMID preferred) for all mechanistic and clinical claims
  • Prioritize recent reviews and landmark papers
  • Include direct quotes from abstracts where possible to support key statements
  • Distinguish evidence source types: human clinical, model organism, in vitro, computational

Output Format

Structure your response as a comprehensive narrative organized by the sections above. For each section, provide: - Factual content with specific details (numbers, percentages, gene names, variant nomenclature) - Ontology term suggestions (HPO, GO, CL, UBERON, CHEBI, NCIT, MONDO) where applicable - Evidence citations with PMIDs - Direct quotes from abstracts to support key claims - Clear indication when information is not available or not applicable for this disease

This report will be used to populate a disease knowledge base entry with: - Pathophysiology descriptions with causal chains - Gene/protein annotations (HGNC, GO terms) - Phenotype associations (HP terms) with frequencies - Cell type involvement (CL terms) - Anatomical locations (UBERON terms) - Chemical entities (CHEBI terms) - Treatment annotations (NCIT terms) - Evidence items with PMIDs and exact abstract quotes - Epidemiology, prognosis, diagnostic, and prevention information - Animal model descriptions with phenotype recapitulation details

Bilateral Microtia–Deafness–Cleft Palate Syndrome

Executive summary

Bilateral microtia–deafness–cleft palate syndrome is an exceptionally rare congenital Mendelian disorder caused, in its defining family, by a homozygous missense variant in HOXA2. It is characterized by bilateral Marx type II microtia, prelingual symmetric severe-to-profound mixed hearing impairment, and partial/incomplete cleft palate. The entire syndrome-specific evidence base consists essentially of four affected relatives in one consanguineous Iranian family reported in 2008; unilateral cochlear absence was found in one person. Consequently, pedigree fractions must not be interpreted as population frequencies, and prevalence, penetrance outside that family, prognosis, and treatment-response statistics remain unknown. The association is catalogued as MONDO:0012854 and linked to HOXA2 in contemporary disease–target resources. (alasti2009geneticsofmicrotia pages 11-14, alasti2009geneticsofmicrotia pages 18-20, OpenTargets Search: Bilateral microtia-deafness-cleft palate syndrome-HOXA2)

Domain Syndrome-specific established evidence Evidence basis Confidence/limitations
Identity Bilateral microtia-deafness-cleft palate syndrome; MONDO:0012854; HOXA2-associated Mendelian disorder. Disease–target aggregation identifies HOXA2 as the sole associated target (OpenTargets Search: Bilateral microtia-deafness-cleft palate syndrome-HOXA2). High for MONDO identity and HOXA2 association; other identifiers should not be inferred without direct database confirmation.
Human evidence base Reported in one consanguineous Iranian pedigree with four affected individuals. Original family report and subsequent HOX-disorder review (alasti2009geneticsofmicrotia pages 11-14, alasti2009geneticsofmicrotia pages 18-20). Very limited: four relatives from one family; percentages calculated from this pedigree are not population frequencies.
Genetics Autosomal-recessive segregation of homozygous HOXA2 p.Gln186Lys (p.Q186K), affecting a highly conserved homeodomain residue. Primary linkage and sequencing study (alasti2009geneticsofmicrotia pages 11-14, alasti2009geneticsofmicrotia pages 18-20). Strong segregation evidence in the original pedigree; historical variant interpretation predates current ACMG/AMP criteria, so a contemporary laboratory should reassess classification and transcript-level HGVS nomenclature.
Mapping and functional support Linked to chromosome 7p14.3–p15.3 with maximum multipoint LOD 4.17; p.Q186K was absent from 231 Iranian and 109 Belgian controls. Structural modeling predicted loss of a homeodomain–DNA phosphate hydrogen bond and altered DNA binding. Primary human genetic and computational study (alasti2009geneticsofmicrotia pages 11-14). Strong linkage and rarity evidence; protein effect was modeled computationally rather than demonstrated with a syndrome-specific cellular functional assay.
Core phenotype Congenital bilateral Marx type II microtia, prelingual symmetric severe-to-profound mixed hearing impairment, and partial/incomplete cleft palate. Original report summarized in authoritative review (alasti2009geneticsofmicrotia pages 11-14). High within the pedigree; penetrance and expressivity in unrelated families remain unknown.
Inner-ear involvement Unilateral cochlear absence occurred in one affected individual, showing that inner-ear involvement is possible in addition to predominant external- and middle-ear disease. Human clinical/imaging observation (alasti2009geneticsofmicrotia pages 11-14). Moderate; single-patient observation and not a reliable frequency estimate.
Mechanism Reduced HOXA2 homeobox transcription-factor function is inferred to impair second-pharyngeal-arch cranial-neural-crest identity and patterning, leading to malformed pinna and middle-ear skeletal structures; abnormal palate development provides a route to cleft palate. Human variant modeling plus Hoxa2 mouse developmental studies (alasti2009geneticsofmicrotia pages 11-14, cox2014thegeneticsof pages 3-3, alasti2009geneticsofmicrotia pages 5-8). Biologically compelling but partly inferred; the complete molecular chain has not been demonstrated in patient-derived cells or tissues.
Mouse-model evidence Hoxa2-deficient mice lack pinnae, have transformed or duplicated middle-ear skeletal elements and a wide secondary-palate cleft, and die shortly after birth; ectopic expression experiments establish a dosage-sensitive role in pharyngeal-arch identity. Knockout/ developmental evidence summarized in reviews and primary-model literature (alasti2009geneticsofmicrotia pages 11-14, cox2014thegeneticsof pages 3-3, cox2014thegeneticsof pages 3-4). Strong developmental evidence, but null-mouse lethality and severity exceed the surviving human missense phenotype.
Diagnosis Molecular confirmation should identify biallelic HOXA2 variants after detailed craniofacial examination and audiologic assessment; diagnostic ABR should be performed by 2–3 months, with air- and bone-conduction thresholds. Temporal-bone CT/MRI is selected according to age, anatomy, suspected inner-ear disease, and surgical planning. HOXA2 family evidence plus general microtia/atresia expert guidance (truong2022integratedmicrotiaand pages 4-6, truong2022integratedmicrotiaand pages 2-4, paul2021congenitalabnormalitiesassociated pages 3-3). Genetic testing is syndrome-directed; audiologic and imaging pathways are extrapolated because no syndrome-specific diagnostic guideline exists.
Management Phenotype-directed multidisciplinary care may include early amplification and speech/language intervention, bone-conduction hearing systems when appropriate, anatomy-dependent atresia/hearing surgery, cleft-palate repair and speech therapy, and coordinated auricular reconstruction. General microtia/atresia consensus and integrated-care recommendations (truong2022integratedmicrotiaand pages 4-6, zhang2019internationalconsensusrecommendations pages 2-3, truong2022integratedmicrotiaand pages 16-17, truong2022integratedmicrotiaand pages 1-2). No HOXA2-specific outcome data; treatment must account for the mixed hearing loss and possible cochlear aplasia rather than assuming isolated conductive loss.
Epidemiology and natural history Syndrome-specific prevalence, incidence, carrier frequency, sex ratio, life expectancy, and longitudinal progression are unknown. Only one pedigree has established the recessive syndromic phenotype (alasti2009geneticsofmicrotia pages 11-14, alasti2009geneticsofmicrotia pages 18-20). Very low epidemiologic certainty; general microtia prevalence or sex ratios must not be assigned to this syndrome.
Disease-modifying therapy and trials No established pharmacologic, gene, RNA, or cell therapy and no syndrome-specific interventional trial were identified; current care treats hearing, palate, speech, and reconstructive consequences. Available disease evidence and microtia management literature (OpenTargets Search: Bilateral microtia-deafness-cleft palate syndrome-HOXA2, truong2022integratedmicrotiaand pages 4-6, zhang2019internationalconsensusrecommendations pages 2-3). Search-dependent negative finding; broader ear-reconstruction or hearing-device studies are not evidence for correction of the HOXA2 developmental lesion.
2024 development A distant approximately 600-kb craniofacial global control region was shown to interact with anterior HOXA genes; deletion in mice produced highly penetrant skull defects and orofacial clefts resembling Hoxa2-null phenotypes, while human copy-number changes were associated with severe craniofacial abnormalities. Human embryonic epigenomics, mouse deletion experiments, and human CNV cases (wilderman2024adistantglobal pages 13-13, wilderman2024adistantglobal pages 1-2). Important HOXA regulatory insight, but not direct evidence that this control region causes the named p.Q186K recessive syndrome or changes current treatment.

Table: This table separates observations established in the single reported HOXA2-associated pedigree from mouse-mechanistic evidence and clinical guidance extrapolated from broader microtia, hearing-loss, and cleft-care literature.

Evidence-grading note

In this report, direct evidence means observations from the original human family; supportive human evidence means other HOXA2-related microtia families; model evidence means principally mouse developmental experiments; and extrapolated care means guidance for microtia/aural atresia, congenital hearing loss, or cleft palate generally. This distinction is essential because no syndrome-specific cohort, guideline, therapeutic trial, patient-derived model, or longitudinal natural-history study was identified.

1. Disease information

Definition and nomenclature

The disorder is a congenital craniofacial and auditory developmental syndrome comprising:

  • bilateral microtia, reported as Marx type II;
  • congenital/prelingual, symmetric, severe-to-profound mixed hearing impairment; and
  • partial or incomplete cleft palate.

The original article’s abstract described “a consanguineous Iranian family segregating with autosomal-recessive bilateral microtia, mixed symmetrical severe to profound hearing impairment, and partial cleft palate.” The report was published in April 2008 in The American Journal of Human Genetics as Alasti et al., “A Mutation in HOXA2 Is Responsible for Autosomal-Recessive Microtia in an Iranian Family,” DOI: https://doi.org/10.1016/j.ajhg.2008.03.014, PMID 18394579. An erratum appeared in September 2008, DOI: https://doi.org/10.1016/j.ajhg.2008.08.014; it did not alter the principal genetic result. (alasti2009geneticsofmicrotia pages 18-20, alasti2008amutationin pages 1-1)

Identifiers

  • MONDO: MONDO:0012854.
  • OMIM phenotype: commonly catalogued as Microtia, hearing impairment, and cleft palate / bilateral microtia–deafness–cleft palate syndrome; MIM 612290 is reported in secondary disease tables. Because the retrieved primary evidence did not reproduce the live OMIM record, database curators should verify the current preferred title and number before import.
  • Gene: HOXA2, homeobox A2; Ensembl ENSG00000105996. Open Targets identifies HOXA2 as the sole associated target for MONDO:0012854. (OpenTargets Search: Bilateral microtia-deafness-cleft palate syndrome-HOXA2)
  • Orphanet: no syndrome-specific ORPHA number was confirmed in the retrieved evidence.
  • ICD-10/ICD-11 and MeSH: no unique syndrome-specific code or heading was identified. Component abnormalities should be coded separately rather than assigning a broader syndrome code without verification.

Common names include bilateral microtia-deafness-cleft palate syndrome, HOXA2-related autosomal-recessive microtia, and microtia, hearing impairment, and cleft palate. “HOXA2-related disorder” is broader and also includes autosomal-dominant, usually nonsyndromic microtia with variable hearing impairment; those dominant conditions should not be merged with this recessive phenotype. Supportive reports show that heterozygous HOXA2 loss-of-function can cause dominant bilateral microtia and variable hearing loss without the defining cleft-palate phenotype. (meddaugh2020novelhoxa2variant pages 3-3)

The evidence is aggregated disease-level literature derived from a small family study, not EHR-derived individual-patient data.

2. Etiology

Causal factor

The defining cause is a germline homozygous HOXA2 homeodomain missense variant, p.Gln186Lys (p.Q186K), segregating recessively in the Iranian pedigree. Genome-wide linkage mapped the locus to 7p14.3–p15.3, with a maximum multipoint LOD score of 4.17. The variant was absent from 231 Iranian and 109 Belgian controls—680 control chromosomes if all were diploid and unrelated. Structural modeling predicted displacement of the mutant lysine side chain from a DNA phosphate group, loss of a hydrogen bond, and impaired DNA-binding activity. (alasti2009geneticsofmicrotia pages 11-14)

A commonly reported transcript-level rendering is c.557A>C (p.Gln186Lys), but clinical laboratories should normalize HGVS against the current MANE transcript rather than copying historical nomenclature uncritically. The original interpretation predates ACMG/AMP standards. The combination of strong linkage, recessive segregation, absence from controls, conservation, phenotype concordance, and model support is compelling, but the retrieved evidence did not show a patient-cell transcription assay. Thus, pathogenic/likely pathogenic reassessment in a current clinical laboratory is preferable to treating the historical label as an automatically current ClinVar classification.

Risk factors

  • Genetic: biallelic pathogenic HOXA2 variation; consanguinity increased the probability of homozygosity in the original family.
  • Family history: an affected sibling or similarly affected relative is a major diagnostic clue.
  • Environmental, infectious, lifestyle, maternal-age, sex, and occupational risks: none have been demonstrated for this molecularly defined syndrome.
  • Modifier genes: none established. BMP4, BMP5 and TWSG1 have been investigated within Hoxa2-regulated auricular programs, but they are not validated modifiers of the human p.Gln186Lys syndrome. (sparascio2017studyofmolecular pages 16-20)

General microtia studies discuss maternal/perinatal and environmental associations, but those data must not be assigned to this single-gene syndrome. General microtia prevalence and associated-anomaly figures likewise do not estimate this syndrome’s incidence. (llanos2023riskfactorsfor pages 5-7, wahdini2024genotypephenotypeassociationsin pages 14-16)

Protective factors and gene–environment interaction

No protective allele, diet, exposure, medication, or lifestyle intervention is known. No syndrome-specific gene–environment interaction has been demonstrated. Standard avoidance of recognized teratogens is sound prenatal practice but is not proven to prevent HOXA2-associated disease.

3. Phenotypes

All principal findings are congenital, although hearing impairment may be documented only after newborn screening or diagnostic audiology.

Phenotype Type and characteristics Frequency evidence Suggested HPO term
Bilateral Marx type II microtia Physical sign; congenital, stable structural malformation; severity substantial but short of anotia Core finding in the four reported relatives; not a population frequency Bilateral microtia, HP:0008551; Microtia, HP:0008551—verify the current bilateral child term/version
Mixed hearing impairment Functional sign; prelingual, symmetric, severe-to-profound; likely lifelong without habilitation Core family phenotype Mixed hearing impairment, HP:0000410; Severe hearing impairment, HP:0012715; Profound hearing impairment, HP:0012714; Congenital hearing impairment, HP:0008527
Partial/incomplete cleft palate Congenital physical sign; stable anatomical defect until repaired Core family phenotype Cleft palate, HP:0000175; Incomplete cleft palate—use current HPO child term if available
Unilateral cochlear aplasia Imaging/anatomical abnormality; congenital, nonprogressive One of four reported patients, but 1/4 is not a generalizable frequency Absent cochlea, HP:0011372; Unilateral abnormality qualifier where supported
External/middle-ear malformation Structural correlate inferred from microtia and mixed conductive component; directly emphasized in the clinical review Predominant affected auditory compartments; exact person-level frequency unavailable Abnormal external ear morphology, HP:0000356; Abnormal middle ear morphology, HP:0000370

The literature does not establish developmental delay, intellectual disability, seizures, renal disease, cardiac disease, immunodeficiency, or metabolic abnormalities as features of this syndrome. These should not be added based merely on broader syndromic-microtia differentials.

Quality-of-life consequences

No syndrome-specific EQ-5D, SF-36, PROMIS, speech, educational, or psychosocial data exist. Expected burdens include impaired access to spoken language from bilateral severe/profound prelingual hearing loss, feeding and speech difficulties from cleft palate, repeated procedures, and appearance-related psychosocial stress. These are extrapolations. A 2023 narrative review of 64 microtia/craniofacial-microsomia studies found care stressful from diagnosis, possible social and language risks, and generally high satisfaction after reconstruction/canaloplasty; it did not study this HOXA2 syndrome specifically.

4. Genetic and molecular information

HOXA2 encodes a nuclear homeobox transcription factor that binds DNA through its homeodomain and specifies positional identity during craniofacial development. The disease allele is germline, not somatic. No recurrent founder allele, carrier frequency, gnomAD frequency, or additional unrelated recessive family with the full triad was established in the retrieved evidence.

The p.Gln186Lys substitution affects a highly conserved residue in the DNA-binding homeodomain. Its modeled effect—loss of a DNA-contact hydrogen bond—supports reduced transcription-factor function. Complete biochemical loss of function, gain of function, or dominant-negative activity was not directly demonstrated in patient cells; the recessive inheritance and mouse loss-of-function concordance favor a hypomorphic/loss-of-function mechanism. (alasti2009geneticsofmicrotia pages 11-14)

Other heterozygous nonsense/frameshift HOXA2 alleles cause dominant microtia with variable hearing impairment, demonstrating dosage sensitivity but a distinguishable phenotype and inheritance pattern. Reported dominant alleles include truncating variants around Glu224, Glu229, and Gln235; these are useful differential evidence, not variants causing the defining recessive syndrome. (meddaugh2020novelhoxa2variant pages 3-3)

No syndrome-specific:

  • modifier gene;
  • DNA-methylation “episignature”;
  • histone/chromatin biomarker;
  • pathogenic aneuploidy, translocation, or inversion;
  • somatic variant;
  • repeat expansion; or
  • mitochondrial lesion

has been reported.

A 2024 study identified an approximately 600-kb noncoding global control region between NPVF and NFE2L3 that interacts over long distances with anterior HOXA genes in human and mouse embryonic craniofacial tissue. Mouse deletion caused perinatal lethality, skull defects, and highly penetrant orofacial clefts resembling Hoxa2-null phenotypes; two humans with de novo copy-number changes had severe craniofacial abnormalities. This is important evidence for HOXA regulatory architecture, but it is not evidence that those CNVs cause MONDO:0012854, nor does it reclassify p.Gln186Lys. (wilderman2024adistantglobal pages 13-13, wilderman2024adistantglobal pages 1-2)

5. Environmental information

No toxin, radiation exposure, pollution source, infection, diet, smoking, alcohol exposure, or other lifestyle factor has been shown to cause or modify this HOXA2 syndrome. It is noninfectious and nontransmissible. Environmental associations reported for microtia overall concern etiologically heterogeneous cases and cannot be causally imported into this Mendelian entry.

6. Mechanism and pathophysiology

Ordered causal chain

  1. Homozygous HOXA2 p.Gln186Lys leads to alteration of a conserved homeodomain residue.
  2. The altered homeodomain is predicted to lead to loss of a DNA-contact hydrogen bond and reduced/abnormal DNA binding; this step is computationally supported rather than demonstrated in patient cells. (alasti2009geneticsofmicrotia pages 11-14)
  3. Reduced HOXA2 transcriptional function is inferred to lead to defective positional specification and patterning of rhombomere-4-derived cranial neural crest populating the second pharyngeal arch.
  4. Defective second-arch identity leads to abnormal proliferation/differentiation and homeotic patterning of neural-crest-derived auricular and middle-ear mesenchyme.
  5. Auricular-patterning failure results in bilateral microtia; middle-ear skeletal malformation results in a major conductive component of hearing loss. Mouse experiments strongly support these branches. (cox2014thegeneticsof pages 3-3, cox2014thegeneticsof pages 3-4, alasti2009geneticsofmicrotia pages 5-8)
  6. A parallel or downstream disturbance of otic development results in a sensorineural component and, in one human, unilateral cochlear aplasia; the exact human cellular route is not demonstrated.
  7. Abnormal HOXA2-dependent palatal growth/patterning leads to incomplete fusion of the secondary palate and partial cleft palate; this is supported strongly by Hoxa2-null mice and inferred for humans. (alasti2009geneticsofmicrotia pages 11-14)
  8. The combined ear and palate lesions result in congenital craniofacial difference, severe-to-profound prelingual mixed hearing loss, and risks to feeding, speech, language, education, and psychosocial well-being.

Pathway and cellular detail

HOXA2 is better understood as a developmental transcriptional identity regulator than as a component of one canonical kinase cascade. Its critical context is the HOX regulatory network in cranial neural crest and pharyngeal-arch mesenchyme. Proposed downstream auricular effectors include BMP4, BMP5, and TWSG1, linking HOXA2 to BMP-dependent cartilage proliferation and differentiation, but their exact contribution to the human syndrome is unproven. (sparascio2017studyofmolecular pages 16-20)

Relevant suggested ontology annotations include:

  • GO biological process: anterior/posterior pattern specification (GO:0009952); embryonic cranial skeleton morphogenesis (GO:0048701); neural crest cell development (GO:0014032); pharyngeal system development (GO:0060037); ear morphogenesis (GO:0042471); palate development (GO:0060021); regulation of transcription by RNA polymerase II (GO:0006357).
  • GO molecular function: sequence-specific DNA-binding transcription-factor activity (use the current HOX-specific child term); DNA binding (GO:0003677).
  • GO cellular component: nucleus (GO:0005634); transcription regulator complex (GO:0005667, where experimentally appropriate).
  • Cell Ontology: neural crest cell (CL:0000333); cranial neural crest cell—use current CL term if available; chondrocyte (CL:0000138); osteoblast (CL:0000062); fibroblast (CL:0000057); otic epithelial and palatal mesenchymal cells require version-checked mappings.

There is no evidence for primary inflammation, autoimmunity, immunodeficiency, fibrosis, ischemia, enzyme deficiency, channelopathy, or systemic metabolic disturbance. No syndrome-specific patient transcriptome, proteome, metabolome, lipidome, single-cell atlas, spatial transcriptome, CRISPR screen, organoid, or multi-omics profile was identified. Broader 2024 microtia cartilage studies reporting noncoding-RNA and extracellular-matrix signatures used nonsyndromic tissue and should not be annotated as HOXA2-syndrome molecular profiles.

7. Anatomical structures affected

Primary sites are the bilateral auricles/pinnae, external and middle auditory apparatus, palate, and potentially inner ear/cochlea. The external and middle ear derive substantially from first- and second-pharyngeal-arch structures, whereas the inner ear has otic-placode origins. HOXA2 is especially important in second-arch cranial-neural-crest mesenchyme; mixed arch origins help explain why some auricular substructures, such as the tragus, may be relatively spared. (cox2014thegeneticsof pages 3-4, alasti2009geneticsofmicrotia pages 5-8)

Suggested anatomical mappings:

  • auricle/pinna — UBERON:0001757;
  • external ear — UBERON current external-ear term;
  • middle ear — UBERON:0001756;
  • auditory ossicle — UBERON:0001684;
  • cochlea — UBERON:0001844;
  • secondary palate — UBERON:0001717;
  • second pharyngeal arch — use the current UBERON developmental-structure term;
  • cranial neural crest — use the current UBERON/CL developmental mapping.

Subcellular dysfunction is centered on the nucleus and DNA-bound transcriptional regulatory complexes. Lateralization is bilateral for microtia and reported hearing impairment; cochlear aplasia was unilateral in one individual.

8. Temporal development

The initiating defect acts during embryonic craniofacial organogenesis, particularly pharyngeal-arch, auricular, ossicular, otic, and palatal development. The anatomical malformations are congenital and structurally stable rather than inflammatory, episodic, or relapsing.

Hearing impairment is congenital/prelingual and expected to be lifelong, although its functional impact can improve markedly with early amplification, surgery when anatomically suitable, and communication intervention. Cleft palate persists until repaired; residual velopharyngeal, speech, dental, or otologic problems can continue afterward. No syndrome-specific stages, progression rate, remission pattern, or adult natural history have been documented.

Critical clinical windows are early infancy for objective hearing diagnosis and amplification, infancy for feeding and palate planning, early childhood for speech/language intervention, and later childhood for anatomy-dependent auditory and auricular reconstruction. These windows derive from general care standards, not a HOXA2-specific trial. (truong2022integratedmicrotiaand pages 4-6, truong2022integratedmicrotiaand pages 2-4)

9. Inheritance and population

Inheritance in the defining pedigree is autosomal recessive. For two heterozygous carrier parents, standard Mendelian counseling gives each pregnancy a 25% probability of an affected child, 50% probability of an unaffected carrier, and 25% probability of inheriting neither familial allele, assuming full genotype penetrance. Actual penetrance of p.Gln186Lys cannot be estimated independently from one pedigree.

Only four affected individuals from one consanguineous Iranian family were reported in the available HOX-disorder literature. There are no defensible syndrome-specific estimates of prevalence, incidence, sex ratio, carrier frequency, geographic distribution, age distribution, founder effect, germline-mosaicism rate, or reproductive fitness. (alasti2009geneticsofmicrotia pages 11-14, alasti2009geneticsofmicrotia pages 18-20)

General microtia estimates—such as 0.8–17.5 per 10,000 births, male predominance, or mainly unilateral disease—describe heterogeneous microtia and must not populate this syndrome’s epidemiology fields. A 2024 systematic review included 1,459 microtia patients across 40 phenotype papers but did not establish syndrome-specific population statistics for the recessive HOXA2 triad. (wahdini2024genotypephenotypeassociationsin pages 14-16)

Anticipation is not expected for a missense allele and has not been observed. Variable expressivity is suggested by cochlear aplasia in only one relative, but precise penetrance and expressivity remain unknown.

10. Diagnostics

Clinical evaluation

Diagnosis begins with congenital bilateral microtia plus objective bilateral hearing loss and cleft-palate examination. Infants with microtia/atresia should be referred directly to pediatric audiology regardless of newborn-screening outcome. Diagnostic auditory brainstem response should ideally be completed by two months and no later than three months, including air- and bone-conduction thresholds and masked bone conduction where feasible. Tympanometry and otoacoustic emissions should be performed where anatomy permits, followed by behavioral audiometry from approximately six months and regular monitoring through early childhood. These recommendations are extrapolated from expert microtia/atresia guidance. (truong2022integratedmicrotiaand pages 4-6, truong2022integratedmicrotiaand pages 2-4)

Temporal-bone high-resolution noncontrast CT defines canal, ossicular, middle-ear, and cochlear anatomy and is useful for reconstructive candidacy. Routine CT is often deferred until approximately age five or until operative planning, limiting radiation exposure; earlier imaging may be justified for sensorineural loss, suspected cholesteatoma/fistula, or major inner-ear disease. Diffusion-weighted MRI is useful when cholesteatoma is suspected, and MRI is important for cochlear nerve and membranous-labyrinth assessment when cochlear implantation is considered. (truong2022integratedmicrotiaand pages 4-6, paul2021congenitalabnormalitiesassociated pages 3-3)

Cleft evaluation should include feeding, airway, otologic, speech-language, dental/orthodontic, and velopharyngeal assessment. No blood chemistry, urine test, enzyme assay, biopsy, metabolite, or circulating biomarker diagnoses the syndrome.

Genetic testing strategy

  1. In a patient with the defining triad and recessive pedigree, perform sequence analysis of HOXA2 with deletion/duplication analysis.
  2. A comprehensive hearing-loss/craniofacial-malformation panel including HOXA2 is reasonable when the phenotype is less specific.
  3. Trio WES or WGS is preferred when targeted testing is negative, when additional anomalies suggest another syndrome, or when noncoding/structural variation is suspected.
  4. Chromosomal microarray is useful for multiple congenital anomalies or concern for CNVs, including 22q11.2 deletion and regulatory rearrangements; it does not reliably detect a small HOXA2 missense variant.
  5. Karyotype/FISH are reserved for cytogenetically indicated cases. Mitochondrial and repeat-expansion testing are not routinely indicated.

Familial variants require Sanger or equivalent orthogonal confirmation and segregation analysis. RNA sequencing is not an established diagnostic test for p.Gln186Lys, although it may help investigate splice or regulatory variants in unresolved cases.

Differential diagnosis

Important alternatives include:

  • Autosomal-dominant HOXA2-related microtia: vertical transmission, often nonsyndromic and without cleft palate.
  • Treacher Collins syndrome: TCOF1/POLR1D/POLR1C-related mandibulofacial dysostosis, malar/mandibular hypoplasia and eyelid findings.
  • Nager syndrome: mandibulofacial dysostosis plus preaxial upper-limb defects.
  • 22q11.2 deletion syndrome: palatal defect with cardiac, immune, calcium, and characteristic craniofacial findings.
  • Branchio-oto-renal spectrum: branchial anomalies, preauricular pits and renal disease.
  • HOXA1-related disorder: horizontal-gaze palsy, brainstem/autonomic and cardiovascular findings, and sensorineural deafness.
  • Craniofacial microsomia/OAV spectrum: facial asymmetry, epibulbar dermoids and vertebral abnormalities.
  • Diamond–Blackfan anemia-associated craniofacial disease: macrocytic anemia/red-cell aplasia.

There are no standardized syndrome-specific clinical diagnostic criteria; molecular confirmation is therefore important.

Screening

This syndrome is not part of routine biochemical newborn screening. Applicable measures are universal newborn hearing screening, immediate diagnostic follow-up, and cascade testing for the familial HOXA2 variant. Carrier, prenatal, and preimplantation testing are technically possible once the familial pathogenic variant is established.

11. Outcome and prognosis

No survival curves, mortality rates, life-expectancy estimates, hospitalization rates, or validated prognostic biomarkers exist. The four reported human patients survived beyond the neonatal period, unlike Hoxa2-null mice; therefore, mouse neonatal lethality should not be assigned to affected humans. (alasti2009geneticsofmicrotia pages 11-14)

Likely long-term morbidity is auditory-communication disability, reconstructive burden, and cleft-associated feeding, speech, dental, and psychosocial effects. Prognosis depends more on anatomy and access/timing of habilitation than on a demonstrated progressive molecular process. Particularly relevant prognostic features include residual cochlear and cochlear-nerve anatomy, bone-conduction thresholds, middle-ear anatomy, device use, age at intervention, palate repair result, and access to speech/language and educational services. No molecular marker predicts severity.

12. Treatment

There is no therapy that reverses the embryonic HOXA2 lesion. Care is individualized and multidisciplinary, involving clinical genetics, pediatric otolaryngology, audiology, cleft/craniofacial surgery, plastic surgery, speech-language pathology, dentistry/orthodontics, pediatrics, psychology, and educational services. Close coordination is essential because canal/hearing surgery can affect later auricular reconstruction. (zhang2019internationalconsensusrecommendations pages 2-3, truong2022integratedmicrotiaand pages 1-2)

Hearing and communication

For bilateral disease, expert guidance recommends diagnostic assessment by 2–3 months, amplification by about 4 months, and early intervention by 3–6 months. Nonimplantable bone-conduction systems—softband BAHA/Ponto-type processors or adhesive systems—are common early options where cochlear function is adequate. Because the syndrome causes mixed, not necessarily purely conductive, loss and can include cochlear aplasia, treatment must be based on ear-specific air/bone thresholds and imaging. Cochlear implantation may be considered only when sensorineural loss is severe/profound and a stimulable cochlea/cochlear nerve is present; unilateral cochlear absence can make that side unsuitable. (truong2022integratedmicrotiaand pages 4-6, silva2023taskforceguideline pages 2-3)

Atresiaplasty or middle-ear reconstruction requires adequate inner-ear function and favorable anatomy. International consensus supports the Jahrsdoerfer CT scale and generally considers a score of at least 7 favorable. Implantable bone-conduction or middle-ear devices are typically considered after approximately age five, depending on device approval, skull thickness, anatomy, and local practice. (zhang2019internationalconsensusrecommendations pages 2-3)

Suggested NCIt concepts include Hearing Aid Device, Bone Conduction Hearing Device, Cochlear Implantation, Auditory Rehabilitation, and Speech Therapy; exact NCIt codes should be version-checked.

Palate and speech

Primary palatoplasty is generally performed during infancy within an accredited cleft pathway, followed by surveillance for fistula, velopharyngeal dysfunction, otitis media, hearing deterioration, dentofacial growth, and articulation. Speech-language therapy is often required. Exact timing and technique should follow the treating cleft team’s protocol; no HOXA2-specific comparison exists.

Auricular reconstruction

Options include autologous costal cartilage reconstruction, porous polyethylene framework, or an adhesive/osseointegrated prosthesis. Consensus sources place autologous cartilage reconstruction approximately from 5–9 years onward, often around nine years when rib cartilage is adequate; porous polyethylene may be considered after about five years. Canal surgery should be sequenced with the reconstruction method—generally before polyethylene reconstruction but after or combined with rib-cartilage reconstruction. (zhang2019internationalconsensusrecommendations pages 2-3, truong2022integratedmicrotiaand pages 16-17)

Pharmacotherapy and advanced therapeutics

No disease-specific drug, pharmacogenomic recommendation, gene therapy, genome editing, RNA therapy, cell therapy, immunotherapy, or targeted molecular therapy exists. Medicines are used only for routine perioperative care, otitis, pain, or other complications.

Trials

No interventional trial specifically for MONDO:0012854 or HOXA2 p.Gln186Lys was identified. Trials of hearing devices or ear reconstruction in heterogeneous microtia/ear-aplasia populations are not disease-modifying and cannot supply syndrome-specific response rates.

13. Prevention

Because the disorder is inherited, lifestyle modification, vaccination, sanitation, and prophylactic medication cannot prevent expression in a fetus who inherits the causal biallelic genotype.

  • Primary prevention: nondirective genetic counseling; carrier testing of at-risk relatives; reproductive options including prenatal diagnosis and preimplantation genetic testing for the known familial variant.
  • Secondary prevention: newborn hearing screening followed by rapid diagnostic ABR, molecular diagnosis, amplification, and early communication intervention. These prevent avoidable developmental consequences, not the congenital malformations.
  • Tertiary prevention: palate repair, hearing habilitation, speech-language therapy, dental/orthodontic care, psychosocial and educational support, and surveillance for ear-canal or reconstructive complications.

For carrier parents, recurrence counseling is 25% per pregnancy under standard autosomal-recessive assumptions. Testing should be accompanied by counseling about uncertain phenotype prediction, especially the risk of inner-ear involvement.

14. Other species and natural disease

No naturally occurring animal disease proven to reproduce the complete human bilateral microtia–deafness–cleft-palate syndrome from the orthologous p.Gln186Lys allele was identified. There is no zoonotic or cross-species transmission.

The most relevant ortholog is mouse Hoxa2 in Mus musculus (NCBI Taxonomy 10090). HOXA2 function is evolutionarily conserved in vertebrate craniofacial patterning. Other animal microtia caused by distinct genes or enhancer duplications may inform auricular morphogenesis but should not be represented as natural HOXA2 syndrome.

15. Model organisms

Mouse models

Hoxa2-null mice lack the external pinna, exhibit transformations/duplications of middle-ear bones, and develop a wide secondary-palate cleft. They die within about 24 hours, probably because the cleft prevents effective feeding. These models strongly recapitulate the affected anatomical systems but are more severe than the surviving human missense phenotype. (alasti2009geneticsofmicrotia pages 11-14)

Lineage and ectopic-expression experiments establish that Hoxa2 specifies second-pharyngeal-arch identity in cranial-neural-crest-derived mesenchyme. Loss produces homeotic transformation and duplicated first-arch-like skeletal elements; ectopic first-arch expression can produce mirror-image auricular duplication. These models are useful for dissecting pinna, auditory-meatus, ossicle, and palate morphogenesis. (cox2014thegeneticsof pages 3-3, alasti2009geneticsofmicrotia pages 5-8)

Dosage experiments also show that cranial neural crest is highly sensitive to Hoxa2 level: ectopic expression at approximately 60% of normal second-arch levels was sufficient for pinna duplication, while higher levels produced progressively broader homeotic or destructive craniofacial phenotypes. This supports dosage sensitivity but does not quantify residual activity of human p.Gln186Lys.

Advanced models and limitations

The 2024 global-control-region deletion mouse provides a regulatory model for anterior HOXA insufficiency and orofacial clefting, not a precise knock-in model of the human missense allele. (wilderman2024adistantglobal pages 1-2)

No syndrome-specific p.Gln186Lys knock-in mouse, zebrafish model, patient-derived fibroblast/iPSC line, cranial-neural-crest culture, ear organoid, palate organoid, or CRISPR rescue study was identified. A priority model would be an isogenic human iPSC pair differentiated into cranial neural crest and chondro-osteogenic derivatives, coupled to HOXA2 occupancy and target-gene assays. Such work could distinguish partial loss of DNA binding from altered target specificity and test why the human phenotype is viable whereas complete mouse loss is lethal.

Recent developments and research priorities

The most important 2023–2024 development is not a new treatment but recognition that anterior HOXA expression depends on distant, tissue-specific regulatory architecture. Human embryonic craniofacial epigenomics and mouse deletion experiments now show that noncoding structural variants far from HOXA2 can perturb the same developmental program. Meanwhile, a 2024 systematic review confirmed substantial genetic heterogeneity across microtia and concluded that more complete genotype–phenotype datasets are needed. These findings support using WGS and CNV analysis in unresolved cases, but they do not expand the proven case count for the defining recessive syndrome. (wilderman2024adistantglobal pages 13-13, wilderman2024adistantglobal pages 1-2, wahdini2024genotypephenotypeassociationsin pages 14-16)

The highest-priority knowledge gaps are: identification of unrelated biallelic HOXA2 cases; contemporary ACMG/AMP curation and population-frequency analysis of p.Gln186Lys; standardized deep phenotyping of auditory canals, ossicles, cochleae and palate; long-term hearing, speech, educational and psychosocial outcomes; and patient-derived functional models. Until such data exist, the disease knowledge-base entry should prominently state “ultra-rare; evidence based on one family; frequencies and prognosis unknown.”

References

  1. (alasti2009geneticsofmicrotia pages 11-14): F Alasti and G Van Camp. Genetics of microtia and associated syndromes. Mar 2009. URL: https://doi.org/10.1136/jmg.2008.062158, doi:10.1136/jmg.2008.062158. This article has 222 citations and is from a domain leading peer-reviewed journal.

  2. (alasti2009geneticsofmicrotia pages 18-20): F Alasti and G Van Camp. Genetics of microtia and associated syndromes. Mar 2009. URL: https://doi.org/10.1136/jmg.2008.062158, doi:10.1136/jmg.2008.062158. This article has 222 citations and is from a domain leading peer-reviewed journal.

  3. (OpenTargets Search: Bilateral microtia-deafness-cleft palate syndrome-HOXA2): Open Targets Query (Bilateral microtia-deafness-cleft palate syndrome-HOXA2, 1 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

  4. (cox2014thegeneticsof pages 3-3): Timothy C. Cox, Esra D. Camci, Siddharth Vora, Daniela V. Luquetti, and Eric E. Turner. The genetics of auricular development and malformation: new findings in model systems driving future directions for microtia research. European journal of medical genetics, 57 8:394-401, Aug 2014. URL: https://doi.org/10.1016/j.ejmg.2014.05.003, doi:10.1016/j.ejmg.2014.05.003. This article has 125 citations and is from a peer-reviewed journal.

  5. (alasti2009geneticsofmicrotia pages 5-8): F Alasti and G Van Camp. Genetics of microtia and associated syndromes. Mar 2009. URL: https://doi.org/10.1136/jmg.2008.062158, doi:10.1136/jmg.2008.062158. This article has 222 citations and is from a domain leading peer-reviewed journal.

  6. (cox2014thegeneticsof pages 3-4): Timothy C. Cox, Esra D. Camci, Siddharth Vora, Daniela V. Luquetti, and Eric E. Turner. The genetics of auricular development and malformation: new findings in model systems driving future directions for microtia research. European journal of medical genetics, 57 8:394-401, Aug 2014. URL: https://doi.org/10.1016/j.ejmg.2014.05.003, doi:10.1016/j.ejmg.2014.05.003. This article has 125 citations and is from a peer-reviewed journal.

  7. (truong2022integratedmicrotiaand pages 4-6): Mai Thy Truong, Yi-Chun Carol Liu, Jocelyn Kohn, Sivakumar Chinnadurai, David A. Zopf, Melissa Tribble, Paul B. Tanner, Kathleen Sie, and Kay W. Chang. Integrated microtia and aural atresia management. Frontiers in Surgery, Dec 2022. URL: https://doi.org/10.3389/fsurg.2022.944223, doi:10.3389/fsurg.2022.944223. This article has 39 citations.

  8. (truong2022integratedmicrotiaand pages 2-4): Mai Thy Truong, Yi-Chun Carol Liu, Jocelyn Kohn, Sivakumar Chinnadurai, David A. Zopf, Melissa Tribble, Paul B. Tanner, Kathleen Sie, and Kay W. Chang. Integrated microtia and aural atresia management. Frontiers in Surgery, Dec 2022. URL: https://doi.org/10.3389/fsurg.2022.944223, doi:10.3389/fsurg.2022.944223. This article has 39 citations.

  9. (paul2021congenitalabnormalitiesassociated pages 3-3): Antoine Paul, Sophie Achard, François Simon, Nicolas Garcelon, Erea Noel Garabedian, Vincent Couloigner, Charlotte Celerier, and Françoise Denoyelle. Congenital abnormalities associated with microtia: a 10-years retrospective study. Jul 2021. URL: https://doi.org/10.1016/j.ijporl.2021.110764, doi:10.1016/j.ijporl.2021.110764. This article has 24 citations and is from a peer-reviewed journal.

  10. (zhang2019internationalconsensusrecommendations pages 2-3): Tian-yu Zhang, Neil Bulstrode, Kay W. Chang, Yang-Sun Cho, Henning Frenzel, Dan Jiang, Bradley W. Kesser, Ralf Siegert, and Jean-Michel Triglia. International consensus recommendations on microtia, aural atresia and functional ear reconstruction. Aug 2019. URL: https://doi.org/10.5152/iao.2019.7383, doi:10.5152/iao.2019.7383. This article has 175 citations and is from a peer-reviewed journal.

  11. (truong2022integratedmicrotiaand pages 16-17): Mai Thy Truong, Yi-Chun Carol Liu, Jocelyn Kohn, Sivakumar Chinnadurai, David A. Zopf, Melissa Tribble, Paul B. Tanner, Kathleen Sie, and Kay W. Chang. Integrated microtia and aural atresia management. Frontiers in Surgery, Dec 2022. URL: https://doi.org/10.3389/fsurg.2022.944223, doi:10.3389/fsurg.2022.944223. This article has 39 citations.

  12. (truong2022integratedmicrotiaand pages 1-2): Mai Thy Truong, Yi-Chun Carol Liu, Jocelyn Kohn, Sivakumar Chinnadurai, David A. Zopf, Melissa Tribble, Paul B. Tanner, Kathleen Sie, and Kay W. Chang. Integrated microtia and aural atresia management. Frontiers in Surgery, Dec 2022. URL: https://doi.org/10.3389/fsurg.2022.944223, doi:10.3389/fsurg.2022.944223. This article has 39 citations.

  13. (wilderman2024adistantglobal pages 13-13): Andrea Wilderman, Eva D’haene, Machteld Baetens, Tara N. Yankee, Emma Wentworth Winchester, Nicole Glidden, Ellen Roets, Jo Van Dorpe, Sandra Janssens, Danny E. Miller, Miranda Galey, Kari M. Brown, Rolf W. Stottmann, Sarah Vergult, K. Nicole Weaver, Samantha A. Brugmann, Timothy C. Cox, and Justin Cotney. A distant global control region is essential for normal expression of anterior hoxa genes during mouse and human craniofacial development. Nature Communications, Jan 2024. URL: https://doi.org/10.1038/s41467-023-44506-2, doi:10.1038/s41467-023-44506-2. This article has 20 citations and is from a highest quality peer-reviewed journal.

  14. (wilderman2024adistantglobal pages 1-2): Andrea Wilderman, Eva D’haene, Machteld Baetens, Tara N. Yankee, Emma Wentworth Winchester, Nicole Glidden, Ellen Roets, Jo Van Dorpe, Sandra Janssens, Danny E. Miller, Miranda Galey, Kari M. Brown, Rolf W. Stottmann, Sarah Vergult, K. Nicole Weaver, Samantha A. Brugmann, Timothy C. Cox, and Justin Cotney. A distant global control region is essential for normal expression of anterior hoxa genes during mouse and human craniofacial development. Nature Communications, Jan 2024. URL: https://doi.org/10.1038/s41467-023-44506-2, doi:10.1038/s41467-023-44506-2. This article has 20 citations and is from a highest quality peer-reviewed journal.

  15. (alasti2008amutationin pages 1-1): Fatemeh Alasti, Abdorrahim Sadeghi, Mohammad Hossein Sanati, Mohammad Farhadi, Elliot Stollar, Thomas Somers, and Guy Van Camp. A mutation in hoxa2 is responsible for autosomal-recessive microtia in an iranian family. Sep 2008. URL: https://doi.org/10.1016/j.ajhg.2008.08.014, doi:10.1016/j.ajhg.2008.08.014. This article has 141 citations.

  16. (meddaugh2020novelhoxa2variant pages 3-3): Hannah R. Meddaugh and Regina M. Zambrano. Novel hoxa2 variant presenting with microtia and variable hearing impairment in four-generation pedigree. Clinical Dysmorphology, 29:104-106, Apr 2020. URL: https://doi.org/10.1097/mcd.0000000000000297, doi:10.1097/mcd.0000000000000297. This article has 6 citations and is from a peer-reviewed journal.

  17. (sparascio2017studyofmolecular pages 16-20): F Piceci Sparascio. Study of molecular basis of oculo-auricolo-vertebral-spectrum. Unknown journal, 2017.

  18. (llanos2023riskfactorsfor pages 5-7): Sheyla Teresa Navas Llanos and Carmen Barba Guzmán Variña. Risk factors for microtia and preventive approaches. Sapienza: International Journal of Interdisciplinary Studies, 4:e23046, Sep 2023. URL: https://doi.org/10.51798/sijis.v4isi1.707, doi:10.51798/sijis.v4isi1.707. This article has 2 citations.

  19. (wahdini2024genotypephenotypeassociationsin pages 14-16): Siti Isya Wahdini, Fina Idamatussilmi, Rachmaniar Pramanasari, Almas Nur Prawoto, Citrawati Dyah Kencono Wungu, Indri Lakhsmi Putri, and Gunadi. Genotype-phenotype associations in microtia: a systematic review. Orphanet Journal of Rare Diseases, Apr 2024. URL: https://doi.org/10.1186/s13023-024-03142-9, doi:10.1186/s13023-024-03142-9. This article has 17 citations and is from a peer-reviewed journal.

  20. (silva2023taskforceguideline pages 2-3): VAR Silva, HF Pauna, and J Lavinsky. Task force guideline of brazilian society of otology–hearing loss in children–part ii–treatment. Unknown journal, 2023.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 11
Resolved 11
Unresolved (possible confabulation) 0
Unverifiable 0
References weighed for topical relevance 11
On topic 2
Off topic 1

References that may not be about this subject

These identifiers resolve, so they are not fabrications, but the records they resolve to share almost none of this report's vocabulary. That is a clue and not a verdict - a paper can be relevant in ways its title and abstract do not spell out - so read them before deciding:

  • DOI:10.5152/iao.2019.7383 (3 mentions) - International Consensus Recommendations on Microtia, Aural Atresia and Functional Ear Reconstruction
  • shared terms: microtia

Weighed against this report's own most characteristic terms: disease, microtia, hoxa2, palate, syndrome, clinical, hearing, human, gene, genetic, bilateral, cleft, phenotype, loss, model, variant, affected, syndrome-specific, molecular, diagnostic.

All extracted references resolved successfully. Resolving is not the same as being relevant, though - see the references listed above as possibly off topic.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 29
Resolved 29
Unresolved (possible confabulation) 0
Obsolete 0
Unverifiable 0
Terms whose name was checked 2
Terms named correctly 0
Terms named as a different term 0
Terms whose name is worth a second look 2

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

  • GO:0009952 (1 mention) - the report calls it "GO biological process: anterior/posterior pattern specification"; GO calls it anterior/posterior pattern specification**
  • GO:0005634 (1 mention) - the report calls it "GO cellular component: nucleus"; GO calls it nucleus**, and lists "cell nucleus" among its other names

Every term resolved, and every label the report gave matched.